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Abstract 
In our centre, we had developed nanovibrational bioreactor generating 
nanoscale vibration by piezo actuator for bone tissue engineering. 
Recently, nanovibrational stimulation (NS; 30 nm at 1000 Hz) showed the 
success of osteogenic induction in mesenchymal stem cells (MSCs) seeded 
collagen hydrogel without chemical supplement. However, culturing 
MSCs in the collagen hydrogel for long term NS stimulation in NS 
bioreactor is challenging due to its mechanical properties. The principle 
aim of this thesis is to develop the scaffold for nanovibrational bioreactor 
which is suitable for surgical application. Three strategies including in-
gel scaffolds, collagen concentration optimization and genipin 
crosslinking were trialled which aimed to improve hydrogel stiffness and 
handleability, possess biocompatibility and allow NS force transmission. 
The role of high amplitude stimulation (90 nm at 1000 Hz) on 3D 
osteogenesis was also studied. Interestingly, increasing NS amplitude 
successfully enhanced 3D osteogenesis through multiple pathways and it 
was biologically safe. Metabolomics during NS revealed the evidence of 
low level of reactive oxygen species production and inflammation which 
was controlled in physiological level through multiple intracellular 
signals such as redox balancing, NFκB and MAPK pathways. 
To propose the technique how to use NS induced MSCs for clinics, MSCs 
seeded biphasic scaffolds compositing collagen hydrogels and freeze 
dried collagen sponges were developed. Cell-hydrogel-sponge composite 
(CHSC) was reproducible, handleable and biologically safe. CHSC allowed 
a good fidelity of NS. NS with high amplitude stimulation successfully 
induced 3D osteogenesis. NS protocol in CHSC was optimized in order to 
identify a stimulating duration which can induce osteogenesis without 
phenotypic reversibility. Interestingly, two-week stimulation possibly 
committed MSCs in the preosteoblast stage.  
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Definition and abbreviations 
Abbreviation Name Definitions and functions Chapters 
AA Arachidonic acid AA is a polyunsaturated omega-6 fatty 
acid converted from linoleic acid. AA is 
the precursor of eicosanoids which 
plays role in inflammation.  
5 
AC Adenylate cyclase Enzyme which is regulated by G 
proteins and calcium ions.  
4 
Acetyl-CoA Acetyl coenzyme A A molecule which is derived from 
carbohydrate, and fatty acid 
metabolism. Acetyl-CoA enters TCA 
cycle generating NADH and CO2. 
5 
ACC1 and 2 Acetyl-CoA carboxylases Enzyme converts acetyl-CoA to 
malonyl-CoA for fatty acid synthesis. 
5 
AKT Protein kinase B (PKB) AKT is serine/threonine-specific 
kinase. AKT controls cell survival, 
metabolism and NFκB. 
5 
ALP Alkaline phosphatase Enzyme which is present in many 
tissues including bone. ALP regulates 
phosphate ion initiating mineralization. 
1-6 
Atf6 Activating transcription 
factor 6 
Atf6 is an endoplasmic reticulum 
membrane-bound bZIP transcription 
factor. Atf6 plays role on osteogenesis 
by regulating RUNX2.  
4 
ATGL Activating adipose 
triglyceride lipase 
Enzyme, found in lipolysis, which 
breaks down triacylglycerol and 
promotes fatty acid oxidation. 
5 
ATP Adenosine triphosphate Organic chemical which provides 
energy. ATP is produced by glycolysis, 
TCA cycle and β-oxidation.  
1, 5 
AMPK AMP-activated protein 
kinase 
AMPK functions as energy sensor. AMPK 
activation promotes catabolism 
producing energy, syntheses anti-
oxidants as well as reduces anabolism.  
5 
BC β-catenin Protein which involves in many cellular 
pathways. In bone, with canonical 
Wnt, β-catenin promotes early phase 
of osteogenesis.  
1, 4, 5 
 
BMP2 Bone morphogenetic protein 
2 
Protein which plays role in bone 
development. 
1, 4, 5 
BMPR1a Bone morphogenetic protein 
receptor type 1A 
BMPs receptor which plays role in bone 
and cartilage development.  
4 
  
XXIV 
Abbreviation Name Definitions and functions Chapters 
β-oxidation Beta-oxidation 
The process which breakdowns fatty 
acid to produce acetyl-CoA in turn 
entering TCA cycle.  
5 
cAMP 
Cyclic adenosine 
monophosphate 
Molecule which is synthesised from ATP 
by AC. cAMP interacts with protein 
kinase A regulating TRP channels.  
4 
CaMKs 
Calmodulin-dependent 
kinase 
Enzyme which interacts with 
Ca2+/calmodulin (CaM) complex.  
Ca2+/CaM complex binds to CAMKII in 
turn activating AP-1 to promote 
osteoblast differentiation.  
4 
CaSR Calcium-sensing receptor 
G-protein coupled receptor which 
controls calcium homeostasis and 
extracellular calcium.  
5 
CD105 
Cluster of differentiation 
105 (Endoglin) 
CD105 is a co-receptor of TGF-β and 
also expresses in endothelial cells.  
1 
CD11b 
Cluster of differentiation 
11b (Integrin alpha M) 
Expresses in leukocytes.  1 
CD14 Cluster of differentiation 14 
CD14 is found in neutrophils, dendritic 
cells, and macrophages. 
1 
CD19 Cluster of differentiation 19 Expresses in B cell lymphocytes. 1 
CD34 Cluster of differentiation 34 
CD34 is found in hematopoietic cells, 
MSCs and endothelial progenitor cells 
1 
CD45 
Cluster of differentiation 45 
(protein tyrosine 
phosphatase receptor type 
C; PTPRC) 
Commonly found in leukocytes. 1 
CD73 
Cluster of differentiation 73 
(5’-nucleotidase; NT5E) 
Expressed by stromal cells, dendritic 
cells and lymphocyte.  
1 
CD79 Cluster of differentiation 79 Expresses on B cell lymphocytes.  1 
CD90 Cluster of differentiation 90 
Found in non-lymphoid tissues e.g. 
neuron cells, fibroblasts, myoblast, 
and endothelial cells.  
1 
CDK Cyclin dependent kinase 
Protein kinase plays role in cell cycle 
regulation. ROS can also activate CDK. 
5 
Col1A1 Collagen type I alpha 1 
ECM protein which is found in 
cartilage, bone and tendon. 
1, 4 
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Abbreviation Name Definitions and functions Chapters 
COX Cyclooxygenase 
Enzyme which catalyses arachidonic 
acid to prostanoids e.g. thromboxanes 
and prostaglandins. 
5 
DAG diacylglycerol 
Secondary messenger which can 
activate PKC in turn regulating calcium 
ion channels.   
4 
DAMPs 
Damaged-associated 
molecular patterns 
Molecules which are produced by 
injured cells for noninfectious 
inflammatory response. 
5 
DHA 
Docosahexaenoic acid 
 
DHA (omega-3 fatty acid; 22:6(n-3)) is 
synthesised (by elongation and 
desaturation) from alpha-linolenic 
acid. DHA is converted from DPA and 
EPA. 
5 
Dlx5 Distal-less homeobox 5 
Transcription factor plays role in 
osteogenesis.  
4 
DPA Docopentaenoic acid 
Omega-3 fatty acid consists of 22 
carbons and 5 double bonds (22:5).  
5 
ECM Extracellular matrix 
Networks, produced by cells, which 
provide microenvironment to support 
cells.  
1-6 
EPA Eicosapentaenoic acid 
Omega-3 fatty acid consists of 20 
carbons and 5 double bonds (20:5). EPA 
is elongated by Δ5 elongase to produce 
DPA.   
5 
ERK1/2 
Extracellular signal-
regulated kinase 1 and 2 
ERK1/2 (MAPK members) is involved in 
many cellular processes such as 
proliferation, differentiation and 
migration.  
1, 2, 4, 
5 
ESCs Embryonic stem cells 
Pluipotent stem cells which are 
derived from blastocyst after 
fertilization.  
1 
FAK Focal adhesion kinase 
Tyrosine kinase which plays role in 
integrin signaling.  
1, 5 
Fas - 
Fas or CD95 (APO-1) is a member of 
TNFs. Fas links to cytoskeleton. 
5 
FGF2 Fibroblast growth factor 2 
Growth factor which is not only 
involved in many cell activities but also 
important for bone regeneration. 
1 
FHL2 
Four and a half LIM domains 
protein 2 
Protein which can interact with Wnt/β-
catenin pathway in turn promoting 
RUNX2 expression. 
1 
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Abbreviation Name Definitions and functions Chapters 
FOXO Forkhead box, class O 
Transcription factor which regulates 
cellular stress and promote anti-
oxidation. FOXO is regulated by AMPK-
AKT pathway.  
5 
G3P shuttle 
Glycerol-3-phosphate 
shuttle 
Process which produces energy, 
generates NADH and bypasses complex 
I in electron transport chain. This 
shuttle links between glycolysis, 
lipogenesis and OXPHOS through G3P 
dehydrogenase (GPDH) enzyme. 
5 
GLUTs Glucose transporters 
Proteins promoting glucose 
transportation at cell membrane. 
5 
GPCRs G protein coupled receptors 
Receptors on cellular membrane which 
can recognize molecules such as 
ligands in turn activating intracellular 
signals. 
5 
GSH Glutathione 
GSH plays role as anti-oxidant via 
redox balancing. 
5 
GSK-3β 
Glycogen synthase kinase 3-
beta 
Serine/threonine kinase which involves 
in glycogen synthesis. GSK-3β can 
decrease RUNX2 expression and Wnt/β-
catenin. 
1 
GSSG Glutathione disulfide Oxidized form of GSH.  5 
Hh Hedgehog 
Protein which plays role in osteoblast 
differentiation. Hh consists of Shh 
(sonic), Ihh (indian) and Dhh (desert).  
1 
HIF1α 
Hypoxia-inducible factor 1-
alpha 
Transcription factor which plays role in 
MSCs differentiation and is regulated 
by oxygen condition.  
5 
HLA-DR 
Human leukocyte antigen- 
DR isotype 
Molecules which is found in antigen 
presenting cells and activated T-cells.  
1 
HMG-CoA 
reductase 
β-Hydroxy β-methylglutaryl-
CoA reductase 
Enzyme in mevalonate pathway which 
involves in cholesterol synthesis.  
5 
H2O2 Hydrogen peroxide 
Oxidizer which is used for oxidative 
stress induction. 
5 
IDO 
Indoleamine 2,3-
dioxygenase 
Enzyme which promotes tryptophan 
degradation. IDO reduces inflammatory 
response and inactivates T-cell 
function. 
5 
IGF Insulin like growth factor 
Hormone which involves in 
proliferation and differentiation 
(including osteogenesis).  
5 
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Abbreviation Name Definitions and functions Chapters 
IκB 
Nuclear factor of kappa-
light-chain-enhancer of B-
cells inhibitor 
Protein which binds to NFkB to inhibit 
NFκB function in resting stage. IκB 
degradation allows NFκB nuclear 
translocation.  
1 
IKKs IκB kinases 
Enzyme of NFκB pathway consists of 
IKKα, and IKKβ. Phosphorylated IKK 
complex degrades IκB.   
1 
IL-1 Interleukin-1 
IL-1 plays role in inflammatory 
response commonly produced by 
inflammatory cells such as 
macrophages, monocytes and dendritic 
cells.  
1, 5, 7 
IL-6 Interleukin-6 
Cytokine which plays role in both pro- 
and anti-inflammation. MSC can also 
secrete IL-6 to convert monocytes to 
M2 macrophages  
1, 5,  7 
IL-10 Interleukin-10 
Cytokine which is produced by 
macrophage for anti-inflammatory 
effects. 
1, 5 
IL-11 Interleukin-11 
IL-11 involves in osteoclastogenesis, 
neurogenesis and hematopoitic effect.  
1 
IL-18 Interleukin-18 
Cytokine which involves in 
inflammation.  
1 
IP3 Inositol-1,4,5-triphosphate 
IP3 promotes calcium release from 
endoplasmic reticulum (ER) via IP3 
receptor. 
4 
Igβ1,5 Integrin β1, 5 
Cell membrane receptors play role in 
cell adhesion.  
4 
iPSCs 
Induce pluripotent stem 
cells 
Pluripotent stem cells which are 
derived from somatic cells through 
transduction process using Oct, SOX, 
Klf2 and Myc factors.  
1, 7 
JAKs Janus kinases 
Tyrosine kinases which play role in 
bone development.  
5 
JNKs c-Jun N-terminal kinases 
JNK (MAPK member) responds to 
oxidative stress.  
5 
KCNK 2 
Potassium channel 
subfamily K member 2 
(TREK1) 
Potassium channel which responds to 
mechanical stimuli.  
4 
KCNK 4 
Potassium channel 
subfamily K member 4 
(TRAAK1) 
Potassium channel which is found in 
neuron relating to mechanical 
stimulation.  
4 
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LC-PUFAs 
Long chain polyunsaturated 
fatty acids 
Fatty acids (with 18 carbons or more) 
consisting of omega 3 and omega 6. LC-
PUFAs are precursors of eicosanoids.  
5 
LINC complex 
Linker of nucleus and 
cytoskeleton complex 
Proteins on nuclear membrane which 
consist of SUN (links to lamin) and 
nesprin (links to actin). 
1 
LOX Lipoxygenase 
Enzyme which catalyses AA or LC-
PUFAs to eicosanoids such as 
leukotrienes. 
5 
LR Lipid raft 
Plasma membrane which is composed 
of lipids, cholesterol and protein 
receptors. Clusters of protein 
receptors in LR provide signals 
responding to the environment. 
5 
LRP5 and 6 
Low-density lipoprotein-
related receptor-5 and -6 
Proteins on cellular membrane 
function as co-receptor of Frizzled 
receptor. LRPs sense to mechanical 
stimuli and activate Wnt canonical 
pathway.  
1, 4 
MAPK 
Mitogen-activated protein 
kinase 
MAPK (protein kinase) involves 
proliferation, differentiation, 
inflammation and apoptosis. MAPK 
consists of ERK1/2, JNK and p38.  
1, 4, 5 
MKP1 
Mitogen-activated protein 
kinase phosphatase 1 
Phosphatase enzyme which can 
downregulate MAPK signaling. MKP1 
plays role in transdifferentiation of 
preadipocyte to osteoblast.  
1 
MSCs Mesenchymal stem cells 
Multipotent stem cells which can 
differentiate to osteoblast, 
chondrocyte, adipocyte and fibroblast. 
MSCs can be found in adiposed tissue 
(AMSCs), bone marrow (BM-MSCs), and 
cord blood (CB-MSCs). 
1-7 
Msx2 MSh homeobox 2 
Transcription factor which promotes 
osteogenesis.  
4 
mTOR 
Mammalian target of 
rapamycin 
mTOR is a nutrient sensor for cells. 
mTOR is regulated by both AMPK and 
AKT thus balancing catabolic and 
anabolic pathways. mTOR plays role in 
growth function and survival. 
5 
NCX Na+/Ca2+ exchanger 
Ion channel on plasma membrane 
which allows sodium ion influx 
exchanged with calcium ion efflux.  
4 
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NCKX Na+/Ca2+-K+ exchanger 
Ion channel which allows sodium ion 
influx exchanged with calcium and 
potassium ion efflux. 
4 
NFκB 
Nuclear factor kappa-light-
chain-enhancer of activated 
B cells 
Transcription factor which is known as 
a stress sensor regulating immune 
responses and survival pathways. 
5 
NLRs NOD-like receptor 
Receptor in cytoplasm which 
recognises PAMPs and DAMPs  
5 
NLRP3 NOD-like receptor protein 3 
Receptor which senses to various 
inflammasomes and plays a role in 
immune system.  
5 
NO Nitric oxide 
Molecule which involves in cell 
proliferation, apoptosis and bone 
homeostasis.  
5 
NOS Nitric oxide synthase 
Enzyme produced endogenous NO. NOS 
can be found in endothelial cells 
(eNOS), central nervous system (nNOS), 
or induced by inflammation (iNOS).  
5 
NOX 
Nicotinamide adenine 
dinucleotide phosphate 
oxidase (NADPH oxidase) 
Enzyme on plasma membrane which 
catalyses NADPH to NADP which, in 
turn, produces ROS. 
5 
Nrf2 
Nuclear factor erythroid 2-
related factor2 
Transcription factor which promotes 
anti-oxidative enzyme synthesis such 
as SOD and heme oxygenase 1(HO-1). 
5 
OCN Osteocalcin 
OCN is an osteoblast secreted hormone 
which regulates bone mineralization.  
1-6 
Omega-3 - 
Polyunsaturated fatty acids with 3 
double bonds (such as α-linolenic acid 
and DHA).  
5 
Omega-6 - 
Polyunsaturated fatty acids with 6 
double bonds (such as linoleic acid and 
AA). 
5 
ON Osteonectin 
ON is an osteogenic marker protein 
which can bind to collagen and 
hydroxyapatite to trigger 
mineralization process.   
1-6 
OPG Osteoprotegerin 
Protein which can bind to RANKL to 
inhibit RANK-RANKL interaction. 
1 
OSX Osterix 
OSX is a transcription factor which can 
regulate osteoblast commitment.  
1-6 
  
XXX 
Abbreviation Name Definitions and functions Chapters 
OPN Osteopontin 
OPN is an extracellular matrix protein 
which can regulate mineralization and 
bone remodeling.  
1-6 
OXPHOS Oxidative phosphorylation 
The process of nutrient metabolism 
which produces ATP under aerobic 
condition in mitochondria.  
5 
P38 - 
MAPK member which responds to 
stress.  
1, 4, 5 
PAMPs 
Pathogen-associated 
molecular patterns 
Molecules on bacteria or endotoxin 
which can be recognized by TLRs.  
5 
PC 1 Polycystin 1 
PC1 is G-protein coupled receptor on 
cellular membrane. PC1 senses to fluid 
shear stress to regulate calcium ion 
channels.  
5 
PCL Polycarpolactone 
Biodegradable synthetic polymer which 
is commonly used in tissue 
engineering. 
1 
PDH Pyruvate dehydrogenase 
Enzyme which converts pyruvate to 
acetyl-CoA.  
5 
PDK1 
Pyruvate dehydrogenase 
kinase 1 
PDK1 is a HIF1α activated enzyme 
which can inactivate PDH.   
5 
PGE2 Prostaglandin E2 
Inflammatory mediator which is 
derived from AA.  
5 
PDGF 
Platelet-derived growth 
factor 
Growth factor which plays role in MSC 
differentiation and angiogenesis. PDGF 
is found during normal bone healing.  
1 
PGA Polyglycolic acid 
PGA is a widely used synthetic 
biomaterial (such as suture). PGA is 
degradable by hydrolysis.  
1 
PHDs Prolyl hydroxylases Enzyme which inhibits HIF1α. 5 
PI3K Phosphoinositide 3-kinase 
PI3Ks is an enzyme involving in cell 
functions. PI3Ks activates AKT in 
PI3K/AKT/mTOR pathway.  
5 
PIP2 
Phosphatidylinositol 4,5 –
bisphosphate 
PIP2 is a phospholipid of cell 
membrane. PIP2 is hydrolysed by PLC 
into DAG and IP3.  
4 
PKB Protein kinase B Refer to AKT.  5 
PKC Protein kinase C 
Enzyme which plays role in 
intracellular calcium signals. PKC is 
activated by DAG and calcium ions.  
1, 4, 5 
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PLA Polylactic acid 
Biodegradable material which is 
commonly used for 3D printing 
material.   
1 
PLC Phospholipase C 
Enzyme which hydrolyses PIP2 to DAG 
and inositol-1,4,5-triphosphate (IP3).  
4 
PLGA Poly (lactide-co-glycolide) 
Biodegradable material which is 
derived from glycolic acid and lactic 
acid.  
1 
PMCA 
Plasma membrane Ca2+ 
ATPase 
PMCA is a plasma membrane protein 
driving calcium efflux. PMCA plays role 
in maintaining calcium ion level in 
cytoplasm.   
4 
PPARγ 
Peroxisome proliferator-
activated receptor γ 
Master regulator of adipogenesis. 4 
PPP Pentose phosphate pathway 
PPP is a glucose pathway which 
converts glucose-6-phosphate to 
ribose-5-phosphate and produces 
NADPH.  
5 
RANK 
Receptor activator of 
nuclear factor kappa-B 
Osteoclast receptor which can bind to 
RANKL promoting osteoclast 
differentiation. 
5 
RANKL 
Receptor activator of 
nuclear factor kappa-B 
ligand 
Membrane protein on osteoblast binds 
to RANK (on osteoclast) and OPG. 
5 
Ras Rat sarcoma 
Ras is a protein which regulates 
cytoskeleton, migration, cell 
differentiation and proliferation. Ras 
activates MAPK pathway. 
5 
RGD Arg-Gly-Asp motif 
Amino acid on ECM (such as 
fibronectin) which plays role on cell 
attachment interacting with intergrins.  
1 
ROCK Rho-associated kinase 
ROCK is a kinase enzyme which plays 
role in cell migration and cytoskeleton. 
Rho family consists of Rho, Rac and 
Cdc42. 
1, 4, 5 
ROS Reactive oxygen species 
Oxygen derived molecules such as 
superoxide anion and hydrogen 
peroxide which is produced at 
mitochondria or cell membrane (via 
NADPH oxidase).  
1, 4, 5 
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Ror2 
Receptor tyrosine kinase-
like orphan receptor 2 
Tyrosine kinase receptor which plays 
role in bone homeostasis. Ror2 (on 
osteoclast) interacts with Wnt5a (from 
osteoblast) to promote 
osteoclastogenesis.   
1 
RUNX2 
Runt-related transcription 
factor 2 
Major transcription factor of 
osteogenesis.  
5 
RyR Ryanodine receptors 
Calcium ion channel on endoplasmic 
reticulum which releases calcium ion 
from storage to cytosol.  
4 
SERCA 
Sarco-endoplasmic reticular 
Ca2+-ATPase 
Ca2+ ATPase allows cytosolic calcium 
to storage in sarco- or endoplasmic 
reticulum. SERCA can be found in many 
cell types such as myocyte (most 
common), cardiocyte and monocyte. 
4 
SMAD1/5 - 
Proteins which involves in BMP 
canonical pathway for osteogenesis.  
1, 4, 5 
SMAD2/3 - 
With canonical TGF-β, SMAD2/3 
promotes early osteogenesis 
1 
SOD Superoxide dismutase 
SOD is an anti-oxidant enzyme which is 
found in cytoplasm (ZnSOD) and 
mitochondria (MnSOD). 
5 
Src Steroid receptor coactivator 
Src (intracellular tyrosine kinase) plays 
many roles in cellular responses. Src 
activates FAK phosphorylation. 
1 
STATs 
Signal transducer and 
activator of transcription 
proteins 
STATs are transcription factors 
regulating bone homeostasis and 
skeletal development as well as 
controlling MSC proliferation.  
5 
SVCT2 
Sodium dependent vitamin 
C transporter 2 
SVCT2 is a glycoprotein which plays 
role in ascorbic acid (vitamin C) 
transportation. 
1 
TAZ 
Transcriptional coactivator 
with PDZ-binding motif 
TAZ is an effector of Hippo signaling 
pathway and plays role in mechanical 
sensing and phenotypic memory.  
1, 4, 6 
TBC1D1 
Tre-2/USP6, BUB2, cdc16 
domain family member 1 
TBC1D1 is a protein regulating glucose 
transportation. AMPK increases glucose 
uptake via TBC1D1 phosphorylation in 
turn   promoting GLUT1 and 4 
membrane localization. 
5 
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TCA Tricarboxylic acid cycle 
Biochemical pathway which oxidizes 
Acetyl-CoA in order to generate NADH 
to enter OXPHOS for ATP production. 
5 
TGF-β 
Transforming growth factor 
beta 
Cytokine which promotes 
osteoprogenitor proliferation and early 
osteoblastic differentiation. 
5 
TLRs Toll-like receptor 
TLRs are membrane receptors on 
leukocyte. TLRs recognise to PAMPs in 
turn activating immune responses. 
5 
TNFα Tumor necrosis factor alpha 
Cytokine which involves inflammatory 
responses. TNFα inhibits osteoblast and 
promotes osteoclastogenesis.  
5 
TRAF6 
Tumor necrosis factor 
receptor associated factor 6 
TRAF6 is a mediator of NFκB and 
MAPKs involving in immunological and 
inflammatory responses. 
1 
TRPA1 
Transient receptor potential 
Ankyrin 1 
Ion channel which senses to pain and 
oxidative stress.  
4 
TRPM 
Transient receptor potential 
melastatin 
Ion channel which senses to heat.   4 
TRPP 
Transient receptor potential 
polycystin 
Refer to polycystin. 4 
TRPV1 
Transient receptor potential 
vanilloid type 1 
Calcium and sodium ions channel which 
senses to temperature and pain. 
1-5 
TXAs Thromboxanes 
Eicosanoids play roles in 
vasoconstriction and platelet 
aggregation.  
5 
VEGF-D 
Vascular endothelial growth 
factor D 
Growth factor which plays role in 
angiogenesis. VEGF-D also promotes 
osteoblast differentiation. 
5 
VEGFR3 
Vascular endothelial growth 
factor receptor 3 
VEGFR3 is a VEGF receptor which can 
be found in osteoblast. VEGFR3 can 
recognise VEGF-D.  
5 
VGCCs 
Voltage-gated calcium 
channels 
Calcium ion channels on cell 
membrane which allow calcium influx 
activated by depolarization.  
4 
VHL 
Von Hippel-Lindau ubiquitin 
ligase 
VHL binds to prolyl hydroxylase domain 
(PHD) and factor inhibiting hypoxia-1 
(FIH-1) in order to inhibit HIF-1α under 
normoxic condition.  
5 
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Wnt 
Wingless-related integration 
site 
Wnt is a protein which is recognised by 
Frizzled receptor. Wnt signaling 
pathway promotes osteogenesis in 
early phase.  
1, 4, 5 
YAP Yes-associated protein 
Transcriptional factor which is related 
to skeleton and phenotypic memory. 
YAP is regulated by hippo pathway. 
4, 6 
 
 
Chapter 1: Introduction 1  
Chapter 1 Introduction
Chapter 1: Introduction 2  
Chapter 1 Introduction to nanovibrational 
stimulation   
1.1 From Bedside to Bench; What do orthopaedic 
surgeons want from bone tissue engineering? 
Nowadays, introducing tissue engineered bone substitutes for clinical 
orthopaedic applications is challenging. There are a diversity of 
indications that could use bone substitutes such as spinal fusion, 
nonunion, etc (Baldwin et al., 2019). However, the most difficult 
situation is the segmental bone defect resulting from a traumatic 
event or bone tumor removal. Because of the large defect 
complicated with poor surrounding tissue, many orthopaedic patients 
suffer from the long-term process of treatment, multiple operations 
and surgical complications (L., C., J., A., & Baldy, 2010).  
The most popular and effective surgical technique for large bone 
defect treatment is the distraction osteogenesis by external ring 
fixator, invented by Professor GA. Illizarov (Spiegelberg et al., 2010). 
Distraction osteogenesis provides a successful approach for large bone 
defect treatments (Aktuglu, Erol, & Vahabi, 2019). However, there 
are many drawbacks. For instance, awkward, heavy and long-term 
application of the ring frame makes patients feel uncomfortable. In 
addition, the external rods and pins may introduce pathogens into the 
bone which may then develop into a pin track infection and 
osteomyelitis. Also, the patient’s self administered daily distraction 
adjustment may also lead to unfavorable outcomes (Kempton, 
McCarthy, & Afifi, 2014; Lascombes, Popkov, Huber, Haumont, & 
Journeau, 2012; Paley, 1990). 
The induced membrane technique (IMT) is a another strategy for 
treatment of the segmental bone loss proposed by Masquelet et al 
(Giannoudis, Faour, Goff, Kanakaris, & Dimitriou, 2011; A. C. 
Masquelet & Begue, 2010). IMT is a two-staged procedure (A. 
Masquelet, Kanakaris, Obert, Stafford, & Giannoudis, 2019).  
Polymethyl- methacrylate (PMMA) is implanted at the bone defect in 
turn allowing the host to create membrane encapsulation. At the 
second stage, the PMMA spacer is removed. The bone void is filled 
with autologous bone graft (Giannoudis et al., 2011). Nevertheless, 
this technique requires an abundance of bone graft which inevitably 
leads to donor site morbidity, causing fracture and pain (Stafford & 
Norris, 2010). In large defects, chemical supplements such as BMPs 
may be required to improve healing (Giannoudis et al., 2011). 
Chapter 1: Introduction 3  
Biologically, the induced membrane is comprised of fibroblast, blood 
vessels and inflammatory cells (Christou, Oliver, Yu, & Walsh, 2014). 
This membrane produces bone morphogenetic protein-2 (BMP-2), 
vascular endothelial growth factor (VEGF) and transforming growth 
factor β1 (TGF-β1) during week 4-6 (Pelissier, Masquelet, Bareille, 
Pelissier, & Amedee, 2004; X. Wang, Wei, Luo, Huang, & Xie, 2015). 
However, clinical outcomes of the IMT for bone defect treatment is 
varied (A. C. Masquelet, 2003; Niccolai, Di Mento, Mocchi, & 
Berlusconi, 2018; R., M., A., & I., 2017; J. Wang, Yin, Gu, Wu, & Rui, 
2019). In the future, a combination of the IMT with stem cells and 
tissue engineering concepts may potentially improve the outcome of 
large bone defect treatments (Dilogo, Primaputra, Pawitan, & Liem, 
2017; Viateau et al., 2010). 
1.2 Bone structure and bone marrow cells niche 
Bone structurally consists of cortical bone (compact bone) and 
cancellous bone (spongy or medullary bone) (Clarke, 2008). 
Histologically, bone can be classified into woven (immature, 
disorganized collagen fiber) and lamellar bone (mature, organized 
collagen fiber) (Tzelepi, Tsamandas, Zolota, & Scopa, 2009).  
Cortical bone is an outer and dense part of bone. Cortical bone 
consists of osteons (or Haversian system) which is a lamellar 
mineralized matrix. Osteocytes reside in osteons and communicate 
each other through canaliculi (Hideki Yoshikawa, Tsumaki, & Myoui, 
2009). The lamellar structures of osteons surround the haversian 
canels where mesenchymal stem cells, vessels and nerves are located. 
Vessels in haversial canels play role on transferring oxygen and 
nutrients to osteocytes (Khurana & Safadi, 2010).  
Endosteum, lining at the inner layer of cortical bone, consists of MSCs, 
pre-osteoblasts, osteoblasts, fibroblast. Lining osteoblasts play 
interactive roles with hematopoietic stem cells (HSCs) in medullary 
canel (Lévesque, Helwani, & Winkler, 2010). Surfaces of lamellar bone 
are lined with quienscent osteoblasts. Osteoclasts formed a Howship’s 
lacunae on endosteum to resorb bone mineralized matrix for 
enhancing bone homeostasis and remodelling (Safadi et al., 2009). 
Cancellous bone (medullary bone) is trabecular network of lamellar 
bone (Tzelepi et al., 2009). Cancellous bone is filled with bone 
marrow (BM) consisting of hematopoietic cells (red marrow) and 
adipose tissue (yellow marrow). BM consists of osteoprogenitor cells, 
osteoblast, osteoclast precursor cells, haematopoietic stem cells 
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(HSCs), stromal cells, MSCs, adipocytes, endothelial cells and nerve 
cells (Travlos, 2006).  
In BM, MSCs plays role not only in bone regeneration but also 
supporting HSCs (Crippa & Bernardo, 2018; Frenette, Pinho, Lucas, & 
Scheiermann, 2013). At endosteum (endosteal niche), HSCs interact 
with osteoblasts, MSCs and adipose tissues affecting on HSCs 
mobilization, quiescence, and differentiation (Lévesque et al., 2010). 
BM adipose tissue also links to bone metabolism (Yujue Li, Meng, & 
Yu, 2019). BM is vascularized by medullary artery, arterioles, capillary 
and sinusoids. Many cells, e.g. endothelial cells, CXCL12 abundant 
reticular cells, pericytes and megakaryocytes, are resided nearby 
sinusoids creating vascular niche. Vascular niche plays important roles 
on HSCs growth and functions. (Lilly, Johnson, & Bunce, 2011; Tamma 
& Ribatti, 2017).  
1.3 Bone healing: What can we learn from nature? 
Bone healing is a dynamic process involving vascularization, cartilage 
and osteogenic differentiation and then mineralization. Thus, 
understanding the natural bone healing process could help in 
developing synthetic bone substitutes. Vascularization, linking to 
oxygen conditioning (Y. Wang et al., 2007), is a key modulator of bone 
healing (Drager, Harvey, & Barralet, 2015; Marenzana & Arnett, 2013). 
Hypoxic condition suits chondrogenic differentiation (Schipani, 2006) 
while normoxic conditions promotes osteoblast differentiation (Shyh-
Chang, Daley, & Cantley, 2013). Considering orthopaedic fixation 
treatment, fracture reduction and fixation stability affect 
vascularization and thus fracture healing (Claes, Eckert-Hubner, & 
Augat, 2003; Lienau, Schell, Muchow, & Duda, 2004). In primary bone 
healing, internal fixation with fracture compression technique 
restores blood flow thus enhancing osteogenic differentiation. While 
in secondary bone healing, relative stability allows interfragmentary 
micromotion (Perren, 2002). Gaps at the fracture site represent 
vascular disruption indicating hypoxic conditions (Kunze, Hofstetter, 
Posalaky, & Winkler, 1981). Hypoxic condition initially promotes 
chondrogenesis thus enhances enchondral ossification. Osteogenesis 
and mineralization then occur after intensive vascularization (Claes, 
Recknagel, & Ignatius, 2012). Bone healing consists of 3 stages, 
inflammation, reparation and remodelling (Figure 1.1).   
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1.3.1 Inflammatory phase 
The inflammatory phase occurrs within 24 hours to 1 week in order to 
activate and recruit essential cells such as MSCs and immune cells into 
the fracture site to enhance regeneration (Jiliang Li, Kacena, & 
Stocum, 2019).  At the fracture site, a hematoma is formed to create 
a fracture niche. Surrounding injured tissues generate inflammatory 
signals and cytokines preparing adjacent structures for the healing 
process such as vasodilation and increase vessel permeability (Ryan E. 
Tomlinson & Silva, 2013). Inflammatory cytokines such as tumor 
necrosis factor alpha (TNFα), interleukin-1 (IL-1), IL-6, IL-11 and IL-18 
(Giannoudis et al., 2015) are secreted aiming to promote 
vascularization, and recruit cells to fracture sites such as 
macrophages (eliminating death cells via phagocytosis) and precursor 
cells (such as MSCs) which are essential for bone healing and 
angiogenesis (Giannoudis et al., 2015; Florence Loi et al., 2016).  
1.3.2 Reparation phase  
The reparation phase is affected by fracture niche including fracture 
gap (Claes et al., 2003; Meeson et al., 2019), interfragmentary 
micromotion (Elliott et al., 2016) and vascular supply at fracture site 
(Marenzana & Arnett, 2013; Ryan E. Tomlinson & Silva, 2013). In the 
reparation phase, woven bone (immature bone) is developed from a 
soft (cartilaginous) callus to become a hard (mineralized) callus (J. Li 
et al., 2019). The fracture characteristics can also influence the 
applied fracture fixation technique and mode of bone healing.  
1.3.2.1 Direct fracture healing  
Direct fracture healing (primary bone healing) occurs when the 
fracture is simple with less periosteal injury, thus preserving 
periosteal blood supply (Ryan E. Tomlinson & Silva, 2013). This type 
of fracture can be anatomically reduced and an absolute stability of 
fixation can be achieved (Perren, 2002). After reduction, the 
haversian system is restored allowing intraosseous blood flow. 
Normoxic condition then induces MSC to osteogenic cell fate (Shyh-
Chang et al., 2013). Direct fracture healing can be divided into 
contact healing (gap < 10 μm) and gap healing (gap 800 μm-1 mm) 
(Marsell & Einhorn, 2011). The process of contact healing involves a 
direct remodelling process (via the cutting cone (Eriksen, 2010)), 
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while gap healing generates lamellar bone to fill the gap before bone 
remodelling (Marsell & Einhorn, 2011).  
1.3.2.2 Indirect fracture healing 
Indirect bone healing (secondary bone healing) occurs in comminuted 
fractures where some fixation stability has been achieved (Perren, 
2002). This mode of bone healing involves both intramembranous and 
endochondral bone healing (Marsell & Einhorn, 2011). At the fracture 
gap, recruited MSCs produce various growth factors such as 
transforming growth factor beta (TGF-β; involved in chondrogenesis), 
BMPs (promoting osteogenesis), VEGF (angiogenesis), platelet-derived 
growth factor (PDGF; cell migration), and fibroblast growth factor 2 
(FGF2; angiogenesis) (Ghiasi, Chen, Vaziri, Rodriguez, & Nazarian, 
2017). At 2-6 weeks, a soft callus, consisting of blood vessels, 
cartilage and spongy bone, is formed and, in turn, is mineralized to a 
hard callus (Holmes, 2017). 
1.3.3 Remodelling 
After the reparation phase, active osteoclasts remodel woven bone to 
lamellar bone restoring the harversian system (Eriksen, 2010). 
Osteoclasts attach on to bone, form a ruffled membrane as well as 
secreting H+, ATPase and Cathepsin K in vesicles in order to degrade 
mineralized bone (Boyle, Simonet, & Lacey, 2003; Rucci, 2008). In this 
phase, high levels of inflammatory cytokines such as IL-1 and TNFα 
can be found (Marsell & Einhorn, 2011).  
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Figure 1.1  Phase of bone healing  
In the inflammatory phase, a hematoma is formed. Precursor 
cells are recruited to the fracture site. After that, granulation 
tissue is formed, in turn developing soft and hard callus in the 
reparation phase. Vascularization is also found in this phase. 
Bone remodelling occurs after hard callus formation. (With 
permission of Einhorn., et al 2015 (Einhorn & Gerstenfeld, 
2015)) 
1.4 Osteogenic pathways 
Diverse osteogenic pathways are orchestrated at specific time points 
(James, 2013; Javed, Chen, & Ghori, 2010) and the same pathways 
may provide different functions at different stages of osteoblast 
development. Major pathways involved in osteogenesis include TGF-
β, BMPs, Hedgehog, Wnt and Notch are reviewed below (Figure 1.2).   
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1.4.1 TGF-β signaling pathway 
TGF-β promotes proliferation and osteoblast commitment in 
mammalian development (G. Chen, Deng, & Li, 2012). TGF-β  consists 
of canonical (using TGF-β ligand via SMAD2/3) and non canonical (via 
p38; mitogen-activated protein kinase; MAPK pathways (M. Wu, Chen, 
& Li, 2016)). TGF-β (e.g. TGF-β1) coordinates between bone 
formation and bone remodeling by recruiting MSCs to the resorption 
area showed in in vitro and in vivo studies (Y. Tang et al., 2009). TGF-
β also itself induces progenitor cell proliferation and differentiation 
in vitro and in vivo studies (Matsunobu et al., 2009; Salkın, Gönen, 
Ergen, Bahar, & Çetin, 2019). In in vitro studies, canonical TGF-β (via 
SMADs) promotes early phase osteogenic differentiation but inhibits 
mineralization and maturation of osteoblasts (S. Maeda, Hayashi, 
Komiya, Imamura, & Miyazono, 2004; M. Wu et al., 2016). In in vitro 
studies, optimal levels of TGF-β promote osteoclast migration and 
differentiation. However, high levels of TGF-β inhibit osteoclast 
differentiation (Itonaga et al., 2004; Pilkington, Sims, & Dixon, 2001; 
M. Wu et al., 2016; Yasui et al., 2011). 
1.4.2 BMPs signaling pathway 
BMPs are members of the TGF-β superfamily. BMPs relay signals 
through SMAD-dependent and SMAD–independent (MAPK) pathways to 
enhance osteogenesis (M. Wu et al., 2016). BMP2 and BMP7 have been 
commonly used in orthopaedics (Conway, Shabtai, Bauernschub, & 
Specht, 2014; Cook, Salkeld, Patron, & Rueger, 2000; S.D., T.A., H.S., 
S.E., & Sofamor, 2002; Suk, 2008) and dentistry (Taşlı, Aydın, Yalvaç, 
& Şahin, 2014). In in vitro and in vivo studies, BMP2 enhances RUNX2 
through SMADs 1/5/8 for osteogenesis (Kopf, Petersen, Duda, & 
Knaus, 2012; Phimphilai, Zhao, Boules, Roca, & Franceschi, 2006; 
Retting, Song, Yoon, & Lyons, 2009). BMP2 also enhances osteocalcin 
(OCN) (Jang et al., 2012), osteopontin (OPN) in vitro (X. Yang et al., 
2009), as well as promoting alkaline phosphatase (ALP) through the 
MAPK pathway (W. Huang, Yang, Shao, & Li, 2007). In in vivo study, 
BMP7 also enhances osteogenesis (Cook et al., 2000). In in vitro 
studies, BMP 7 promotes ALP and mineralization (Xue et al., 2015; 
Yeh, Tsai, & Lee, 2002). BMP/SMAD signalling induces early phase 
osteoblast differentiation while SMAD-independent (MAPK) promotes 
osteogenic differentiation and bone development by phosphorylating 
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RUNX2 and thus stimulating osterix (OSX) (Rahman, Akhtar, Jamil, 
Banik, & Asaduzzaman, 2015; M. Wu et al., 2016). 
1.4.3 Hedgehog signaling pathway 
Hedgehog (Hh) signaling plays important roles in bone development 
and osteoblast differentiation in mammals (Jing Yang, Andre, Ye, & 
Yang, 2015). Hh signaling consists of Sonic hedgehog (Shh), Indian 
hedgehog (Ihh) and Desert Hedgehog (Dhh). Shh and Ihh play pivotal 
roles in skeletal development. Shh modulates osteogenic 
differentiation, bone homeostasis and angiogenesis as well as anti-
adipogenesis (James et al., 2010; Lamplot et al., 2013). Ihh is 
important for enchondral ossification. Ihh triggers both 
chondrogenesis and osteogenesis during enchondral ossification 
(Ohba, 2016; Razzaque, Soegiarto, Chang, Long, & Lanske, 2005). Hh 
and Wnt are reciprocally antagonists (M. Ding & Wang, 2017; Song, Li, 
Liu, & Zhao, 2015).  
1.4.4 Wnt signaling pathway 
Wnt signaling is involved in cell proliferation, differentiation and 
migration (Barbáchano, Larriba, Ferrer-Mayorga, Muñoz, & González-
Sancho, 2014). Canonical Wnt signals via β-catenin while non-
canonical Wnt activates JNK or Rho pathways linked to the 
cytoskeleton (in Wnt/planar cell polarity signaling) as well as protein 
kinase C (in Wnt/Calcium signaling) (Niehrs, 2012). In canonical Wnt 
signaling, frizzled protein receptors and low-density lipoprotein 
receptor-related protein 5 (LRP5) senses mechanical stimulation 
regulating osteoblast differentiation showed in in vivo studies (H. Q. 
Gao et al., 2017; K. S. Kang & Robling, 2015; Y. Wang et al., 2014). 
Canonical Wnt with LRP5 promotes increase in bone density (Johnson, 
2004; Krishnan, Bryant, & Macdougald, 2006; Norwitz, Mota, Misra, & 
Ackerman, 2019). As showed in in vitro and in vivo studies, the Wnt 
pathway promotes osteoblastic differentiation of MSCs in the early 
phase of osteogenesis but inhibits differentiation into mature 
osteoblasts (Eijken et al., 2008; Rodda & McMahon, 2006).  
Wnt canonical and noncanonical signals also play roles in osteoclast 
differentiation (Yasuhiro Kobayashi, Shunsuke Uehara, Masanori 
Koide, & Naoyuki Takahashi, 2015). In in vivo and in vitro studies, 
osteoblasts secrete Wnt16 activating Wnt/β-catenin which, in turn, 
suppresses osteoclast differentiation through the receptor activator 
of nuclear factor kappa B/osteoprotegerin (RANKL/OPG) axis (Y. 
Kobayashi, G. J. Thirukonda, et al., 2015; Moverare-Skrtic et al., 
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2014). However, non-canonical Wnt promotes osteoclast 
differentiation. Osteoblasts secrete Wnt5a binding to receptor 
tyrosine kinase Ror2 (Ror2) in osteoclast precursors promoting RANK 
in in vivo studies (Y. Kobayashi, S. Uehara, M. Koide, & N. Takahashi, 
2015; Kobayashi, Uehara, & Udagawa, 2018; K. Maeda et al., 2012). It 
is noteworthy, however, that Wnt5a can also enhance osteoblast 
differentiation (via LRP5-6/Wnt/ β-catenin) in in vitro study (Okamoto 
et al., 2014). Noncanonical Wnt links to JNK. In in vitro study, 
Wnt5a/Ror2/JNK signaling suppresses osteoblasts which may prevent 
over-mineralization (Hasegawa et al., 2018). Wnt can crosstalk to 
many pathways (Y. Wang et al., 2014) such as BMPs (Y. Chen et al., 
2007), Hedgehog (M. Ding & Wang, 2017), and Notch (Collu, Hidalgo-
Sastre, & Brennan, 2014).  
1.4.5 Notch signaling pathway 
Notch signaling modulates osteogenesis, osteoclastogenesis and 
angiogenesis in mammals (Z. Luo et al., 2019). Notch inhibits 
differentiation in the early phase of osteogenesis by interacting with 
β-catenin, RUNX2 and OSX. Notch and RUNX2 are reciprocal 
antagonists as RUNX2 can inhibit Notch showing in in vitro study (Ann 
et al., 2011). By in vitro and in vivo study, Notch can also inhibit 
RUNX2 (through Hes, Hey proteins) maintaining progenitor cells 
(Hilton et al., 2008) as well as inhibiting Wnt/ β-catenin (Hayward, 
Kalmar, & Martinez Arias, 2008). However, in some in vitro literature 
studying in MG63, Notch has also been seen to upregulate RUNX2 and 
OSX (Ongaro et al., 2016). In in vitro study, Notch can suppress 
glycolysis in turn reducing oxidative phosphorylation and inhibiting 
osteogenic differentiation through lack of metabolic energy (S.-Y. Lee 
& Long, 2018). In late osteogenesis, activation of Notch in mature 
osteocytes promotes bone formation and mineralization showed in in 
vitro and in vivo studies (P. Liu et al., 2016). Notch promotes 
osteoclast maturation and bone remodelling in in vitro study(Ashley, 
Ahn, & Hankenson, 2015).  
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Figure 1.2 Interaction of BMPs, TGF-β, Wnt, Notch and 
Hedgehog pathways in osteogenesis and 
osteoclastogenesis  
BMPs promote the process of osteogenic differentiation. In the 
early phase of osteogenesis, Wnt enhances the commitment of 
MSCs to preosteoblast thus promotes osteogenesis. In the late 
stage (mineralization), Wnt inhibits the maturation of 
osteoblasts. Wnt is involved in osteoclast differentiation via the 
RANK/OPG axis. Notch inhibits differentiation in early the phase 
of osteogenesis resulting in pooling of osteoblast progenitors. 
Notch also promotes maturation of osteoclasts. Hh is an 
antagonist to Wnt (green arrow; activation, red arrow; 
inhibition) (Eijken et al., 2008; Rahman et al., 2015; Regard, 
Zhong, Williams, & Yang, 2012; Rodda & McMahon, 2006; M. Wu 
et al., 2016). 
1.5 Stem cell source for bone tissue engineering  
 Various stem cell types are extensively studied for their 
potential use in bone tissue engineering. However, driving stem cell 
based therapy into clinics is challenging. Many obstacles, including 
immunological responses, ethical issues, patient safety, tumorigenic 
potency, etc require intensive research before approval. The 
summary of advantages and disadvantages of available stem cell types 
is shown in table 1.1.  
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Table 1.1 Comparison the advantages and disadvantages of stem cell type. 
 ESCs IPSCs BM-MSCs CB-MSCs ASCs Osteoblast 
Sources embryos Somatic cells Bone marrow Cord blood Fat tissue Bone graft 
Proliferation 
capacity 
Unlimited Unlimited Limited Limited Limited Limited 
Differentiation 
potency 
Pluripotency Pluripotency Multipotent Multipotent Multipotent Osteoblast 
Osteogenic 
differentation 
capacity 
Fair-Good Fair-Good Good Good Good Very good 
Preparation 
technique, 
isolation and 
expansion 
problems 
Donor safety 
concern, 
Difficult 
isolation 
Retroviral 
problem, 
Require large 
expansion 
Senescence 
Difficult 
isolation 
Senescence, 
Multiple step 
of isolation 
Senescence 
Ethical issue 
Yes 
(Embryo 
ternination) 
No No No No No 
Tumoriginicity Yes Yes No No No No 
Immunogenic Possibly 
No 
(Autologous) 
No 
(Autologous) 
No 
(Autologous) 
No 
(Autologous) 
No 
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1.5.1 Embryonic stem cells 
Embryonic stem cells (ESCs) are derived from the blastocytes of 
embryos. ESCs are pluripotent thus providing benefits of high 
proliferation (Kargozar et al., 2019). Human embryonic stem cell 
(hESC) research is growing (W. C. Chen et al., 2013; Kuhn et al., 2014), 
however, using hESCs in tissue engineering has ethical issues arising 
from termination of embryos issue and safety of donor oocytes (Lo & 
Parham, 2009). Moreover, the tumorigenic potency of ESCs is 
controversial (X. Wang et al., 2012).  
ESCs can be osteogenically induced using standard osteogenic media 
(dexamethasone, ascorbic acid, and β-glycerolphosphate) (Boast & 
Stern, 2013). However, the osteogenic differentiation potency of ESC 
derived MSCs is controversial. Some studies showed that 
osteogenically induced ESCs provided comparable results for 
osteogenesis with bone marrow derived mesenchymal stem cells (BM-
MSCs) (Arpornmaeklong, Brown, Wang, & Krebsbach, 2009). However, 
some literature reported less effective outcomes of osteogenic 
induction of ESCs compared to those of BM-MSCs (Brown, Squire, & Li, 
2014). At present, hESCs are widely studied in bone tissue engineering 
(W. C. Chen et al., 2013; Marolt et al., 2012) and fracture healing 
induction (Undale et al., 2011). 
1.5.2 Induced pluripotent stem cells (iPSCs) 
Induced pluripotent cells (iPSCs) are derived from genetic 
reprogramming of somatic cells (such as fibroblasts) by transduction 
of Yamanaka’s factors (Oct, Sox2, Klf4 and Myc) studied in mouse 
fibroblasts (K. Takahashi & Yamanaka, 2006) and human fibroblasts 
(K. Takahashi et al., 2007). iPSCs are pluripotent and posses unlimited 
self-renewal. As somatic cells are derived from an autologous donor, 
there is no genetic matching problem nor ethical issues (Kargozar et 
al., 2019; King & Perrin, 2014; Lo & Parham, 2009; Sugarman, 2008; 
Yousefi et al., 2016). However, there are critical hurdles towards 
clinical application such as teratogenicity (Gutierrez-Aranda et al., 
2010; Mitchell, Wanczyk, Jensen, & Finck, 2019), drawbacks of using 
retrovirus transfection as well as reproducibility of transfection 
(Medvedev, Shevchenko, & Zakian, 2010). 
There are many techniques for inducing iPSCs towards MSC and 
osteoprogenitor cells, such as through embryoid body formation or 
direct differentiation using osteogenic media (dexamethasone, 
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ascorbic acid, and β-glycerolphosphate) (Bastami et al., 2017; Illich 
et al., 2011). Osteogenic differentiation potency of iPSCs is 
comparable to MSCs (Bastami et al., 2017; Fliefel, Ehrenfeld, & Otto, 
2018). iPSCs are also studied in many fields of tissue engineering such 
as cardiac disease treatment (Miyagawa & Sawa, 2018; Musunuru et 
al., 2018), and organoids (Ogura, Sakaguchi, Miyamoto, & Takahashi, 
2018), etc. To introduce iPSCs into clinic in the future, pretreatment 
such as irradiation to reduce tumorigenesis may be required (Inui et 
al., 2017).  
1.5.3 Mesenchymal stem cells (MSCs) 
MSCs are the most popular stem cell source for bone tissue 
engineering. MSCs are multipotent, differentiating into osteogenic, 
chondrogenic, reticular and adipogenic lineages. The International 
Society for Cellular Therapy (Dominici et al., 2006) defined the 
characteristics of MSCs. MSCs must adhere on to tissue culture plates 
and be multipotent. Moreover, MSCs should express surface markers – 
they are positive for CD73, CD90, CD105 and negative for CD14, CD34, 
CD45 or CD11b, CD79α or CD19 and HLA-DR (Dominici et al., 2006). 
Stro1, another surface marker, is commonly used for enriching MSCs 
from the bone marrow (G. Lin et al., 2011; F. J. Lv, Tuan, Cheung, & 
Leung, 2014). Stro1 selected MSCs can differentiate into osteoblasts, 
chondrocytes, adipocytes fibroblasts and hematopoietic supporting 
cells such as vascular smooth muscle cells, thus they are suitable for 
the studies of osteogenesis together with angiogenesis (Dennis, 
Carbillet, Caplan, & Charbord, 2002; Melchiorri, Nguyen, & Fisher, 
2014). MSCs can be harvested from many tissue sources such as bone 
marrow (BM-MSCs), adipose tissue (AMSCs) and cord blood (CB-MSCs). 
Among the three sources, osteogenic differentiation potency is 
comparable (Heo, Choi, Kim, & Kim, 2016; Rebelatto et al., 2008; 
Wagner et al., 2005).  
1.6 MSC in vitro Microenvironments 
Microenvironments play important roles in stem cell self-renewal or 
differentiation (Donnelly, Salmeron-Sanchez, & Dalby, 2018). Stem 
cell fate is influenced by various factors such as extracellular matrix, 
secreted factors, cell-to-cell interaction, inflammation, physical 
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factors (such as shearing and material stiffness) as well as hypoxia and 
metabolism (Lane, Williams, & Watt, 2014) (Figure 1.3).  
In material sciences, extracellular matrix is the keystone of 
microenvironment fabrication integrating all factors of MSCs niche for 
bone regeneration. Multiple modalities had been proposed to create 
MSC niches. For example, ECM physical modifications (such as tuning 
stiffness and topography) affect cell adhesion, cell cytoskeleton and, 
in turn, regulating cell growth (Dalby et al., 2007). Furthermore, 
integrating surface chemistry and growth factors on matrices can also 
promote cell adhesion and differentiation in in vitro and in vivo 
studies (Llopis-Hernández et al., 2016)(X. Zhao et al., 2017).  
Cell-to-cell interaction is a part of the cellular niche. MSCs 
communicate to neighboring cells through cell adhesion molecules 
(such as tight junctions, gap junctions, adherens junctions (Hartsock 
& Nelson, 2008) or cytokines (J.-M. Zhang & An, 2007).  Cell-to-cell 
interaction can occur between cells of the same phenotype or 
different cell types, for example, osteoblasts require connexin 43 for 
bone development (Moorer & Stains, 2017). Adhesions amongst 
different cells are also important in the bone marrow compartment, 
e.g. osteoblasts promote HSC functions (X. Gao, Xu, Asada, & 
Frenette, 2018) and osteoclast development (X. Chen et al., 2018; 
Sharaf-Eldin, Abu-Shahba, Mahmoud, & El-Badri, 2016).  
The metabolic and oxygen niche also affect cell lineage. Oxygen links 
to hypoxic inducible factor 1-alpha (HIF-1α) controlling energy 
synthesis via balance of glycolysis and oxidative phosphorylation 
(Drager et al., 2015; Mohyeldin, Garzón-Muvdi, & Quiñones-Hinojosa, 
2010). Moreover, inflammation and oxidative stress are also involved 
in cell differentiation (Bernardo & Fibbe, 2013; Kyurkchiev et al., 
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2014). The role of oxygen, metabolism and oxidative stress are 
discussed in chapter 5.  
 
Figure 1.3  The stem cell niche  
Stem cell niche consists of complex factors influencing on stem 
cell function and growth. For example, ECM and physical cues 
(e.g. topography and external force) involve stem cells through 
adhesion-cytoskeletal complex. Further, stem cells also interact 
and communicate to other cell types (via cytokines, etc) 
maintaining cellular function, and quiescence. Hypoxic 
condition also affects cellular metabolism and differentiation 
(With permission of Lane et al., 2014 (Lane et al., 2014)).   
1.6.1 Extracellular matrix  
Understanding the structure and components of ECM is essential for 
scaffold design and material selection. The ECM, where cells reside, 
plays important roles in cellular functions (Lozito, Kolf, & Tuan, 
2009). In nature, ECM is composed of soluble factors (such as 
cytokines, growth factors) and insoluble components (e.g. 
glycoproteins, proteoglycans and proteins) (Kular, Basu, & Sharma, 
2014). The insoluble components play roles in cell-ECM interaction, 
for example, collagens provide structural support relating to 
composite stiffness (Kular et al., 2014). Fibronectin, containing the 
cell binding domain Arg-Gly-Asp (RGD), is important for cell adhesion 
(J. Xu & Mosher, 2011). Currently, ECM modification for tissue 
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regeneraton is extensively studied. Designed ECM for bone tissue 
engineering must allow cell adhesion and should allow transmission of 
external mechanical signals.  
1.6.1.1 Cell adhesion  
Adhesion proteins, such as fibronectin and laminin, play pivotal roles 
in cell adhesion (J. Xu & Mosher, 2011). Cells use integrin to bind 
peptide motifs of adhesion proteins such as RGD to attach to the ECM. 
In in vitro study, controlling the density and patterning of RGD ligands 
can regulate the cell signaling pathways of MSC differentiation (Dalby, 
Gadegaard, & Oreffo, 2014). Another experimental study reported 
that patterned RGD ligands (distance <70 nm) can cluster integrins 
and promote focal adhesion formation (J. Huang et al., 2009). At the 
focal adhesion, integrins connect with actin binding proteins such as 
talin, vinculin, filamin and focal adhesion kinase (FAK) (Brakebusch & 
Fassler, 2003). Talin, connected to vinculin, controls the optimal 
force for maintaining the stability of cell-matrix adhesion (Neumann 
& Gottschalk, 2016; Yao et al., 2016). Vinculin, linking to actin, 
induces actin polymerization (Atherton, Stutchbury, Jethwa, & 
Ballestrem, 2016; Golji & Mofrad, 2013). Activation of FAK controls 
intracellular mechanotransduction (Lachowski et al., 2018). FAK 
regulates actin polymerization and organization (Schaller, 2010). The 
activation of FAK also promotes RhoA and Rho-associated protein 
kinase (ROCK) which then crosstalks to ERK1/2 (Khatiwala, Kim, 
Peyton, & Putnam, 2009; Shih, Tseng, Lai, Lin, & Lee, 2011). ERK1/2, 
in turn, phosphorylates RUNX2 driving osteogenesis (Khatiwala et al., 
2009). The focal adhesion formation activates G proteins (e.g. Rac, 
Cdc42 and Rho) and, in turn, triggers actin-myosin contraction 
(Lawson & Burridge, 2014; Price, Leng, Schwartz, & Bokoch, 1998). 
Cell adhesion and contraction link to intracellular tension. High 
intracellular tension promotes osteogenesis while low tension 
enhances adipogenesis (Kilian, Bugarija, Lahn, & Mrksich, 2010; 
McBeath, Pirone, Nelson, Bhadriraju, & Chen, 2004).   
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1.6.1.2 ECM Stiffness 
It is known that two dimensional (2D) ECM stiffness affects MSCs 
commitment through complex crosstalk networks (Figure 1.4A). A 
seminal in vitro study by Engler et al elucidated how MSCs respond to 
ECM stiffness (Engler, Sen, Sweeney, & Discher, 2006). Soft stiffness 
(E~0.1-1 kPa) were considered to drive neurogenic fate of MSCs. 
Stiffer matrices (E~8-17 kPa) promoted myogenic fate. High stiffness 
(E~25-40 kPa) promotes osteogenesis, with MSCs spread in polygonal 
morphologies (Engler et al., 2006). However, the cause of cell fate 
regulation is still debated whether from substrate stiffness or 
tethering effects of proteins on the substrate surfaces. Some in vitro 
studies explained that fiber tethering of protein ECM and density of 
crosslinkers affected cell differentiation (Trappmann et al., 2012). 
Low collagen fiber density allows ECM fiber deformation resulting in 
soft feedback while higher fiber density, or high levels of crosslinking, 
allow cells to generate rigid feedback. Rigid feedback enhances actin 
polymerization (F. M. Watt & Huck, 2013). After that, Wen et al. 
argued that protein tethering and substrate porosity did not affect 
cell differentiation but substrate stiffness was the determining factor 
in MSC commitment (Wen et al., 2014). 
By transferring signals from the ECM to the nucleus, MSCs sense ECM 
stiffness using integrins as a stiffness sensor. Integrins (such as 
integrins β3, α2) bind to the extracellular proteins in ECM which in 
turn form the focal adhesion. Integrins link to actin-myosin 
complexes. Perinuclear actin is an important key factor affecting 
nuclear shape (Khatau et al., 2009). LINC complexs (linker of nucleus 
and cytoskeleton) is a protein complex joining the cytoskeleton and 
nucleus (nucleoskeleton). LINC complexes consist of SUN and nesprin 
proteins. Nesprins connect to actin while SUN interacts with lamins 
and nuclear pore complexs (Dahl, Ribeiro, & Lammerding, 2008). 
Lamins are intermediate filament proteins consisting of Lamins A-C, 
located at the inner nuclear membrane. In in vitro studies, Lamins 
interact with chromatin and play a role in coveyance of cytoskeletal 
forces into the nucleus (S. Cho, Irianto, & Discher, 2017; Dalby et al., 
2014). Lamins play roles in control of viscoelastic nuclear properties. 
In in vitro study, Lamin A functions in a viscous manner while lamin B 
is elastic (Swift et al., 2013). In stiff ECM, lamins are not 
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phosphorylated, thus their degradations are prevented (S. Cho et al., 
2017; Dingal & Discher, 2014) (Figure 1.4B).  
Cell interactions with stiff ECM result in increased actin tension, in 
turn pulling nesprins which activate emerin by Src kinase (S. Cho et 
al., 2017). In in vitro study, phosphorylated emerin controls stress 
fiber formation (Guilluy et al., 2014). Cytoskeletal tension modulates 
nuclear pore opening subsequently promoting Yes associated protein 
(YAP) translocation into nucleus (in vitro study)(Elosegui-Artola et al., 
2017). Adequate accumulation of YAP in the nucleus, in turn,  
promotes an irreversible osteogenic phenotype (C. Yang, Tibbitt, 
Basta, & Anseth, 2014). 
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Figure 1.4  Crosstalk network responding to matrix stiffness  
A) Crosstalk network responding to matrix stiffness (from soft 
to stiff matrices; left to right). In soft matrice, BMP/Smad 
pathway was inhibited promoting neurogenic 
differentiation. In medium stiffness, myogenic 
differentiation was enhanced through ROCK-MLCK pathways. 
In stiff matrice, osteogenic differentiation is enhanced via 
ROCK-FAK-ERK1/2 and smad 1/5/8 pathways (With 
permission of Lv et al., 2015 (H. Lv et al., 2015), licensed 
under Creative Common Attribution License; CC; 
https://creativecommons.org/licenses/by/4.0/)). 
B) Signal transduction from ECM to nucleus. Integrins attach on 
ECM transferring force through actin. Nesprin is connected 
actin and SUN. SUN is linked to lamin and chromatin 
regulating gene positioning (With permission of Wang et al., 
2009 (Ning Wang, Tytell, & Ingber, 2009). 
1.7 Difference between 2D and 3D cultures: cell 
physiology and cytoskeleton  
In two dimensions (2D), monolayer cells adhere and migrate on planar 
surfaces (Figure 1.5A). Spread cells in 2D culture have high surface-
to-volume ratio, thus, soluble nutrients and growth factors in culture 
media can interact with receptors on the dorsal cell surface (Meyers, 
Craig, & Odde, 2006). In three dimensional models (3D), cells are 
entrapped in 3D-ECM mimicking natural microenvironment of MSCs 
(Naito et al., 2013) (Figure 1.5B). Focal adhesions distribute in all 
dimensions thus cells interact with ECM around the cells. In 3D-ECMs, 
nutrients and molecules unequally distribute across the scaffold 
depending on diffusion rate, porosity of scaffolds, etc (Cheema et al., 
2012; Rouwkema, Koopman, van Blitterswijk, Dhert, & Malda, 2010). 
Gradients of soluble factors may affect cell functions (Baker & Chen, 
2012).   
Comparing cellular responses between 2D and 3D culture, in 2D 
culture, cytoskeleton plays a major role responding to stiffness 
(McBeath et al., 2004; Provenzano & Keely, 2011). However, the 
effect of myosin-based cytoskeletal tension on differentiation is 
controversial in 3D culture (H. Lv et al., 2015). For example, Parekh 
et al., reported a wider range of stiffness (0.2 kPa-59 kPa) which can 
induce osteogenesis in MSCs in 3D compared to 2D (20-40 kPa) (Parekh 
et al., 2011). They also found that material driven 3D osteogenesis did 
not involve cytoskeletal and ROCK activity (Parekh et al., 2011). 
Huebsche et al., elucidated that MSCs are driven towards osteogenic 
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fate by 3D-ECM where the stiffness is 11-30 kPa. The authors also 
reported that the organization of integrin binding in relation to ECM 
stiffness was important to osteogenic committment, but cell 
morphology was not (Huebsch et al., 2010).  
 
Figure 1.5  Cell characteristics in 2D vs 3D culture 
(A) 2D-MSC culture, cells spread on 2D planar surface (10x 
magnification, scale bar 100 μm). (B) 3D-MSC cuture, cells have 
satellite and branched shape (10x magnification, scale bar 100 
μm) 
1.8 Chemically induced osteogenesis  
Chemical induction of osteogenesis is a common and widely used 
approach. Various growth factors (such as BMP2, BMP7) (M. 
Knippenberg, M. N. Helder, B. Zandieh Doulabi, P. I. J. M. Wuisman, 
& J. Klein-Nulend, 2006; Marupanthorn, Tantrawatpan, Kheolamai, 
Tantikanlayaporn, & Manochantr, 2017; Yeh et al., 2002) as well as 
chemical supplements (such as dexamethasone, ascorbic acid, β-
glycerophosphate, statins and calcium phosphates) (Langenbach & 
Handschel, 2013), are proposed for regulating osteogenic 
differentiation of MSCs. However, the high cost of growth factors and 
targeted delivery is challenging. Growth factor coating on material 
surfaces can reduce the cost of growth factors (Llopis-Hernández et 
al., 2016). However, drug/growth factor release requires matching to 
the dynamical changes of the bone healing process and this is hard to 
achieve (M. Wu et al., 2016).   
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1.8.1 Chemicals  
Currently, many chemicals are used for osteogenic induction. 
Dexamethasone, the most commonly used agent, induces RUNX2 
expression which is a major transcription factor for osteoblastogenesis 
(Langenbach & Handschel, 2013). Dexamethasone induces Four and a 
half LIM domains protein 2 (FHL2) which then interacts with Wnt/-
catenin and results in RUNX2 expression (Hamidouche et al., 2008). 
Moreover, dexamethasone also promotes RUNX2 activity through 
transcriptional coactivator with PDZ-binding motif (TAZ) upregulation 
which is a RUNX2 transcription coactivator as well as mitogen-
activated protein kinase 1 (MKP1) upregulation promoting RUNX2 
transactivation (Langenbach & Handschel, 2013). Some literature 
shows that glucocorticoids (GC) inhibit the ERK signaling pathway 
(Bladh, Johansson-Haque, Rafter, Nilsson, & Okret, 2009; Y. Lu, 
Fukuda, Liu, Kumagai, & Nishida, 2004). However, ERK is required for 
RUNX2 phosphorylation which, in turn, drives osteogenesis 
(Arumugam, Vairamani, Partridge, & Selvamurugan, 2017; Ge et al., 
2009). Sustained exposure of dexamethasone has been shown to 
down-regulate collagen type I synthesis and induce maturation of an 
adipocyte subpopulation within bone marrow stem cell cultures 
(Porter, Huckle, & Goldstein, 2003). High doses of GC inhibit 
osteoblast differentiation (Shalhoub et al., 1992; Smith et al., 2000). 
GC inhibit cytokines such as IL-11 thus reducing osteoblast 
differentiation (Rauch et al., 2010). In tissue engineering, 
dexamethasone can be used in many forms, such as direct loading in 
scaffolds (S. Ding et al., 2013; Tsiapla et al., 2018), loading in calcium 
phosphate nanoparticles (Ying Chen, Chen, Kawazoe, & Chen, 2018; 
Y. Chen, Kawazoe, & Chen, 2018) or direct mixing with 3D printed 
materials (X. Li et al., 2018).  
Ascorbic acid (vitamin C) and β-glycerophosphate are commonly used 
in osteogenic induction cocktails. Ascorbic acid promotes collagen 
type I and fibronectin secretion which are ECM proteins, as well as 
integrin β1 expression (F. Wei et al., 2012). The transportation of 
ascorbic acid into MSCs (via sodium dependent vitamin C transporter 
2; SVCT2) also reduces oxidative stress (Sangani et al., 2015). 
However, high doses of ascorbic acid (5-250 μM) provide toxicity, 
reducing cell density and changing cell morphology (K. M. Choi et al., 
2008). β-glycerophosphate provides an inorganic phosphate source for 
mineralization (Chung, Golub, Forbes, Tokuoka, & Shapiro, 1992), 
promotes ERK1/2 phosphorylation and regulates osteopontin (Beck & 
Knecht, 2003). However, high level of phosphate ions induces 
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osteoblast apoptosis (Meleti, Shapiro, & Adams, 2000). Ascorbic acid 
and β-glycerophosphate can be supplemented in composites for bone 
tissue engineering (Faikrua, Jeenapongsa, Sila-asna, & Viyoch, 2009; 
T. Liu et al., 2018; C. Wang, Cao, & Zhang, 2017).  
Statins or β-Hydroxy β-methylglutaryl-CoA (HMG-CoA) reductase 
inhibitors are commonly used in hyperlipidemia treatment (H. D. Choi 
& Chae, 2018). In bone, statins upregulate BMP2 and RUNX2 enhancing 
osteoblastic differentiation and reducing osteoclastogenesis (Oryan, 
Kamali, & Moshiri, 2015). However, some studies have shown that high 
doses of statins may induce apoptosis (Izadpanah et al., 2015; 
Kupcsik, Meurya, Flury, Stoddart, & Alini, 2009). Statins can be used 
in tissue engineering, for example, simvastatin can be supplemented 
in form of microspheres (Yu et al., 2017).  
1.8.2 Growth factors 
BMPs, growth factors inducing bone induction, are widely studied in 
bone tissue engineering (Jian Yang et al., 2014). BMP2 (Beazley & 
Nurminskaya, 2014), BMP6 (Akman, Seda Tigli, Gumusderelioglu, & 
Nohutcu, 2010), BMP7 (Cook et al., 2000) and BMP9 (Dumanian et al., 
2017; T. Fu et al., 2019; Tasli, Aydin, Yalvac, & Sahin, 2014) provide 
potent osteoinductive activity. BMP7 not only promotes osteogenesis 
but also enhances chondrogenesis (F. Chen et al., 2019; M. 
Knippenberg, M. N. Helder, B. Zandieh Doulabi, P. I. Wuisman, & J. 
Klein-Nulend, 2006; Tasli et al., 2014). However, there is much 
literature reporting clinical complications of BMPs overdosing such as 
ectropic bone ossification, vertebral osteolysis, radiculitis, etc 
(Carragee, Hurwitz, & Weiner, 2011; Shimer, Oner, & Vaccaro, 2009). 
Moreover, BMP protein degradation is rapid (El Bialy, Jiskoot, & Reza 
Nejadnik, 2017). It is difficult to design scaffolds which can slowly and 
continuously release BMPs sustaining the growth factor within the 
safety range. Further, not only clinical complications, but also the 
cost effectiveness of using BMP-2  is controversial. The use of BMPs 
for spinal fusion surgery may increase the cost of the procedure to the 
UK-NHS by about 1.3 million pounds per year and 3.5 million pounds 
per year in open tibial fractures treatment (Garrison et al., 2007). To 
reduce this problem, BMP2 nanocoatings on materials has been 
proposed (Llopis-Hernández et al., 2016). This technique potentially 
reduces the cost of growth factor using and also diminishes side 
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effects of high dose BMPs (Z. A. Cheng et al., 2019; Llopis-Hernández 
et al., 2016).  
1.9 Mechanical stimulation, mechanotransduction and 
osteogenesis 
It is known that mechanical stimulation can promote bone healing and 
bone homeostasis (Bouletreau, Warren, & Longaker, 2002; X. Huang, 
Das, Patel, & Duc Nguyen, 2018; Steward & Kelly, 2015). In bone tissue 
engineering, many studies propose techniques to promote 
osteogenesis using mechanical stimuli such as cyclic stretch (J. Gao et 
al., 2016; Y. Yang, Wang, Chang, Wan, & Han, 2018), compression 
(Burger, Klein-Nulend, & Veldhuijzen, 1992), tensile stretch 
(Grottkau, Yang, Zhang, Ye, & Lin, 2013) and fluid shear (Stolberg & 
McCloskey, 2009; Yourek, McCormick, Mao, & Reilly, 2010). Even 
though mechanical osteogenic induction is widely studied, the 
challenge remains in precisely controlling the stimulus intensity as 
well as upscaling to industry.  
Mechanotransduction is the process that converts extracellular 
physical stimuli to biological signals resulting in cellular responses 
such as cell adhesion, proliferation, differentiation and survival. After 
cells sense the stimuli, mechanical signals are transferred through 
specific pathways. The MAPK pathway is activated to regulate cellular 
response (Plotnikov, Zehorai, Procaccia, & Seger, 2011). Intracellular 
signals also activate nuclear factor kappa B (NFκB) functioning as 
stress sensor (Ahn & Aggarwal, 2005). Overdose of stimuli may 
activate cell survival pathways to maintain proper cellular function 
(T. Wang, Zhang, & Li, 2002). Yes-associated protein (YAP) functions 
in stress memory (C. Yang et al., 2014). YAP accumulation from 
adequate dose/duration of mechanical stimuli and, in turn, switches 
on genes for differentiation (Elosegui-Artola et al., 2017) (Figure1.6). 
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Figure 1.6  Mechanotransduction model; from receptors into 
nucleus 
1.9.1 Mechanical stimuli, sensors and related pathways 
As aformentioned, various types of physical stimuli induce 
osteogenesis, such as tension, compression, fluid shear stress and 
substrate material properties (Kyle H. Vining & David J. Mooney, 
2017). Cells sense mechanical stimuli and environment using 
mechanosensors such as focal adhesion-cytoskeleton, membrane ion 
channels, and primary cilia (J. C. Chen & Jacobs, 2013). Single stimuli 
may activate multiple mechanical sensors. For example, fluid shear 
stress can involve integrin-dependent pathways and also activates 
cilia (Yavropoulou & Yovos, 2016). Thus, single mechanical stimulus 
may activate multiple pathways, such as cyclic stretch which can 
activate BMP2, Wnt, ROCK, etc (J. Gao et al., 2016; Suzuki, Nemoto, 
& Shimauchi, 2014; C. Zhao et al., 2017). Examples of stimuli and 
related pathways are summarized in Table 1.2-1.3.   
Chapter 1: Introduction 26  
1.9.1.1 Integrin dependent pathway   
Integrins are major mechanoreceptors sensing ECM stiffness or 
topography. Integrins on cell memebranes form focal adhesion 
complexes. At the focal adhesion, tyrosine kinases (e.g. FAK and Src) 
in turn regulate G-proteins (e.g. Rho and Rac) and actin 
microfilaments generating localized signaling for lamellipodia and 
filopodia formation and cytoskeletal contraction (Burridge & 
Wennerberg, 2004; Guilluy, Garcia-Mata, & Burridge, 2011).  The 
ROCK/Rho pathway also activates the MAPK pathway (e.g. ERK1/2, 
JNK) which takes an important role in the integrin dependent pathway 
controlling MSC growth and differentiation (McMurray et al., 2011; 
Tsimbouri et al., 2012). 
1.9.1.2 Stretch activated ion channels  
Mechanical stimuli can also affect mechano-sensitive ion channels on 
the cell membrane which subsequently allow extracellular calcium 
influx. Each ion channel senses mechanical stimuli at different 
intensity of stimuli (Figure 1.7) (Bavi et al., 2017). There are two 
models explaining how mechanosensitive ion channels respond to 
mechanical stimuli. Tension force may be transferred via the cellular 
membrane in turn directly opening ion channels thus called “force 
from membrane”. Another model explains the mode of channel 
response to stimuli via the tethering effect of intracellular or extra-
cellular structures called  “force from filament” (Martinac & Poole, 
2018).  
It is difficult to prove whether ion channels respond directly or 
indirectly to mechanical stimuli. Some evidence suggested that piezo1 
may directly respond to stimuli via membrane tension (Charles D. Cox 
et al., 2016; Syeda et al., 2016). However, some literature reports the 
evidence of the channel response via cytoskeletal activation 
(Albarran-Juarez et al., 2018). Piezo1 can be found in many cell types 
(Coste et al., 2010). Piezos can sense shear flow (Albarran-Juarez et 
al., 2018; Jetta, Gottlieb, Verma, Sachs, & Hua, 2019), stiffness 
(Pathak et al., 2014), tissue tension (Lewis & Grandl, 2015), and sound 
waves (Coste et al., 2012). Osteoblasts also use piezo1 for mechanical 
sensing relating to bone formation (W. Sun et al., 2019). Moreover, 
MSCs respond to mechanical stimuli such as hydrostatic pressure 
producing BMP2 through piezo1 activation (Asuna Sugimoto et al., 
2017). Transient receptor potential vanilloid 4 (TRPV4) is another ion 
channel that senses mechanical stimuli such as deflection (Rocio 
Chapter 1: Introduction 27  
Servin-Vences, Moroni, Lewin, & Poole, 2017) and cell swelling 
(Becker, Blase, Bereiter-Hahn, & Jendrach, 2005). TRPV4 allows 
calcium influx which in turn crosstalks with abundant intracellular 
pathways (Hasan & Zhang, 2018). Increased intracellular calcium may 
enhance osteogenic differentiation (Boonrungsiman et al., 2012). 
TRPV4 also plays a role as themosensor and nociceptor (Plant & 
Strotmann, 2007; Shibasaki, 2016) and may modulate inflammation 
releasing IL-6 through MAPK pathways (Nayak et al., 2015). 
 
Figure 1.7  The mechanical response spectrum of ion channels 
stimulated by patch-clamp technique  
(With permission of Bavi., et al 2017 (Bavi et al., 2017; C. D. 
Cox, Bavi, & Martinac, 2017; Morris, 2011; Sachs, 2010)).  
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1.9.1.3 Primary cilia movement  
Osteoblasts use primary cilia to sense fluid flow (Malone et al., 2007) 
and cyclic tensile strain (J. Bodle et al., 2019). Some literature shows 
that activation of primary cilia potentially promotes osteogenesis (J. 
C. Bodle et al., 2013; Hoey, Tormey, Ramcharan, O'Brien, & Jacobs, 
2012). Fluid flow induces extracellular calcium influx through cilium-
localized Ca2+-permeable channels polycystin-2 (PC-2) and TRPV4 (K. 
L. Lee et al., 2015). However, Malone et al., showed that primary cilia 
activation can induce osteogenesis through cilia but does not relate 
to calcium influx and stretch activated ion channels (Malone et al., 
2007).  
1.9.1.4 Other  
Gap junctions may be considered as mechanical sensors. Gap 
junctions (such as connexins) allow molecule and ion transportation 
between cells which may be stimulated during mechanotransduction 
(Saunders et al., 2003). Connexin 43, for example, plays a role in the 
osteogenic fate through the glycogen synthase kinase 3-beta (GSK-
3β)/β-catenin pathway (F. X. Lin et al., 2018).  
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Table 1.2  Examples of cyclic stress studies and related pathways 
Types 
%strain/ 
frequency/duration 
Cell type Related pathways 
2D/3D 
cellular 
response 
Outcomes References 
Cyclic 
compression 
10%, 0.5 Hz, 4 hr Pre-osteoblast BMP2 2D & 3D 
Induce BMP2/SMAD5, RUNX2, ALP OCN, ON, OPN 
and Col1A 
Rath et al 2009 (Rath, Nam, Knobloch, 
Lannutti, & Agarwal, 2008) 
Cyclic stretch 
3, 5, 10%, 0.016 Hz, 
6 hr 
Periodontal 
ligament cells 
BMP2 2D 
- Increase BMP2 (via ERK1/2, p38 
- Induce COX2  
Suzuki et al 2013 (Suzuki et al., 2014) 
2 mm, 0.2 Hz,1 hr BMSCs, rats Wnt/β catenin 2D 
- Increase proliferation 
- Upregulate ALP, Wnt3a, LRP5, β catenin and 
RUNX2 
Zhao et al 2017 (C. Zhao et al., 2017) 
0-8%, 0.5 Hz, 4 hrs 
Human patellar 
tendon fibroblasts 
TGF-β1 2D - Increase TGF-β and Col-1 gene expression 
Yang et al 2004 (G. Yang, Crawford, & 
Wang, 2004) 
12%, 24 hrs MG63 
Cytoskeleton 
(Cofilin) 
2D ALP, OCN, RUNX2, Col-1 upregulation Gao et al 2016 (J. Gao et al., 2016) 
10%, 0.1 Hz, 24 hrs HDPLCs ROCK and YAP 2D 
- Increase CTGF and CYR61 (YAP target gene) 
- YAP links to ROCK pathway 
Yang et al 2018 (Y. Yang et al., 2018) 
15%, 1/12 Hz MC3T3-E1 ERK1/2 2D - Upregulate ALP and RUNX2 through ERK1/2  
Kanno et al 2007 (Kanno, Takahashi, 
Tsujisawa, Ariyoshi, & Nishihara, 2007) 
15%, 0.5 Hz Dermal fibroblasts MAPK 3D 
ERK1/2 upregulation at 6 hrs or increase stimuli 
Incremental stretch increase collagen 
transcription 
Schmidt et al 2016(Schmidt, Chen, & 
Tranquillo, 2016) 
10%, 1 Hz 
Bovine aortic 
endothelial cells 
Cytoskeleton 
(Rho kinase and mDia) 
2D 3% stretch enhance stress fiber orientation 
Kaunas et al 2005 (Kaunas, Usami, & 
Chien, 2006) 
1-5%, 0.01-10 Hz PMEFs 
Cytoskeleton, YAP, 
MRTF-A 
2D 
- Cell spreading and stress fiber formation  
- Increase YAP and MRTF-A nucler localization 
Cui et al 2015 (Cui et al., 2015) 
25%, 12 Hz, 1 hr Satellite cells, rat Calcium ion channels 2D 
- Mechanical sensing and L-VGC channel allow 
extracellular calcium influx 
Hara et al 2012 (Hara et al., 2012) 
CYR61; cysteine-rich angiogenic inducer 61, HPDLCs; Human periodontal ligament cells, PMEFs; Primary mouse embryo fibroblast  
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Table 1.3  Examples of fluid flow, vibration, stiffness studies and related pathways 
Types Intensity/duration Cell type Related pathways 
2D/3D 
Cellular 
response 
Outcomes References 
Fluid flow 
Primary cilia, 1 Pa, 52.5 ml/min, 
1 Hz, 2 hrs 
C3H10T1/2 murine 
MSCs 
TRPV4 2D - TRPV4 localization at primary cilium 
Corrigan et al 2018 (Michele A. 
Corrigan et al., 2018) 
Pulsatile fluid flow, 
0.8 Pa, 1-4 hrs 
ROS17/2.8 osteoblast Wnt 
2D on 3D 
scaffold 
- Upregulate ALP, LRP5, Wnt3a and β-catenin Jia et al 2014 (Jia et al., 2014) 
12 dynes/cm2, 2 hrs HPDLCs MAPK 2D - Upregulate ALP, Col-1, ERK1/2, p38 
Tang et al 2014 (M. Tang et al., 
2014) 
Shear stress, flow rate 0.274 
μL/min, 48 hrs 
hMSCs TAZ 2D 
- Upregulation of CTGF and Cyr61 (TAZ 
related) 
- Upregulate RUNX2 DLX5 and Msx2 
Kim et al 2014 (K. M. Kim et al., 
2014) 
9 dynes/cm2, 24 hrs hMSCs BMP2 2D - Upregulation of BMP2, OPN  
Yourek et al 2010 (Yourek et al., 
2010) 
Vibration 
LMHFV, 0.3g, 40 Hz, 
50 μm, 15 mins/day 
MSCs MAPK 2D - Promote adipogenesis (PPARγ) and p38  
Zhao et al 2017 (Zhao, Lu, Gan, & 
Yu, 2017) 
LMHFV, 0.3g, 60 Hz, 1 hr Rat BMSCs - 2D - Decrease osteogenesis and mineralization Lau et al 2011 (Lau et al., 2011) 
LMHFV,0.3g, 40 Hz, 
30 mins/day 
Rat BMSCs Wnt/β-catenin 2D 
- Increase fibronectin, integrin, vinculin  
expression  
- Upregulate Wnt10B, β-catenin, RUNX2, OSX 
Chen et al 2016 (B. Chen et al., 
2016) 
LMHFV,0.3g, 45 Hz, 
20 mins/day, 5 day/week 
MC3T3-E1 Cytoskeleton 2D 
- Cell proliferation and Cox2 expression 
related to estrogen receptor α 
- Vibration involved ROCK pathway 
Haffner-Luntzer et al 2018 
(Haffner-Luntzer, Lackner, 
Liedert, Fischer, & Ignatius, 2018) 
stiffness 
134, 16 and 1.2 kPa, PDMS Rat Osteoblast ROCK 2D 
- Soft stiffness decreases RUNX2, OCN which 
related to ROCK pathway 
Zhang et al 2017 (T. Zhang et al., 
2017) 
2-20 kPa 
Polyacrylamide gels 
 
HCT-116 Colorectal 
cancer cell line 
YAP/TAZ 2D Stiffness increase Lamin A/C regulated by YAP 
Tan et al 2017 (F. Tan et al., 
2018) 
0.5-1 kPa and 100 kPa 
Polyacrylamide gels 
BMSCs, primary 
chondrocytes 
Wnt/ β-catenin 2D 
Stiffness enhance Wnt/ β-catenin pathways 
and also activate FAK pathway 
Du et al 2016 (Du et al., 2016) 
LMHFV; low-magnitude high frequency vibration, LRP5; lipoprotein receptor-related protein 5, HPDLCs; Human periodontal ligament cell 
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1.9.2 Role of nanoscale mechanical stimulation in osteogenesis 
The concept of nanoscale mechanical stimuli originates from that size 
of structures on cellular membranes, such as integrins (Campbell & 
Humphries, 2011) etc. Thus, nanoscale mechanical stimuli possibly 
affect proteins or receptors on membranes triggering 
mechanotranductive signals into the nucleus. Currently, the effect of 
nanotopography is elucidated that it can promote osteogenesis of 
MSCs (Dalby et al., 2007), regulate cytoskeletal tension and 
transcriptional co-activator with PDZ-binding motif (TAZ) (Qian et al., 
2017). Various types of nanotopography, such as nanopits (Davison, 
McMurray, Smith, Dalby, & Meek, 2016), nanowires (H. H. Pan et al., 
2015), nanopillars (Sjostrom et al., 2009) and nanorods (Ning et al., 
2016) show interaction with the cytoskeleton. Patterning of 
nanotopography, such as disordered patterns, regulates formation of 
nanopodia and focal adhesion in turn modulates cytoskeletal tension 
(Dalby et al., 2014; McNamara et al., 2014). Cytoskeleton links to the 
LINC complexs, potentially triggering chromosome reorganization 
(Dalby et al., 2014).   
1.9.3 Role of MAPK-NFκB pathways and mechanosensing in 
physiological and inflammatory conditions  
During physiological or inflammatory conditions, MAPK (signal 
regulator) and NFκB (stress sensor) play a critical role in controlling 
intracellular signaling to produce proper cellular response to external 
stimuli such as differentiation or apoptosis (Ahn & Aggarwal, 2005; 
Chang et al., 2013; Cowan & Storey, 2003; Lawrence, 2009; T. Liu, 
Zhang, Joo, & Sun, 2017; W. Zhang & Liu, 2002).  
The MAPK signaling pathway is the central pathway responding to 
extracellular stimuli such as stress, cytokines, etc. The MAPK pathway 
mediates the intracellular signaling pathways of proliferation, 
differentiation, inflammation and apoptosis. The MAPK pathway 
consists of extracellular signal regulated kinase (ERK), p38 and c-Jun 
NH2-terminal kinase (JNK) (Plotnikov et al., 2011; W. Zhang & Liu, 
2002). 
ERK1/2 upregulation can be induced by various stimuli such as 
inflammation and stress (Plotnikov et al., 2011). ERK1/2 links to 
cytoskeletal tension induced osteogenesis through Integrin-FAK-ROCK-
ERK1/2 pathways (McBeath et al., 2004; Shih et al., 2011). ERK1/2 is 
also activated by ion channel activation (Vyklicka, Boukalova, 
Macikova, Chvojka, & Vlachova, 2017). Moreover, ERK1/2 is also 
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involved in cell proliferation and apoptosis (Mebratu & Tesfaigzi, 
2009).  
P38, another member of the MAPK family, also affects osteogenesis 
by promoting and suppressing relevant proteins. P38 can be activated 
by stress (Plotnikov et al., 2011) and promotes bone progenitor 
proliferation and differentiation (Rodriguez-Carballo, Gamez, & 
Ventura, 2016). Not only ERK1/2, but also p38 can phosphorylate 
RUNX2 to active bone formation (Rodriguez-Carballo et al., 2016). P38 
is also involved in many osteogenesis pathways such as BMP/TGF-
p38--catenin and WNT-p38--catenin (Rodriguez-Carballo et al., 
2016). 
It has been shown that JNK is involved in apoptosis pathways (A. Lin, 
2003; Weston & Davis, 2007). Activation of JNK together with AKT and 
NFB enhances cell survival (Lamb, Ventura, Hess, Flavell, & Davis, 
2003). JNK can be activated by stress and cytokines such as IL-1 and 
TNF (Plotnikov et al., 2011; Rodriguez-Carballo et al., 2016). ERK1/2 
can directly activate JNK kinase (W. Zhang & Liu, 2002). The role of 
JNK for osteogenesis is not obviously clear. Some reports have shown 
that JNK is important for osteoblast function (R. Xu et al., 2017). On 
the other hand, JNK inhibition may enhance osteogenesis e.g. in 
stromal cells (Doan et al., 2012). 
As aformentioned, optimal mechanical stimulation can enhance 
osteogenesis (J. C. Chen & Jacobs, 2013; K. H. Vining & D. J. Mooney, 
2017). However, high intensity (overdose) mechanical stimulation can 
induce reactive oxygen species (ROS) or inflammatory response 
(Biswas, 2016). Theoretically, a low level of inflammation enhances 
osteogenesis and mineralization as this occurs in the early phase of 
the normal bone healing process (Knapik et al., 2014). However, high 
grade inflammation can suppress osteogenesis (H. Huang et al., 2011; 
Lacey, Simmons, Graves, & Hamilton, 2009). With optimal (low grade) 
inflammatory response, IL-6 and TNF (essential inflammatory 
cytokines) are secreted in the early phase of bone healing. TNF, a 
paracrine cytokine, interacts with MAPK and caspases (J. Liu, 
Minemoto, & Lin, 2004; L. Wang, Du, & Wang, 2008) and activates 
NFB (N. Wang et al., 2016). Moreover, TNF promotes angiogenesis 
(Kwon et al., 2013) and enhances MSCs to secrete IL-6 (De Cesaris et 
al., 1998). Sun et al., proposed that IL-6 could then enhance BMP2 
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production (M. Sun et al., 2017) promoting RUNX2 expression and 
therefore bone production.  
NFB pathways regulate inflammation and the immune system. NFB 
is a stress sensor that is activated for cell survival (Ahn & Aggarwal, 
2005). NFB is involved in proliferation, apoptosis and differentiation 
(T. Liu et al., 2017). NFB prevents TNF-induced apoptosis by 
suppressing caspases and JNK activation (A. Lin, 2003). NFB enhances 
manganese superoxide dismutase (MnSOD) which is a ROS antioxidant 
enzyme (H. Tanaka et al., 2002). Therefore, an increase of NFB 
provides evidence for increased inflammatory response. 
Sudha Agarwal’s group studied the effect of magnitude of mechanical 
stimuli on intracellular signaling response and NFκB signaling pathways 
(Agarwal et al., 2003; Anghelina et al., 2008; Dossumbekova et al., 
2007; Knapik et al., 2014; Madhavan et al., 2007; J. Nam, Aguda, 
Rath, & Agarwal, 2009). At physiological magnitudes, mechanical 
stimulus activates intracellular signals in which it promotes 
osteogenesis from pathways such as BMP2/Smad, calcium signaling, 
ERK1/2, nitric oxide, prostaglandin E2 and Wnt (Knapik et al., 2014). 
The NFκB pathway is also activated to control oxidative stress 
(Oeckinghaus & Ghosh, 2009). In oxidative stress conditions induced 
by mechanical stimuli, NFκB provides anti-oxidative functions such as 
increasing antioxidants and autophagy, reducing ROS and JNK as well 
as increasing pro-oxidant genes such as NADPH oxidase (Lingappan, 
2018). In conditions where cells are injured by exposure to high 
magnitude stimulation, NFκB activates high levels of proinflammatory 
cytokines and signals such as TNFα, IL-1β, NO and ROS resulting in 
supressed osteogenesis (Anghelina et al., 2008; Dickson, Bhakar, & 
Barker, 2004; N. Wang et al., 2016). Interestingly, in inflammatory 
conditions, the physiological magnitude of mechanical stimulation can 
inhibit the NFκB signaling pathway (by suppressing TRAF6 in turn IKKs 
and IκB inactivation), thus promoting anti-inflammatory signals 
(Knapik et al., 2014) (Figure 1.8). 
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Figure 1.8  Effect of stimulating magnitude on inflammation  
In normal conditions (left), physiological magnitudes promote 
osteogenesis through multiple pathways such as SMADs, MAPK 
and β-catenin. High magnitude stimulation (middle) activates 
high levels of NFκB functioning as a pro-inflammatory signal. 
Osteogenesis is thus suppressed. During inflammatory conditions 
(right), low grade machanical stimulation inhibits NFκB to 
promote osteogenesis (With permission of Knapik et al., 2014 
under Mary Ann Liebert, Inc, New Rochelle, NY (Knapik et al., 
2014)).   
Chapter 1: Introduction 35  
1.10 Nanovibrational stimulation; concept and related 
pathways and rationale of 3D study.  
The concept of NS was firstly established by Prof Adam Curtis (1934-
2017) as nanoscale stimuli, such as nanotopography, can modulate cell 
adhesion in turn driving osteogenesis (Dalby et al., 2007). Together 
with, cells can sense the difference of topography at approximately 8 
nm (McNamara et al., 2014). Thus, Prof Curtis proposed that 
application of controllable and precise external force stimulation on 
the nanoscale may drive changes in cell response. Further, osteogenic 
differentiation seemed to be a sensible target because of the 
adhesion-cytoskeleton relationship (Kilian et al., 2010; McBeath et 
al., 2004; Nikukar et al., 2013). 
The NS bioreactor uses piezo actuators to generate stimulating 
amplitudes in Z axis which is perpendicular to the base of culture 
surface (Curtis et al., 2013). In MSCs, NS drove osteogenic induction 
in both 2D and 3D cultures. In 2D culture, Nikukar et al., found that 
NS drives osteogenesis through a RhoA-ROCK pathway (Nikukar et al., 
2013). To explain the mechanism, the hypothesis of 2D-NS mechanism 
was that nanovibration (in the Z-axis) possibly oscillated the culture 
media and attached cells in the culture plate (X-Y plane) resulting in 
repetitive and fast membrane indentation (Curtis et al., 2013). This 
pico Newton force, which is of similar magnitude to stimulate hair 
cells during hearing (Curtis & Tsimbouri, 2014), may flutter the cell 
membrane (Rappaz et al., 2009) and, in turn, initiates intracellular 
signals (D. Wu, Ganatos, Spray, & Weinbaum, 2011) through 
cytoskeletal tension regulation (McBeath et al., 2004), switching on 
gene expression and driving osteogenesis (Childs et al., 2015). 
Moving from 2D towards in vivo and clinical studies, the effect of NS 
in 3D culture were in turn conducted. Recently, Tsimbouri et al., 
showed successful results of 3D NS in collagen hydrogels and proposed 
that NS promotes 3D osteogenesis in hMSCs via the TRPV1 ion channel, 
PKC and β-catenin pathways. Cytoskeleton thus appears to be less 
involved in 3D culture (Tsimbouri P.M., 2017).  Further details are 
discussed in chapter 4.  
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1.10.1 Amplitudes, frequencies and acceleration 
To mechanically induce cellular differentiation, an adequate dose of 
mechanical stimulation vibration, is crucial (Elosegui-Artola et al., 
2017; Y. Yang et al., 2018). The dose of mechanical stimuli such as 
cyclic stretch and vibration affecting cell growth depends on various 
factors including frequency, intensity, and duration (Cui et al., 2015). 
Currently, the effect of vibrational stimulation on osteogenic 
induction is intensively studied (Brooke McClarren & Ronke Olabisi, 
2018). However, large variations of stimulating amplitude, frequency 
and duration have been used for osteogenic induction (Table 1.4-
1.5). Determining the primary factors of NS, among amplitude (nm), 
frequency (Hz) or magnitude (g); which one mainly drives 
osteogenesis, is challenging. 
Biologically, the adequate dose of mechanical stimulation allows YAP 
nuclear translocation, in turn, driving osteogenic differentiation 
(Elosegui-Artola et al., 2017; Y. Yang et al., 2018). Some in vitro 2D 
studies showed that adequate dose of intensity of cyclic strain can 
promote cellular reorientation and stress fiber (Cui et al., 2015; Faust 
et al., 2011). However, the intensity and frequency of stimuli also 
relate to cellular stress (Chapman et al., 2005; Hong et al., 2015). 
Optimal strain promotes osteogenesis while over strain decreases 
osteogenesis (M. Arai, Shibata, Pugdee, Abiko, & Ogata, 2007; Atashi, 
Modarressi, & Pepper, 2015; Chapman et al., 2005; J. Tan et al., 
2015). 
Considering the effect of frequency on cell differentiation, some 
studies showed that increase stimulating frequency affect phenotypic 
expression. Chen X et al studied the effect of increasing frequency in 
acoustic-frequency vibratory stimulation (from 0 upto 800 Hz) and 
reported that higher frequency stimulation (800 Hz) with 0.3 g of 
magnitude promoted osteogenesis and suppressed adipogenesis (X. 
Chen, He, Zhong, & Luo, 2015). However, this study did not control 
the amplitude during stimulation. Interestingly, The stimulating 
frequency of Chen X et al study was comparable to Nikukar’s  
(Nikukar, 2013) and Tsimbouri’s (Tsimbouri P.M., 2017) studies (1000 
Hz) for enhancing osteogenesis in MSCs.  
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Gravity (acceleration) also affects on MSC differentiation. In in vitro 
studies, low gravity condition (e.g. microgravity) induces adipogenesis 
(Dai, Wang, Ling, Wan, & Li, 2007; M. Zayzafoon, Gathings, & 
McDonald, 2004) while hypergravity can induce osteogenesis (S. Zhou, 
Zu, Sun, Zhuang, & Yang, 2015).  
Considering the studies using vibrational stimulation to induce 
osteogenesis in MSCs, low-magnitude high frequency vibration 
(LMHFV) is commonly investigated. LMHFV is defined by a magnitude 
less than 1 g with a frequency of 20-90 Hz (Y. Zhou et al., 2011). In 
our centre, Nikukar et al., (Nikukar, 2013; Nikukar et al., 2013) and 
Pemberton et al., (G.D., 2015; Pemberton et al., 2015) previously 
investigated the effect of NS. They found that NS with 20-30 nm 
amplitude at 1000 Hz frequency enhances osteogenesis. At 20-30 nm, 
the force is extremely small (0.05-0.12 g). As NS (nanovibrational 
stimulation or Nanokick) uses ultra low amplitude (in nanoscale) with 
high frequency (1000 Hz). Thus, term of “ultra low amplitude high 
frequency vibration (ULAUHFV)” was newly proposed for better 
classification. 
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Table 1.4   Examples of low-magnitude high frequency vibration (LMHFV), stimulating dose 
and outcomes 
2D/3D Cell types Amplitude, frequency, duration Outcomes References 
2D MSCs, rats 
0.3 g, 60 Hz, 1 hr/day, 6 
days/week 
Decrease OSX and mineralization Lau et al., 2011 (Lau et al., 2011) 
3D MSCs, rats 
0.3 g, 40 Hz, ±50 μm, 30 mins/12 
hr 
Upregulate RUNX2, ALP, Col1, OCN 
and ERK1/2 
Zhou et al., 2011  (Y. Zhou et al., 
2011) 
3D porous 
titanium alloy 
Primary 
osteoblast, 
rabbits 
0.5 g, 30 Hz, 6 and 12 weeks 
Increase OCN, RUNX2, Wnt3a, Lrp6 
and β-catenin 
Jing et al., 2015 (Jing et al., 2015) 
OP rat, In vivo 
HA coated 
titanium 
0.3 g, 40 Hz, ±50 μm, 30 
mins/12 hr, 5 days 
Upregulate osteoblast 
differentiation via ERK1/2 and 
suppress osteoclastogenesis 
Zhou et al., 2015 (Y. Zhou et al., 
2015) 
2D HA coated 
surface 
MSCs, rats 0.3 g, 40 Hz, 30 min /day 
Increase FN, RUNX2, OSX, ALP, 
Col1, OCN 
Chen et al., 2016 (B. Chen et al., 
2016) 
2D hASCs 0.3 g, 25, 35, 45 Hz 
35 Hz promote cartilaginous tissue 
formation 
Marycz et al., 2016 (Marycz et al., 
2016) 
2D hASCs 
0.3 g, 25, 35, 45 Hz, 10 min 0-3 
week 
25 Hz, increase differentiation and 
mineralization 
Maredziak et al., 2017 (Marędziak, 
Lewandowski, Tomaszewski, 
Kubiak, & Marycz, 2017) 
2D MSCs, rats 0.3 g, 50 μm, 40 Hz, 15 mins/day Promote adipogenesis via p38 
Zhao et al., 2017(Q. Zhao et al., 
2017) 
2D 
MC3T3-E1, mice 
primary 
osteoblasts 
0.3 g 45 Hz, 20 mins/day, 
5days/week 
LMHFV depend on estrogen 
receptor α signaling 
Haffner-Luntzer et al., 2018 
(Haffner-Luntzer et al., 2018) 
3D PEG hTERT-hMSCs 
0.3, 3, 6 g, 0.0149, 0.149,  
0.298 mm, 100 Hz, 24 hr 
3g promotes but 6 g inhibits 
osteogenesis 
Mehta et al., 2018 (Mehta et al., 
2018) 
ASCs; adipose derived mesenchymal stem cells, OP; osteoporotic  
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Table 1.5  Available publication of ultra low magnitude high frequency vibration (ULMHFV) 
2D/3D Cell types Amplitude, frequency, duration Outcomes References 
2D 
L929, MEFs 
EEFs, Hela, 
HUVECs 
100 nm , 1000 Hz 
Increase filopodia formed cells and gene 
expression  
Ito et al., 2011 (Y. Ito et al., 
2011) 
2D hMSCs 0.05 g, 12.57 nm, 1000 Hz Increase BMP2, RUNX2, FAK and ERK1/2 
Nikukar et al., 2013 (Nikukar et 
al., 2013). 
2D 
nanotopography 
Le-2 
endothelial 
cells 
20 nm peak to peak, 
0.8 x10-7 g at 1 Hz, 
0.2 x 10-3 g at 50 Hz 
Increase Kruppel-like factor 2 and cell 
adhesion 
Curtis et al., 2013 (Curtis et 
al., 2013) 
2D 
nanotopography 
hMSCs 
~ 0.12 g, 16-30 nm, 
1000-5000 Hz 
1000 Hz enhance RUNX2, BMP2, OCN, ON 
and mineralization 
Pemberton et al., 2015 
(Pemberton et al., 2015) 
3D collagen hMSCs 
0.10-0.12 g, 25-30 nm, 
1000 Hz, 1-3 weeks 
Promote 3D osteogenesis via TRPV1-PKC-
β-catenin 
Tsimbouri et al., 2017 
(Tsimbouri P.M., 2017) 
3D collagen hMSCs 
0.36 g, 90 nm, 1000 Hz, 
1-3 weeks 
Increase osteogenic gene/protein 
expression, ROS 
Orapiriyakul et al., 2019 
(In this thesis) 
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1.11 Nanovibrational bioreactor development 
The development of the NS bioreactor aimed to improve the generation 
of precise amplitudes (and frequencies) and also consider upscaling for 
industry and clinical application. The first generation NS bioreactor was 
assembled using single petri dishes attached onto single piezo actuators 
(Nikukar et al., 2013) (Figure 1.9A). The first version was difficult to 
assemble and upscale. The second generation (T1000-2000) comprised 
arrays of piezo actuators assembled on aluminium base block. All piezos 
stimulated a rigid metallic top plate where tissue culture plates were 
attached (Figure 1.9B). The third generation (T3000-5000) used a laptop 
signal generator, thus, the user could adjust to the desired stimulating 
amplitude simply (Figure 1.9C). The fourth generation (NTB version) has 
bespoke signal generating apparatus with set applitude and frequency 
(30 nm, 1000 Hz) - i.e. an on/off switch for ease of use. Additionally, 
handles were designed for convenient transfer in the laboratory (Figure 
1.9D). In the fifth generation (NTB version), the piezo-top plate-base 
block assembly was changed from gluing to screwing with C-clamp in 
order to improve precision of stimulating amplitude across different 
areas on top plate and because, with time, it was noted that the glue 
could fail (Figure 1.9E).  
 
Figure 1.9 NS bioreactor development from 1st to 5th generation.  
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1.12 Bone tissue engineering  
Successful bone healing treatments require osteogenic cells, 
osteoconductive scaffolds and osteoinductive factors (such as growth 
factors and mechanical environments) (Giannoudis, Einhorn, & Marsh, 
2007). To achieve these goals, biomaterials science is a key 
consideration in creating cellular microenvironments / scaffolds that can 
promote osteoconductivity and osteoinductivity (Lane et al., 2014). 
Materials for bone tissue engineering require biocompatibility, 
osseointegration and also, optimally, possess biodegradability (Bettina 
M. Willie & Patrick Strube, 2010). Moreover, bone scaffolds require to be 
rigid for mechanical support but need to allow nutrients, oxygen and 
growth factors permeation throughout the scaffolds enhancing cell 
growth and angiogenesis (Rouwkema et al., 2010; Yousefi, Hoque, 
Prasad, & Uth, 2015). Thus, integrating the knowledge of material 
property (e.g. stiffness (Olivares-Navarrete et al., 2017)) and structural 
architecture (e.g. porosity (Karageorgiou & Kaplan, 2005; Loh & Choong, 
2013)) is a fundamental concept to synthesise the scaffold mimicking 
forms and functions of bone. 
1.12.1 Type of materials  
Currently, a diverse range of biomaterials are used for bone scaffolds 
such as polymers, ceramics, etc (Yousefi et al., 2015). Naturally derived 
polymers (e.g. collagen, gelatin, silk, alginate, etc) are widely used for 
tissue engineering due to excellent biocompatibility and bioactivity. 
However, mechanical property modification and reducing degradation 
time are challenging (Garcia-Gareta, Coathup, & Blunn, 2015). Collagen 
is the most popular material used in tissue engineering. In human bone, 
collagen forms a composite with hydroxyapatite providing ductility and 
stiffness (Swift & Discher, 2014; Swift et al., 2013). Collagen contains 
the RGD sequence in its peptide chain allowing cells to adhere via 
integrin binding (Barczyk, Carracedo, & Gullberg, 2010).  
Synthetic polymers (e.g. polylactic acid, and polycaprolactone) provide 
better mechanical support and posses slower degradation (Alizadeh-
Osgouei, Li, & Wen, 2018) but require engineering techniques to improve 
cell adhesion (Serra, Mateos-Timoneda, Planell, & Navarro, 2013). 
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Ceramic scaffolds (e.g. calcium phosphates (Tripathi & Basu, 2012), 
bioglass (Q. Z. Chen, Thompson, & Boccaccini, 2006)) are commonly used 
due to the rigidity. Moreover, calcium phosphate also promotes 
osteogenesis (John, Varma, & Kumari, 2003; Jung, Park, & Han, 2010; 
Samavedi, Whittington, & Goldstein, 2013). However, techniques 
producing interconnective porosity are complex (H. Yoshikawa, Tamai, 
Murase, & Myoui, 2009). The advantages and disadvantages of common 
materials are summarized in table 1.6.  
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Table 1.6  Advantages and disadvantages of natural and 
synthetic polymers for tissue engineering  
(Modified from Mottaghitalab et al (Garcia-Gareta et al., 2015; K. 
Y. Lee & Mooney, 2012; Mottaghitalab et al., 2015; Serra et al., 
2013)) 
  
Types Polymers Advantages Disadvantages 
Natural 
polymers 
Collagen 
Excellent biocompatibility, 
low antigenicity  
Poor mechanical properties, 
Poor cross-linking, high rate 
of degradation 
Gelatin 
Excellent biocompatibility, 
Biodegradable, cheap, low 
antigenicity 
Poor mechanical properties, 
high rate of degradation, 
dissolve at 37°C 
Alginate 
Good biocompatibility, low 
cost, low tissue 
inflammation response  
Non degradable in mammals, 
limited mechanical stiffness 
Chitosan 
Support cell attachment and 
matrix mineralization, non-
toxic 
Poor mechanical resistance 
(hydrogel), toxic if chemical 
crosslinking 
Silk 
Biocompatibility, low 
infection risk (compared to 
other protein-based 
polymer), cost effective  
Production time consuming 
Synthetic 
polymers 
Polylactic acid 
(PLA) 
FDA approved, excellent 
biodegradation, 
biocompatibility  
Low mechanical property, 
low hydrophilicity, tissue 
inflammation  
Polycarpolactone 
(PCL) 
FDA approved, good 
mechanical properties 
Slow degradation, release of 
acidic degradation, lack of 
cell adhesion site  
Polyglycolic acid 
(PGA) 
FDA approved  
Tunable properties 
Lack of cell recognition 
signals, Inflammatory 
reactions, high strength and 
modulus  
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1.12.2 Scaffold forms and functions 
Two common forms of scaffold, hydrogel and rigid, are widely used for 
tissue engineering. Hydrogels, both natural (e.g. collagen, gelatin) and 
synthetic (e.g. PEG (Park et al., 2015; Raic, Rödling, Kalbacher, & Lee-
Thedieck, 2014)), provide 3D-polymeric networks and hydrophilicity (K. 
Y. Lee & Mooney, 2001) allowing cell adhesion in 3D niches. Hydrogels 
provide various advantages such as easy preparation and allowing oxygen 
and nutrient transportation (Cheema et al., 2012). Hydrogel stiffness is 
tunable by various techniques (such as crosslinking). However, 
mechanical properties, syneresis and early degradation remain major 
hurdles (Scherer, 1989a; Y. K. Zhu et al., 2001).  
Rigid scaffolds can be fabricated in various forms such as lattice, fibrous, 
sponge and woven (Z. Izadifar, X. Chen, & W. Kulyk, 2012). Interporous 
connection is an important factor. Rigid and dense scaffolds allow slow 
rates of vascularization, in particular the central area (Rouwkema et al., 
2010). Conventional techniques (such as freeze-drying and leaching, etc) 
are used for fabricating rigid scaffolds together with creating porosity 
with interporous connections. Nevertheless, these techniques are 
complex (Loh & Choong, 2013). Solid free-form fabrication (SFF) or rapid 
prototyping, such as 3D printing, can be used as they can control pore 
size and porous connectivity by scaffold design (Buj-Corral, Bagheri, & 
Petit-Rojo, 2018). However, synthetic materials for SFF tend to be 
hydrophobic resulting in less cell-material affinity and poor cell loading 
(Shim, Kim, Park, Park, & Cho, 2011).  
Biphasic scaffold is an upcoming trend of tissue engineering, combining 
the advantages of rigid scaffolds and hydrogels together. Hydrogels hold 
cells within solid scaffold allowing nutrient and growth factor 
transportation, while porous rigid scaffolds function as structural 
reinforcement. Currently, there are many techniques for biphasic 
scaffold production. Rigid scaffolds can be separately prepared and 
integrated into cell loaded 3D-ECM (Y. Tanaka et al., 2010). 
Furthermore, the concepts of biphasic scaffolds are also applied in 3D 
bioprinting. Multiple materials are simultaneously printed for biological 
and structural support. Synthetic polymer such as PCL is printed as a 
framework while cells loaded in hydrogel inks function as cellular ECMs 
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(H. W. Kang et al., 2016; Stanton, Samitier, & Sanchez, 2015) (Figure 
1.10).  
 
Figure 1.10  Scaffold designs, biphasic scaffold and applications 
A) Examples of rigid scaffolds (sponge,  fibrous, woven) (With 
permission of Izadifar et al., 2012 (Z. Izadifar et al., 2012), 
licensed under Creative Common Attribution License; CC; 
https://creativecommons.org/licenses/by/4.0/)). 
B) Biphasic scaffold - PLLA with sugar leaching technique (0.3 mm 
pore size, 95% porosity) with atelocollagen (With permission of 
Tanaka et al., 2010 (Y. Tanaka et al., 2010)) 
C) Concept of biphasic materials in 3D bioprinting. PCL is a rigid 
construct functioning as the backbone of scaffolds. Hydrogel 
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loading with cells is printed between PCL fibers allowing 
nutrient transportation during cell growth (With permission of 
Kang et al., 2016 (H. W. Kang et al., 2016)).  
1.12.3  Scaffold degradation and host reaction  
The bone regeneration process requires long periods of time. Depending 
on the bone defect size, the bone healing process may be take from 2 
months up to a year (Lerner et al., 2005). Corresponding to material 
degradation by time, implanted bone scaffolds play a role in structural 
support until mineralization is complete (Amini, Wallace, & Nukavarapu, 
2011). Natural polymers possess short term degradation while synthetic 
polymers provide slower rates of degradation (Table 1.7). In in vivo 
studies, macrophages appear to play role in material degradation 
(Valentin, Stewart-Akers, Gilbert, & Badylak, 2009). After implantation, 
the host reacts to scaffolds as foreign body. Inflammation occurs around 
the scaffold driving fibrosis (Onuki, Bhardwaj, Papadimitrakopoulos, & 
Burgess, 2008). Thus, synthetic materials such as poly-L-lactic acid 
(PLLA) and PGA can provide a long-term soft tissue reaction resulting in 
fluid accumulation, swelling and osteolysis. While natural scaffolds such 
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as collagen, which possess short term degradation providing less soft 
tissue reaction (Amini et al., 2011).  
Table 1.7  Degradation time of synthetic materials (Modified from 
Mottaghitalab et al, 2015 (Mottaghitalab et al., 2015)) 
Materials Degradation time 
Polyglycolic acid (PGA) 6-12 weeks 
Polylactic acid (PLA) 12-18 weeks 
Poly (lactide-co-glycolide) (PLGA) 1-12 months 
Polycaprolactone (PCL) >24 weeks 
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1.13  3D Scaffolds for nanovibrational stimulation  
In previous studies, the effect of NS on 3D osteogenesis was studied in 
soft collagen hydrogels (G.D., 2015; Tsimbouri P.M., 2017). However, 
soft hydrogel contraction is a pivotal problem (as will be described). To 
develop scaffolds for the NS bioreactor, scaffold stiffness improvement 
was required to resist the cell pulling force on the ECM as well as 
providing a benefit to the surgeon regarding handleability. Natural 
polymers are still the first option due to their better biocompatibility 
with less cellular reaction (Mottaghitalab et al., 2015). Thus, collagen I 
used in this thesis is considered in hydrogel and biphasic forms.  
1.14 Thesis objectives  
1. To develop the implantable 3D-bone scaffolds for nanovibrational 
bioreactor and propose cell-hydrogel-sponge composite 
 
2. To biologically and mechanically optimise the stimulating 
amplitude for the proposed 3D scaffold and also study the effect 
of the high amplitude nanovibrational stimulation on 3D 
osteogenesis, related biological pathways, metabolomics and 
inflammatory response. 
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Chapter 2 Material and Methods 
2.1 Cell isolation and culture  
Stro-1 selected MSCs from adult human bone marrow (BM) were obtained 
from Prof R.O.C. Oreffo, Bone and Joint Research Group, University of 
Southampton, UK. Cells were cultured in Dulbecco’s modified essential 
medium (DMEM) (Sigma) supplemented with 10% Fetal Bovine Serum 
(FBS; Sigma), 1% (v/v) L-glutamine (200 mM, Gibco), 1% sodium pyruvate 
(11 mg/ml; Sigma), 1% MEM NEAA – (amino acids, Gibco) and 2% 
antibiotics (6.74 U/mL penicillin-streptomycin, 0.2 µg/mL fungizone) 
(Sigma). Cells were cultured in an incubator set at 37°C with 5% CO2 
environment and subcultured to passage 2-3. Culture media was changed 
every 3 days. A similar cell culture process and media were used for the 
MG63 cell line. 
2.2 Gel preparation  
Collagen hydrogels were prepared by using rat tail collagen type I (2 and 
5 mg/ml, First link, UK). 10xDMEM (First link, UK) and FBS (Sigma) were 
used for cell supplement. 0.1M sodium hydroxide (Fluka, UK) was used 
for pH titration adjusting to pH 7.7-8.0 by universal lithmus paper and 
phenol red indicator. The percentage of reagent is shown in Table 2.1. 
After pH titration, MSCs were added in the gel mixture and decanted 2.5 
ml into 12 plates. Gelation was allowed in a 37°C incubator for 30 
minutes.  
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Table 2.1  Collagen hydrogel regimens 
 
0.76 mg/ml hydrogel 
(final concentration) 
1.78 mg/ml hydrogel 
(final concentration) 
% V Vol (ml) % V Vol (ml) 
Collagen type I  
(Rat tail, First link UK) 
35.7% 
8 ml 
of 2 mg/ml 
35.7% 
7.5 ml 
of 5 mg/ml 
10xDMEM 
(First link, UK) 
7.14% 1.5 ml 7.14% 1.5 ml 
Cells in basal media 7.14% 1.5 ml 7.14% 1.5 ml 
FBS (Fisher Scientific) 7.14% 1.5 ml 7.14% 1.5 ml 
0.1M NaOH (Fluka, UK) 42.86% 8.5 ml 42.86% 9 ml 
Total volume 100% 21 ml 100% 21 ml 
2.3 Nanovibrational Bioreactor set up  
Selected nanovibrational stimulation (NS) frequencies in .flac file type 
were operated on Kinsky software (Version 4.3.14). The laptop was 
connected to the amplifier (Linn amplifier, Sneaky DS, UK) and the signal 
was transferred to the nanovibrational bioreactor. The nanovibrational 
bioreactor (T5000 model) incorporating piezo actuators (Thru Ring 
Actuators; P-010.00H, Physik Instrumente, Germany), was used as the 
nanovibration-signal effector. To construct the culture plate-bioreactor 
apparatus, adhesive magnetic sheets (3M, UK) were adhered to the 
bottom of 6 well- or 12 well- plates (Corning, USA) and attached on the 
platform of the bioreactor (Figure 2.1).  
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Figure 2.1  Nanovibrational bioreactor 
12 well plates containing collagen hydrogels were attached onto 
the bioreactor platform. The laptop generating a signal was 
connected to the amplifier and in turn plugged in the bioreactor 
for nanovibrational stimulation 
2.4 Nanovibration stimulating amplitude measurement by 
interferometry 
Interferometry is used to measure displacement of hydrogel surface or 
culture plate during NS. The surface displacement is calculated from the 
interference of 2 split light waves (by a reflecting mirror allowing 
partially laser reflection as well as passing through) which travel in 
different optical paths but are generated from a single light source. The 
phase difference of the 2 waves is analysed with software by Fast Fourier 
Transform (FFT) algorithm. In our technique, a laser with a known 
wavelength, is used as a light source. During NS, reflective tape placing 
on the hydrogel surface reflects a split laser beam back to the detector. 
NS generates a phase difference of the reflected light waves comparing 
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to the reference mirror, which in turn is used for the surface 
displacement amplitude calculation by the software (Figure 2.2).  
 
Figure 2.2  Concept of interferometry 
In this thesis, 0.8 mg/ml or 1.8 mg/ml collagen hydrogels were prepared. 
The hydrogel nanovibration was measured by laser interferometric 
vibrometer (wavelength = 632.8 nm, CW power; 5mW; SIOS, Meβtechnik 
GmbH, Germany). An oscilloscope (72-6800 model; Tenma, UK) was 
connected in order to monitor the interferometer. A 3x3 mm of 
reflective tape was placed on top of the hydrogels underneath 1.5 ml of 
media to reflect the laser beam. The vibration distance was analysed 
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using INFAS Vibro 1.8.4 software (SIOS, Meβtechnik GmbH, Germany) 
(Figure 2.3).  
 
Figure 2.3  Nanovibration measurement by interferometry 
Refective tape is placed on the hydrogel surface. A laser beam is 
aimed to the reflective tape reflecting back to the detector. An 
oscilloscope was used for signal adjustment. The interferencing 
signal is analysed by FFT. 
2.5 Rheology  
Hydrogels were prepared in 6 well plates 24 hours prior to the study. To 
investigate the quantitative viscoelastic property of the hydrogels, 
rheology was studied. Hydrogels were placed on the rheology plate 
(Figure 2.4). Firstly, strain sweep was measured to evaluate the 
breaking point of the hydrogels and then frequency sweep was used to 
assess hydrogel stiffness. A modular compact rheometer (MCR 302, Anton 
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Paar, Austria) was used in this study. To study the rheology of different 
regimen of hydrogel, the parameters were set as follows;  
The study of 0.8 mg/ml hydrogels   
The parallel plate method (PP25) was used. The prepared hydrogels were 
removed from the plate and placed on the rheometer plate. 
Temperature was set at 23°C. The gap size was 1.5 mm, and normal 
force compression was 0.01 N. The strain sweep was measured from 
0.01% to 1% at 10 rad/sec in order to select the strain which was in linear-
viscoelastic regime. Consequently, the frequency sweep test was 
measured at 1% strain starting from 100-0.1 rad/sec.   
The study of 1.8 mg/ml hydrogels    
The parallel plate method (PP25) was used. The gap size was 1.4 mm. 
The samples were placed on 23°C of rheometer plate, and normal force 
compression was 0.01 N. The strain sweep test was measured from 0.1% 
to 10% at 10 rad/sec. Consequently, 1% percent strain was selected. 
Frequency sweep was then measured starting from 100-0.1 rad/sec.  
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Figure 2.4  Rheology 
The hydrogel was transferred onto the rheometer plate. The 
parallel plate (PP25) was leveled down and touched onto the 
samples.  
To study the stiffness of the hydrogels in specific conditions such as the 
addition of hydroxyapatite and genipin crosslinking, the parameters 
were set as shown in Table 2.2. 
Table 2.2  Rheology parameters set up 
Addition 
of 
composite 
Collagen 
conc 
(mg/ml) 
Sample 
volume 
(ml) 
Strain sweep 
test at 10 
rad/sec (%) 
Frequency 
sweep test 
(rad/s) at 
0.1% strain 
Gap 
size 
(mm.) 
Temp 
(°C) 
Pararellel 
plate 
diameter 
(mm.) 
HA 
0.8 2.5 0.01 -1% 100 – 0.1 1.5 23 25 
1.8 2.5 0.1 - 10% 100 – 0.1 1.5 23 25 
Genipin 1.8 2.5 0.1 – 1% 10 – 0.1 2 23 25 
2.6 Alamar Blue assay  
Stro1 selected MSCs in hydrogels with 4x104 cells/ml density (Tsimbouri 
P.M., 2017), were used in all of cell viability tests. The process of Alamar 
Blue assay started by removing the previous culture media. The 10% 
volume of Alamar Blue resazurin (Bio-Rad, UK) diluted in phenol-red free 
media (D5030, Sigma) was added into each sample. After further 
incubation for six hours at 37°C, 5% CO2, the supernatant containing the 
up-taken alamar blue was pipetted and transferred into 96 well plates. 
A microplate reader (Clariostar, Germany) was used to detect light 
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absorbance at the wavelengths of 570 nm and 600 nm. The percentage 
of alamar blue reduction was calculated as following; 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑟𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛 =
(𝜀𝑜𝑥)𝜆2𝐴𝜆1 − (𝜀𝑜𝑥)𝜆1𝐴𝜆2
(𝜀𝑟𝑒𝑑𝜆1𝐴′𝜆2 − (𝜀𝑟𝑒𝑑)𝜆2𝐴′𝜆1
𝑥 100 
 
λ1   = wavelength 570 nm., λ2 = wavelength 600 nm.   
(ԑox)λ2   = molar extinction coefficient of alamarBlue oxidized form of λ2 
(ԑox)λ1  = molar extinction coefficient of alamarBlue oxidized form of λ1 
(ԑred)λ1  = molar extinction coefficient of alamarBlue reduced form of λ1 
(ԑred)λ2  = molar extinction coefficient of alamarBlue reduced form of λ2 
Aλ1  Observed absorbance reading for test well 
Aλ2  Observed absorbance reading for test well 
A’λ1  Observed absorbance reading for negative control well 
A’λ2  Observed absorbance reading for negative control well 
2.7 Live-dead staining 
To study cell viability using live-dead staining, 4x104 cells/ml hydrogels 
were prepared. After the old media were removed, 1%(v/v) calcein AM 
(Life technology, USA) and 1%(v/v) of ethidium homodimer-1 (Life 
technology, USA) diluted in 1.5 ml of media and were added in each well. 
The samples were then re-incubated at 37°C, 5 CO2 for 2 hours. The 10x 
magnification microscopic images were taken (Olympus, US) operated on 
Surveyor software version 9.0.1.4 (Objective Imaging, UK). First and last 
focusing levels at the center of the hydrogel were recorded. The mid 
distance of focusing level was selected for the entire XY plane scan. 
FITC/TRITC channel images were stitched and processed using ImageJ 
(Version 1.50g, USA) and Photoshop CS4 (Adobe, version11 extended, 
Ireland). 
2.8 qRT-PCR 
To assess gene expression changes, 4x104 MSCs/ml in hydrogels were 
prepared for quantitative RT-PCR (qRT-PCR). The samples were removed 
from the bioreactor and transferred to falcon tubes. The 2.5 mg/ml of 
collagenase (Sigma-Aldrich, UK) was added and incubated for 1.5 hours 
to digest collagen hydrogels. Trizol (Life Technologies) and chloroform 
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(Sigma-Aldrich, UK) were then added with ratio 5:1 in order to purify 
nucleic acids. RNA extraction kit (RNeasy extraction Kit, Qiagen) was 
used to purify RNA. The concentration of purified RNA was measured by 
a spectrophotometer (Nanodrop 2000c, Thermo scientific, USA). cDNA 
was then synthesized using the QuantiTect Reverse Transcription Kit 
(Qiagen). The cycling temperature in each process is shown in Table 2.3. 
Forward and reverse primers for qRT-PCR are shown in Table 2.4-2.5. 
GAPDH, house-keeping gene, was used as the internal control of the 
analysis. SYBR Green dye was used to target the synthesized cDNA 
(Quantifast SYBR Green I, Qiagen). Real time PCR was then performed 
(7500 Real Time PCR system, Applied Biosystem, USA). The 2- ∆∆CT method 
was used for the interpretation (Livak & Schmittgen, 2001). The cycling 
protocol was run as shown in Table 2.6. 
Table 2.3  Thermal cycling protocol for cDNA synthesis 
Reaction Temperature Times (minutes) 
Genomic DNA elimination 42° 2 
Reverse transcription 42° 30 
Inactivation 95° 3 
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Table 2.4  Primer sequence used in qRT-PCR 
 Forward primer Reverse primer 
Alkaline 
phosphatase 
ATGAAGGAAAAGCCAAGCAG CCACCAAATGTGAAGACGTG 
BMP2 CCCACTTGGAGGAGAAACAA AGCCACAATCCAGTCATTCC 
CaSR CTACGCACCAGAACTCCCTG CTGTAACAGTGCTGCCTCCA 
COL1A1 CCATGTGAAATTGTCTCCCA GGGGCAAGACAGTGATTGAA 
ERK1 CCCTAGCCCAGACAGACATC GCACAGTGTCCATTTTCTAACAGT 
ERK2 TCTGCACCGTGACCTCAA GCCAGGCCAAAGTCACAG 
GAPDH TCAAGGCTGAGAACGGGAA TGGGTGGCAGTGATGGCA 
Il-6 GATGAGTACAAAAGTCCTGATCCA CTGCAGCCACTGGTTCTGT 
Integrin β5 CTGTGGTCGGTAGCATCCTC GGATCGCTCGCTCTGAAACT 
Integrin β1 GTGCAATGAAGGGCGTGTT GTTGCACTCACACACACGACA 
JNK1 GGGCAGCCCTCTCCTTTA CATTGACAGACGACGATGATG 
JNK2 GAAAGAAGCAAGAATGGTGTTGT GAGAAGGAGTGGCGTTGCTA 
Nestin GTGGGAAGATACGGTGGAGA ACCTGTTGTGATTGCCCTTC 
NFB CAGCTGGCTGAAGATGTGAA GTGTTTTGGAAGGAGCAGGA 
Osteocalcin CAGCGAGGTAGTGAAGAGACC TCTGGAGTTTATTTGGGAGCAG 
Osteonectin AGAATGAGAAGCGCCTGGAG CTGCCAGTGTACAGGGAAGA 
Osteopontin AGCTGGATGACCAGAGTGCT TGAAATTCATGGCTGTGGAA 
Osterix GGCAAAGCAGGCACAAAGAAG AATGAGTGGGAAAAGGGAGGG 
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Table 2.5 Primer sequence used in qRT-PCR (Continue) 
 Forward primer Reverse primer 
PPARɣ TGTGAAGCCCATTGAAGACA CTGCAGTAGCTGCACGTGTT 
Piezo1 TCGCTGGTCTACCTGCTCTT GGCCTGTGTGACCTTGGA 
Piezo2 CCCGGAGTTTGAAAATGAAG CAGTGCCTCTTCTGAATCAATTT 
RUNX2 GGTCAGATGCAGGCGGCCC TACGTGTGGTAGCGCGTGGC 
STAT3 GGCATTCGGGAAGTATTGTCG GGTAGGCGCCTCAGTCGTATC 
SMAD1 
CCACTATAAGAGAGTAGAAAGCCC
TGT 
AAGTTACGGAACTGAGCTAAGAGG 
SMAD5 GGGTGCCATGGAGGAACTGGA AATCCGGCCAGCGCCAAACA 
TNFα CAGCCTCTTCTCCTTCCTGAT GCCAGAGGGCTGATTAGAGA 
TRPA TGGACACCTTCTTCTTGCATT TCTTCTCCATTAGCTCAATTTGG 
TRPV1 AGAGTCACGCTGGCAACC GGCAGAGACTCTCCATCACAC 
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Table 2.6  qRT-PCR cycling protocol 
Stage Ramp rate (%) Temperature Time (mins:sec) 
Holding stage 
100 50 2:00 
100 95 10:00 
Cycling stage 
(40 cycles) 
Starting cycle 2 
100 95 00:15 
100 50 1:00 
Melting curve stage 
100 95 00:15 
100 60 1:00 
1 95 00:30 
100 60 00:15 
2.9 Western blot 
The 4x104 MSCs/ml containing hydrogels were prepared for western blot 
study. To harvest the samples, the collagen hydrogels were digested with 
2.5mg/ml collagenase D (Roche) and centrifuged at 200g for 4 minutes. 
After the supernatant was discarded, the cell pellets were lysed by RIPA 
lysis buffer containing phosphatase and protease inhibitors (Pierce, 
Thermo Fisher). BCA assay (Pierce, Thermo Fisher) was used to quantify 
the protein concentration. The samples were subsequently run on pre-
cast 4-12% Bis-Tris gel system (NOVEX, Invitrogen, 12 -well) and transfer 
onto membrane (Immobilon F, Millipore). The blots were incubated in 5% 
BSA, 0.1%TBS, tween20 and, subsequently, in primary antibodies (shown 
in Table 2.7). Vinculin and GAPDH were used as the housekeeping 
proteins (Bhardwaj et al., 2015; Bhardwaj et al., 2014; D.-Q. Li et al., 
2011; Matsumoto et al., 2013; Riera-Borrull et al., 2017). Primary 
antibodies, prepared in working concentration, were incubated at 4ºC 
overnight. The blots were washed in 0.1% TBST on a shaker for 5 minutes. 
Li-COR secondary antibodies (1:10,000) were used and blots were 
incubated at room temperature for 1 hour. The blots were then washed 
3 times for 5 minutes with 0.1% TBST, and the signal was detected using 
the LICOR system (LICOR Odyssey Sa, UK). Band densitometry was 
measured by ImageJ software (Version 1.50g, USA).   
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Table 2.7  Antibodies used in western blot 
Antibodies Brand Lot No. Species 
Working 
concentration 
pRUNX2 Orb 4788, Biorbyt A5186 Rabbit 1:2000 
RUNX2 Sc-390715, Santa cruz D1817 Mouse 1:1000 
OPN Sc-21742 Santa cruz K0217 Mouse 1:1000 
GAPDH Sc32233, Santa cruz D3018 Mouse 1:1000 
Vinculin V9264, Sigma 
086M4757V 
047M4795V 
Mouse 1:1000 
pTRPV1 PA5-64860, Invitrogen TI2641194 Rabbit 1:1000 
TRPV1 
H00007442-M01, 
Abnova 
E128A-1F5 Mouse 1:1000 
pERK1/2 
(P-
p44/42) 
197G2, Cell signaling, 
No.4377S 
10,15 Rabbit 1:1000 
ERK1/2 
(p44/42) 
137F5, Cell signaling 
No.4695S 
14 Rabbit 1:1000 
β-catenin 07-1653, Milipore 2976288 Rabbit 1:1000 
Active β-
catenin 
05-665, Millipore 3102364 Mouse 1:1000 
2.10 In-Cell Western  
Monolayer Stro1 selected MSCs, seeded at 1x104 MSCs/well density in 24 
well plates, were prepared for this study. Samples were fixed with the 
fixative solution for 15 minutes. The 150 μl of permeabilisation buffer 
was added and incubated at 4°C for 5 minutes. After that, 150 μl of 1% 
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milk in PBS was added and incubated for 1.5 hours at room temperature. 
The 150 μl of primary antibody was then added and incubated at 4°C 
overnight on a shaker (pRUNX2; biorbyt, 1:200, RUNX2; Santa cruz, 
1:100; diluted in 1% milk blocking buffer). The primary antibodies were 
removed. The samples were washed 5 times with washing buffer for 5 
minutes each at room temperature on a shaker. The 150 μl of secondary 
antibody against primary antibody (1: 800, Li-cor, in 1% milk blocking 
buffer) was added for 1 hour on a shaker at room temperature. 
Secondary antibodies were removed and washed with washing buffer for 
5 times, 5 minutes each on a shaker at room temperature. After 
completing the washing process, samples were dried at room 
temperature. The samples were read at 680 and 800 nm. The reagents 
and buffer recipes were shown in Table 2.8. 
2.11 Immunofluorescent staining 
The samples were rinsed with 1xPBS and fixed with fixative at 37°C for 
15 minutes. After that, permeabilisation buffer was added and incubated 
at 4°C for 5 minutes. The samples were then blocked with 1% BSA in PBS 
at 37°C for 5 minutes. Primary antibody (P-myosin light chain 2, cell 
signaling, 3671S, rabbit, 1:50) and rhodamine-phalloidin (Invitrogen, 
Thermo fisher, 1:500) diluted in 1% BSA in PBS were added and incubated 
at 37°C for 1 hour. The samples were then washed with 0.5% PBST for 3 
times (5 minutes each). Biotinylated secondary antibody (anti-rabbit; 
Vector Laboratories, USA, 1:50) diluted in 1% BSA in PBS was added and 
incubated at 37°C for 1 hour. The samples were washed again with 0.5% 
PBST for 3 times. Streptavidin-FITC (Vector Laboratories, USA, 1:50) 
diluted in 1% BSA in PBS was incubated at 4°C for 30 minutes. The 
samples were washed for 3 times. A small drop of DAPI (4’,6-diamidino-
2 phenylindole, Vectashield) was placed onto the samples and covered 
with coverslips. FITC/TRITC channel images were taken (Olympus, US) 
operated on Surveyor software version 9.0.1.4 (Objective Imaging, UK). 
The images were processed using ImageJ (Version 1.50g, USA) and 
Photoshop CS4 (Adobe, version11 extended, Ireland). The reagents and 
buffer recipes were shown in Table 2.8.  
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Table 2.8  Reagents and buffers of In cell western and 
Immunoflurescent staining 
Buffers Chemicals Quantities (unit) 
Fixatives 
Formadehyde 10 ml 
PBS 90 ml 
Sucrose 2 g 
Permeabilisation 
buffer (pH 7.2) 
Sucrose 10.3 g 
NaCl 0.292 g 
MgCl2 0.006 g 
Hepes 0.476 g 
Triton X 0.5 ml 
1% milk or BSA 
(Blocking buffer) 
Milk or BSA 0.5 g 
PBS 50 ml 
0.1% Tween 20 
(Washing buffer) 
Tween 20 1 ml 
PBS 1000 ml 
0.5% Tween 20 
(Washing buffer) 
Tween 20 5 ml 
PBS 1000 ml 
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2.12 Protein Inhibitory study 
After the experiment was set up (in chapter 5, section 5.4.5-5.4.7), 
inhibitors which were diluted in basal media as working concentration, 
were added at day 2 (List of inhibitors and used concentration are shown 
in Table 2.9). Culture media with diluted inhibitor was changed every 2 
days. 
Table 2.9  List of inhibitors and working concentration 
Function Inhibitors 
Cat 
No./Batch 
Working 
concentration 
ERK inhibitor U126, Tocris 1144/5 10 μM 
P38 inhibitor SB 202190, Tocris 1264/5 5 μM 
JNK inhibitor SP600125, Tocris 1496/10 25 μM 
NFkB 
inhibitor 
TPCA-1, Tocris 2559/5 5 μM 
TNF alpha R 7050, Tocris 5432/1 2 μM 
ROCK 
inhibitor 
Y-27632, Tocris 1254/35 10 μM 
ROS inhibitor 
N-acetyl cysteine, 
Sigma Aldrich 
WXBC4028V 10 μM 
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2.13 Protein antibody microarray 
The 4x 104 cells/ml of Stro1 selected MSCs in 1.8 mg/ml collagen 
hydrogels were stimulated with N30 and N90. After stimulation for 1 and 
2 weeks, hydrogel samples were digested with collagenase. Total protein 
amounts were quantified using micro-BCA kit (Pierce, Thermo Fisher). 
The samples were then transferred to Dr. Marc Antoni Fernandez-Yague 
(Centre for Research in Medical devices, National University of Ireland, 
Galway) to process on the protein microarray. β-actin was used as an 
internal protein control. Data were analysed by Excels. Heatmaps were 
generated by Hierarchical Clustering Explorer v3.0 
(http://www.cs.umd.edu/hcil/hce/hce3.html (Appendix I). 
 
2.14 Statistics 
To compare the means of samples more than two groups, One-way 
ANOVA with Tukey’s post hoc test was used in qRT-PCR, ROS 
measurement and AlamarBlue assay. Two-way ANOVA with Tukey’s post 
hoc test was used to analyse hydrogel and CHSCs contraction by times. 
To compare the data between 2 groups, two tailed, paired t- test were 
used in Alamar Blue Assay of CHSCs. Two tailed, Mann-Whitney U test 
was used in interferometric measurement, rheology western blot and 
qRT-PCR. Biological sample population with 4 replicates were always 
used. All results are shown in mean ± standard deviation with 95%, 99% 
and 99.9% of accuracy (* P≤ 0.5, ** P≤ 0.01, *** P≤ 0.001). 
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Chapter 3 Strategies to deal with hydrogel 
contraction for nanovibrational  
bioreactor 
3.1 Introduction  
At present, diverse techniques and materials fabrication of 3D scaffolds 
for bone tissue engineering have been studied (Loh & Choong, 2013). 
Collagen, a natural ECM protein, is a major component of bone and is 
thus commonly used for bone tissue engineering (Ferreira, Gentile, 
Chiono, & Ciardelli, 2012); collagen can enhance MSC adhesion and 
growth (C. Somaiah et al., 2015). Collagen based scaffolds can be 
prepared in many forms such as rigid forms (e.g. freeze dried technique 
(Al-Munajjed & O'Brien, 2009; Kane & Roeder, 2012), electrospinning 
(Jha et al., 2011; Law, Liau, Saim, Yang, & Idrus, 2017; Matthews, Wnek, 
Simpson, & Bowlin, 2002)) and hydrogel form (Hesse et al., 2010; M. Liu 
et al., 2017).  
In our previous publication, we recently elucidated that NS can drive 3D 
osteogenesis in MSCs. The 0.8 mg/ml rat tail collagen type I hydrogels 
was used as an ECM for MSCs cultured in the NS bioreactor. This soft 
hydrogel was selected to avoid hydrogel itself inducing an osteogenicity 
by the effect of stiff ECM (Engler et al., 2006; Tsimbouri P.M., 2017). 
These studies were performed using bought MSCs. However, when switch 
to Stro-1 selected MSCs in my PhD, the fresher, less expanded cells were 
seen to be able to detach gels from the well plates due to increased 
contractility (data not shown). The contraction and detachment of 
collagen hydrogel is a critical problem disrupting long-term 3D cell 
culture in the NS bioreactor. This chapter aims to develop a strategy 
dealing with hydrogel contraction while maintaining the concept of NS 
conducting in MSCs within a soft ECM. 
Considering cell-material interaction, integrins recognize adhesive 
ligands in hydrogels, subsequently allowing cytoskeletal contraction 
(Hoffman, Grashoff, & Schwartz, 2011; Ning Wang et al., 2009). Cell 
pulling force interacts with ECM leading to syneresis (Scherer, 1989a; 
Tranquillo, Durrani, & Moon, 1992). Syneresis is a process by which 
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hydrogels loose fluid and in turn reduce gel size (Scherer, 1989a). Factors 
inducing collagen hydrogel syneresis are physical cues such as gel-
container interaction, ECM factors as well as biological cues e.g. cellular 
contraction.  
The interaction between the gel-container may resist hydrogel 
contraction force and thus extend the starting time of hydrogel 
contraction. In the wells, hydrogel has a meniscus shape which indicates 
that it adheres to the side walls of the well plate and the bonding 
(adhesion between the hydrogel and cultureware) is stronger than the 
cohesive force between particles of hydrogel itself (Marshall, Bayne, 
Baier, Tomsia, & Marshall, 2010). Generally, the culture well surface was 
pre-treated (e.g. corona-gas treatment, Coroning CellBIND surface) to 
promote cell adhesion thus the cultureware surface is hydrophilic and 
negatively charged (Webb, Hlady, & Tresco, 1998). Hydrophilicity helps 
hydrogels to adhere onto container surfaces (Webb et al., 1998). A well 
attached gel may resist cell pulling forces better (Y. K. Zhu et al., 2001). 
Even though the interaction between hydrogel and cultureware can 
resist hydrogel contraction, theorectically, syneresis did not depend on 
the interfacial free energy but may depend on hydrogel permeability, 
viscoelastic property, hydrogel shape and size (Scherer, 1989a, 1989b).  
Hydrogel properties, including hydrogel stiffness, fiber density, hydrogel 
permeability and viscoelastic property also affect hydrogel syneresis rate 
(Bell, 2000; Scherer, 1989a). Loose fibers allow water to be squeezed 
out through pores, while dense fibers hold water inside the hydrogel thus 
reduce syneresis rate (Scherer, 1989b).  
Cellular factors such as cell-seeding number, cell proliferation and 
differentiation rate (Chieh et al., 2010) are crucial factors of cell 
induced syneresis. Cells generate traction forces to migrate through the 
collagen fibers resulting in collagen network deformation, compaction 
of fibrils and squeezing of water from the hydrogel pores, therefore, 
inducing syneresis (Tranquillo et al., 1992) (Figure 3.1).  
In this chapter, the first strategy to deal with hydrogel contraction was 
aimed at mechanical modification. Polylactic acid (PLA) rings were 
fabricated by 3D printing and implanted into hydrogels to re-balance the 
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hydrogel contraction force and cell pulling force. This ring-in-gel concept 
maintained the soft ECM property using a standard 0.8 mg/ml collagen 
hydrogel formulation used in previous studies with bought-in MSCs 
(Tsimbouri P.M., 2017). PLA is the widely used for bone tissue 
engineering as it is rigid, biodegradable, biocompatible and approved by 
the FDA (Lopes, Jardini, & Maciel, 2012).  
 
 
Figure 3.1  Factors related to hydrogel contraction 
1) Hydrogels attached to the side wall of a tissue culture well by 
adhesive surface tension force together with hydrophilicity 
resisting cell pulling force. Hydrogel syneresis rate can be affected 
by various factors.  2) A high number of seeded cells accelerates 
gel contraction. 3) Dense fibers, stiffer ECM and poor liquid 
permeability (small pores) decrease the syneresis rate. Gel 
detachment allows adhesive forces to fully contract the hydrogel.  
The second strategy was aimed at ECM modification without extra-
chemical use based on the concept that stiffer ECM (increasing 
viscoelastic properties) may reduce syneresis rate. Theoretically, many 
physicochemical factors have an effect on collagen hydrogel 
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polymerization such as ratio of collagen mass per total volume (Doyle, 
2016), pH, temperature and ionic strength (Achilli & Mantovani, 2010). 
These factors influence collagen hydrogel fibrillary microstructure, 
matrix pores, and stiffness (Achilli & Mantovani, 2010). In 2D culture, 
where MSCs are seeded onto ECM after e.g. gelation, some publications 
showed successful osteogenic induction of MSCs by the use of 
physicochemical modifications. For example, collagen hydrogels which 
are polymerized at 4C produce long and low fiber stiffness and possibly, 
in turn, promote cell spreading and focal adhesion formation thus 
enhancing osteogenic differentiation (Xie, Bao, Bruekers, & Huck, 2017). 
Furthermore, gelation at 4C and pH 10 provides a high compressive 
modulus (Achilli & Mantovani, 2010). On the other hand, achieving these 
mechanical advantages by using extreme environments (low 
temperature and high alkaline pH) may be impossible for 3D culture due 
to poor biocompatibility.  
To prepare cells in 3D collagen hydrogels, cells are added into collagen 
hydrogels and gelation is then initiated. Thus, cells are directly exposed 
to pH and temperature conditions which can have strongly adverse 
effects on cell viability and osteogenic differentiation (Achilli & 
Mantovani, 2010; Fliefel et al., 2016; Monfoulet et al., 2014). Increasing 
collagen concentration is, therefore, an option for improving stiffness 
without the addition of chemicals in 3D culture (Y. K. Zhu et al., 2001). 
Further to these approaches, crosslinking techniques are widely used to 
improve collagen hydrogel viscoelastic properties. Many crosslinking 
techniques had been proposed including chemical (e.g. enzymatic 
induced, Diels-Alder click reaction) and physical (e.g. ionic, thermal, 
hydrogel bonding) crosslinking (Hu, Wang, Xiao, Zhang, & Wang, 2019) 
(Table 3.1). The next strategy in the endeavor to improve collagen 
hydrogel properties to prevent contraction was thus conducted by using 
the genipin crosslinker. Genipin (C11H14O5), a naturally derived substance 
has been widely used for crosslinking hydrogels made from e.g. collagen 
and chitosan due to low cytotoxicity (Muzzarelli, El Mehtedi, Bottegoni, 
Aquili, & Gigante, 2015). Genipin, extracted from Genipa Americana and 
Gardenia jasminoides Ellis, reacts to primary amines of biopolymers to 
form crosslinks (and gives a resultant blue colour) (Butler, Ng, & Pudney, 
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2003), thus increasing stiffness (Fessel, Cadby, Wunderli, van Weeren, & 
Snedeker, 2014; Sundararaghavan et al., 2008).  
3.2 Aims and objectives  
1. To assess the feasibility of the “ring in gel; biphasic scaffold” for 
clinical application in the aspect of gel contraction.  
2. To study the effects of increasing collagen concentration on 
hydrogel handleability, hydrogel contraction and NS force 
transmission. 
3. To investigate the effects of genipin crosslinking collagen in 
mechanical properties and biological response of MSCs.   
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Table 3.1  Example of techniques for collagen hydrogel modification 
Collagen Co-polymer 
Modification 
Techniques 
Cells 
Cell-ECM 
preparation 
Cell 
response 
References 
Type I, bovine 
cornea 
- Crosslinking by EDC, glutaraldehyde 
Immortalized 
human corneal 
epithelial cells 
Separate 2D 
Duan et al., 2006  
(X. Duan & Sheardown, 2006) 
NM Chitosan Crosslinking by Glutaraldehyde preadipocyte Separate IC 
Wu et al., 2006  
(X. Wu, Black, Santacana-
Laffitte, & Patrick, 2007) 
Type I, atelo, 
Porcine 
Chitosan PEG stabilized, crosslinking by carbodiimide 
Immortalized 
human corneal 
epithelial cells 
Separate, seed 
ontop 
2D 
Rafat et al., 2008  
(Rafat et al., 2008) 
Type I, 
2-methacryl 
oyloxyethyl 
phosphoryl choline 
Crosslinking by ethanol-water, EDC, NHS 
L929 (mouse 
fibroblast) 
Separate 2D 
Nam et al., 2010 
(K. Nam, Kimura, Funamoto, & 
Kishida, 2010a, 2010b) 
Type I, Rat tail - Non-enzymatic Glycation (Ribose) 
Bovine aortic 
endothelial cells 
(spheroids) 
Mixed together 3D 
Mason et al., 2013  
(Mason, Starchenko, Williams, 
Bonassar, & Reinhart-King, 2013) 
Type I, Bovine - 
Aldehyde-functionalized dextran, oxidizing 
dextran with sodium periodate 
COS-7, L929, Hela 
cells 
Separate, seed on 
top 
2D 
Zhang et al., 2014 
(X. Zhang, Yang, Yao, Shao, & 
Chen, 2014) 
Calf skin - Crosslinking by Glutaraldehyde - Separate - 
Tian et al., 2016  
(Tian, Liu, & Li, 2016) 
EDC; 1-ethyl-3-(3 dimethylaminopropyl)-1-carbodiimide hydrochloride, NHS; N-hydroxysuccinimide, NM =not mentioned, IC = 
inconclusive 
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3.3 Methodology and experimental design 
Composite optimizations of all hydrogel modification strategies were 
studied. Mechanical validations including hydrogel contraction, 
handleability, interferometry, rheology as well as MSCs viability were 
conducted shown in Figure 3.2.  
 
Figure 3.2  Diagram of hydrogel modification strategies and 
optimization in Chapter 3 
The optimization of three strategies; Ring-in-gel, collagen 
concentration optimization and genipin crosslinking were 
studied. 
3.3.1  ‘Ring in gel’ biphasic scaffold  
To engineer the hydrogel supporting structure, ring shape scaffolds 
were designed (AutoCAD 2016 software, Autodesk, USA) and printed 
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by 3D printer using polylactic acid (PLA). Two generation ring designs 
are shown in Figure 3.3.  
 
Figure 3.3  PLA ring design 
A) The first-generation ring scaffold design. The 4-notches 
function as a centralizer of the PLA ring. The notches can be 
attached to removable holders aiming to remove the Ring-
gel composite. 
B) The second-generation ring scaffold design: Cross hair design 
attached with removable holder for six well plates.  
C) Long term culture ring-gel composite. MG63 seeded in 0.8 
mg/ml collagen hydrogel with the second-generation ring 
scaffold. At day 65, hydrogel attached to the ring. The gel-
ring composite can be transferred from the 6-well plate 
using a holder. 
3.3.2 Collagen concentration  
The 0.8 and 1.8 mg/ml (final collagen concentration) of collagen 
hydrogels were prepared using rat tail collagen type I (2 and 5 mg/ml 
of commercialized concentration, First link, UK) as shown in chapter 
2, section 2.  
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3.3.3 Genipin crosslinking 
The sterile 1x PBS was used to prepare 20 mM of genipin stock solution 
(Sigma Aldrich, UK). The genipin stock was then diluted to 0.5 mM, 1 
mM and 10 mM using basal media. After completing the gelation 
process, 1.5 ml of genipin solution was added onto the gels and 
incubated at 37°C for 12 hours.  
3.3.4 Rheology 
Rheology was performed as shown in Chapter 2, section 2.5. The 0.8 
and 1.8 mg/ml hydrogel and genipin crosslinking hydrogels were 
prepared in 6 well plate, 24 hours prior to the testing. Rheology 
parameters was shown in Table 3.3.  
Table 3.2  Rheology parameter set up 
Experiments 
Collagen 
conc 
(mg/ml) 
Sample 
volume 
(ml) 
Strain 
sweep test 
at 10 
rad/sec (%) 
Frequency 
sweep test 
(rad/s) at 
1% strain 
Gap 
size 
(mm.) 
Temp 
(°C) 
Pararellel 
plate 
diameter 
(mm.) 
Conc test 
0.8 2.5 0.01 -1% 100 – 0.1 1.5 23 25 
1.8 2.5 0.1 - 10% 100 – 0.1 1.5 23 25 
Genipin test 1.8 3.5 0.1 – 1% 10 – 0.1 2 23 25 
3.3.5 Hydrogel contraction 
In order to monitor the hydrogel contraction without NS, percentage 
of hydrogel contraction comparing to initial size was quantified by the 
use of gel diameter or gel surface area in top view. To measure the 
hydrogel diameter, the diameters of 6 and 12 well plates were used 
as references. The center of the hydrogel was identified and the 
shortest diameter of the hydrogel was selected for measurement using 
a scientific ruler. An average of three repeated measurements was 
recorded at each time point, every 3-4 days.  To quantify the hydrogel 
top view area, the hydrogel image was taken in top view every 3-4 
Chapter 3: Hydrogel optimisation  77 
 
days. The hydrogel surface areas in top view were measured and 
analysed by ImageJ software.  
3.4 Results 
3.4.1 Ring in gel strategy  
3.4.1.1 The first-generation ring-in-gel contraction  
To study the efficacy of the first-generation ring design, Stro1 
selected hMSCs seeded in 0.8 mg/ml rat tail collagen type I hydrogels 
were prepared and trialled with a range of culture plates in order to 
study whether different culturewares could improve hydrogel 
adhesion. Thus, four conditions were prepared in two commercial 6-
well plates (A; CytoOne, USA Scientific, B; Corning, Costar, Sigma-
Aldrich): group1; brand A with ring, group2; brand A with no ring, 
group 3; brand B with ring and group 4; brand B with no ring. Hydrogel 
contraction was observed for 4 weeks.  
After 4 weeks of hydrogel observation (Figure 3.4), plain collagen 
hydrogels in plate B (no ring group) showed less gel contraction 
compared to hydrogels in plate A. At day 17, the percentage of 
remaining hydrogel diameter (compared to time 0), where no ring 
scaffold was used, was significantly smaller than where a ring was 
used in plate A. However, there were no significant difference in plate 
B with/without the use of a ring. The results indicated that plate B 
provided better hydrogel adhesion to side wall of wells than that of 
plate A. Furthermore, the first-generation PLA ring could not prevent 
hydrogel contraction.  
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Figure 3.4  Hydrogel contraction in different brand of 
cultureware 
Comparison of the percentage of gel diameter remaining, from 
time 0 (starting diameter), between Stro1 selected MSCs in 0.8 
mg/ml gels seeded into 6 well plates from brand A (CytoOne, 
USA Scientific) and brand B (Corning, Costar, Sigma-Aldrich) 
with/without the first-generation ring scaffold. Hydrogel 
contraction in plate A with ring was greater than plate B with 
ring. However, it was not seen to prevent gel contraction in both 
culturewares. Gel contraction in plate A was significantly higher 
than that in plate B. (n=3, * P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001, 
Two way ANOVA, Tukey’s post hoc test, A; Brand A; B; Brand B, 
R; ring, NR; no ring). 
3.4.1.2 The second-generation ring-in-gel contraction  
The second-generation PLA ring was designed with a cross hair pattern 
aiming to reduce cell pulling force. To study the efficacy of hydrogel 
contraction reduction of the second design ring, MG63 seeded in 0.8 
mg/ml collagen hydrogels were prepared (n=3). Hydrogel contraction 
was observed for 4 weeks. The results showed that the new design of 
ring scaffold prevented the gel contraction (Figure 3.3B). However, 
the hydrogel still detached from the 6-well plate. The significant 
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difference of percentage gel diameter remaining between ring and no 
ring groups began at day 6.  
 
Figure 3.5  Hydrogel contraction in the second-generation ring-
gel composite. 
Comparison of the percentage of gel diameter by time between 
groups with/without the second-generation rings for cells 
seeded into 0.8 mg/ml collagen hydrogels. The second-
generation ring design can prevent further hydrogel contraction 
after day 10. (*n=3, P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001, R; ring, 
NR; no ring, 2-way ANOVA, Sidak’s post hoc tests) 
3.4.2 Collagen concentration and diameter 
It is considered that the ring-in-gel approach might be problematic for 
future clinical use. Thus, physicochemical modulation of hydrogels 
was the next strategy to be trialed. Hydrogel diameter and collagen 
concentration were considered. Previously, 0.8 mg/ml collagen 
hydrogels (2.5 ml) seeded with MSCs in 6 well plates were used in 3D 
NS-induced osteogenesis (Tsimbouri P.M., 2017). However, the 
collagen hydrogel is too thin and difficult to handle in clinical use. To 
improve handleability for clinical application, hydrogel use of 12 well 
plate rather than 6 well plate was trialed (Figure 3.6). Interferometry 
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showed that changing the well plate diameter did not reduce the 
nanovibration amplitude (Figure 3.7).   
Increasing collagen concentration from 0.8 mg/ml to 1.8 mg/ml 
appeared to improve hydrogel handleability (Figure 3.9), improve 
stiffness (Figure 3.10) and extend the starting date of hydrogel 
contraction (Figure 3.11) while still allowing good vibrational fidelity 
(Figure 3.12).  
3.4.2.1 Hydrogel diameter validation   
Considering intended clinical use, a thin and flat hydrogel, seeded in 
a 6 well plate, is difficult to fill the bone defect. Furthermore, 
dividing the scaffold into small pieces, e.g. using a scalpel, could 
potentially injure the nanovibration stimulated MSCs. Comparing well 
plate diameter to human bone morphology, a 12 well plate diameter 
was approximately a transverse diameter of human humerus 
(Murdoch, Mathias, & Smith, 2002) which is a moderate long bone size. 
Whereas, a 24 well plate diameter is approximately the diameter of 
human phalanges (Ash & Unsworth, 2000). Therefore, in this thesis, 
12 well culture plates (22.1 mm well diameter) were selected for 3D 
hydrogel size regarding size and handlability. Moreover, it is an 
optimal scaffold size to fill long bone defect where the common sites 
of injury are tibia, femur and humerus (Kironde, Sekimpi, Kajja, & 
Mubiri, 2019). 
3.4.2.2 Hydrogel handleability and spatula lift test 
By preparing hydrogels with the 2.5 ml volume in 6 well plates, 
hydrogel diameter was larger than finger diameter of the user (Figure 
3.6A). These large, soft and thin characteristics resulted in a floppy 
hydrogel that was difficult to handle. It can be suggested that the 12 
well plate size hydrogel (2.5 ml volume) therefore provides a better 
handleability (Figure 3.6B). 
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Figure 3.6  Hygrogel handleability 
6 well plate (A) and 12 well plate (B) sized hydrogels. (6 and 12 
well plate diameter; 35 mm and 22.1 mm respectively, 2.5 ml/ 
wells). 6 well plate diameter is not suitable for surgeon 
handleability. 
3.4.2.3 Hydrogel surface displacement amplitude 
measurement of 6 and 12 well plates  
The efficacy of nanovibrational transmission through the hydrogels in 
the different sizes of tissue culture plate was then investigated. All 
hydrogels were prepared in 6 and 12 wells plates and measured at 
the centre point by interferometry. There was no significant 
difference in surface displacement amplitudes comparing between 
hydrogels in the 6 well and 12 well plates (Figure 3.7A); at 1000 Hz, 
NS provided a good fidelity of displacement amplitudes in both 
plates. Hydrogels in 12 well plates showed greater average 
amplitude at resonant frequency than those in 6 well plates, but this 
resonant frequency was clear at cell stimulating frequency of this 
study (1000 Hz) (Figure 3.7B). Thus, changing from 6 well to 12 well 
plate diameter did not have an effect on NS force transmission at 
1000 Hz.  
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Figure 3.7  NS amplitude comparison between 6 and 12 well 
plates 
A) The NS amplitude comparison of hydrogels (at the centre point) 
prepared in 6 and 12 well plate and stimulating at 1000 Hz, no 
significant difference were noted (6 wells; mean =55.36 nm, 
SD=5.21 nm, 12 wells; mean 61.87 nm, SD 21.90 nm, * P≤ 0.05, 
** P≤ 0.01, *** P≤ 0.001, n=12-24, Mann-Whitney test, T5000, 
Voltage peak to peak 19.69).  
B) Frequency-amplitude plot showed that NS provided reliable 
amplitude at 1000 Hz in hydrogels both in 6 and 12 well plates. 
The resonant frequency was noted between 1500-3000 Hz 
resulting in amplitude amplification thus providing unreliable 
stimulating amplitudes.   
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3.4.2.4 The homogenicity of stimulating amplitude across the 
wells on the NS bioreactor  
The comparison of the 6 and 12 well plates showed that the NS 
bioreactor generated reliable amplitudes through all wells in both 6 
and 12 well plates. Thus, changing from the 6 to 12 well culture plate 
did not affect NS (Figure 3.8).  
 
Figure 3.8  NS stimulating amplitude across the 6 and 12 
culture wells 
The 3D surface plot showed hydrogel displacement amplitude 
measured at the centre of hydrogels in all wells of the plates. 
During NS at 1000 Hz, the NS bioreactor generated reliable NS 
amplitudes across the 6 (A) and 12 (B) well plates. (6 wells, n=12 
gels, mean 34.6 nm, SD 2.85 nm; 12 wells, n=24 gels, mean= 
34.99 nm, SD=1.78 nm, third generation bioreactor, PSU4003). 
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3.4.2.5 Collagen concentration 
It is known that increasing collagen concentration can increase 
hydrogel stiffness (Swift & Discher, 2014), thus potentially extending 
the starting date of hydrogel contraction (Chieh et al., 2010). 
Increasing collagen concentration is interesting as it is simple and free 
of additional chemical crosslinking, maintaining 3D cellular response 
and still using collagen, which is the naturally derived extracellular 
matrix. To investigate the effect of collagen concentration, 
mechanical properties including hydrogel characteristics and 
stiffness, hydrogel contraction and gel displacement during NS were 
measured. 
3.4.2.5.1 Spatula lift test  
The spatula lift test was performed for simple hydrogel inspection.  
The 0.8 mg/ml hydrogel is very soft while the 1.8 mg/ml hydrogel was 
more handleable and could maintain its shape during the lift up 
(Figure 3.9).   
 
Figure 3.9  Hydrogel characteristics at 2 week. 
The 0.8 mg/ml hydrogel in 6 well plate (2.5 ml collagen 
hydrogel) is very soft. The 0.8 mg/ml hydrogel in the 12 well 
appears floppy while the 1.8 mg/ml hydrogel can maintain its 
shape.   
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3.4.2.5.2 Hydrogel stiffness  
As discussed, to improve hydrogel handleability, the final collagen 
concentration of the hydrogels was increased from 0.8 mg/ml to 1.8 
mg/ml. The hydrogel viscoelastic property was measured by the 
rheometer. Frequency sweep test was conducted to study the 
viscoelasticity of polymer architecture or crosslinking (Zuidema, 
Rivet, Gilbert, & Morrison, 2014). Comparing storage (G’) and loss 
(G”) modulus of the hydrogels, 1.8 mg/ml collagen hydrogel had a 
higher storage modulus (G’= 161.27 Pa; SD 15.17 Pa) than that of the 
0.8 mg/ml hydrogel (G’= 25.67 Pa; SD 2.91 Pa) (Figure 3.10). Even 
though 1.8 mg/ml hydrogel was still soft, it was handleable. 
 
Figure 3.10  Hydrogel stiffness measured by rheology 
Frequency sweep test with angular frequency () ranging from 
-20 rad/second of 0.8 vs 1.8 mg/ml collagen concentration 
studied by rheology (n=3). The 1.8 mg/ml collagen had a higher 
storage modulus (A), thus, indicating higher elastic modulus 
than that of 0.8 mg/ml. The elastic modulus was higher than 
the loss modulus (B) confirming that the properties of both 0.8 
and 1.8 mg/ml collagen were hydrogels, rather than liquid 
(mean±SD, n=4, * P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001, Mann-Whitney 
test).   
3.4.2.5.3 Hydrogel contraction 
To study the effect of cell number and collagen concentration on 
hydrogel contraction, 0.8 and 1.8 mg/ml collagen hydrogels seeded 
with 40,000 and 80,000 Stro1 selected MSCs/ml were prepared. The 
surface areas of hydrogels in top view were quantified every 3-4 days. 
The 0.8 mg/ml cell seeded collagen hydrogels started to contract at 
day 28 in this experiment. Interestingly, increasing collagen 
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concentration to 1.8 mg/ml extended the starting date of hydrogel 
contraction to day 80. Moreover, increasing cell seeding number 
produced greater hydrogel contraction, but did not accelerate the 
start date of contraction (Figure 3.11).  
 
Figure 3.11  Hydrogel contraction observation. 
The 0.8 mg/ml hydrogel contraction started at day 28. 
However, the 1.8 mg/ml hydrogels contracted at day 80. The 
1.8 mg/ml collagen hydrogel with 80,000 MSCs/ml contracted 
more than that with 40,000 MSCs/ml. (mean±SD, n=4, * P≤ 0.05, 
** P≤ 0.01, *** P≤ 0.001, Two-way ANOVA, Tukey’s post hoc test).  
3.4.2.5.4 Interferometry  
To investigate the effect of increasing collagen concentration on NS 
amplitude, the 0.8 and 1.8 mg/ml collagen hydrogels were stimulated 
at 1000 Hz with 30 nm vibrations. NS amplitude of 1.8 mg/ml collagen 
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hydrogels (mean 34.99 nm, SD =1.76 nm) were slightly higher than 
that of 0.8 mg/ml hydrogels (mean 35.83, SD 1.77) (Figure 3.12A).  
Again, the NS bioreactor generated reliable amplitudes at 1000 Hz 
without resonance (Figure 3.12B).  
 
Figure 3.12  Interferometry for 0.8 and 1.8 mg/ml collagen 
hydrogels in 12 wells plates. 
Comparison of 0.8 and 1.8 mg/ml collagen hydrogel in 12 well 
plates: A) During NS, gel surface displacement of 1.8 mg/ml 
collagen hydrogel was significantly higher than that of 0.8 
mg/ml group (mean±SD, n=24, * P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001, 
Mann-Whitney test, PSU4003). B) Frequency-amplitude graph 
showed that both 0.8 and 1.8 mg/ml collagen hydrogels showed 
good fidelity of NS at 1000 Hz. Resonant frequency of both 
hydrogel types ranged approximately from 2,750 to 3,250 Hz.  
Chapter 3: Hydrogel optimisation  88 
 
3.4.3 Genipin crosslinking collagen hydrogel  
In the previous section, it was shown that increasing collagen 
concentration can extend the starting date of hydrogel contraction. 
To achieve better hydrogel stiffness and possibly resist hydrogel 
degradation in vivo, genipin crosslinking was trialed. Mechanical and 
biological optimisations were studied which are described in this 
section.  
3.4.3.1 Genipin-hydrogel characteristics 
To observe hydrogel characteristics after genipin crosslinking, 2.5 ml 
of 1.8 mg/ml collagen gels were prepared in 12 well plates. All 
hydrogels were, in turn, crosslinked with 0, 1, 5, 10 mM of genipin. 
Genipin crosslinking resulted in a gel color change to dark blue, in 
particular at 5 and 10 mM concentrations. However, 5 and 10 mM 
genipin crosslinked hydrogels showed better gel handleability by 
inspection (Figure 3.13).  
 
Figure 3.13  Genipin crosslinked hydrogel 
The 0, 1, 5 and 10 mM (A to D) of genipin crosslinked 1.8 mg/ml 
collagen hydrogels (2.5 ml seeded in 12 wells plate). Improved 
handleability was seen after genipin crosslinking.  
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3.4.3.2 Genipin-crosslinking and hydrogel stiffness  
The 1.8 mg/ml collagen hydrogels crosslinked with 0, 1, 5 and 10 mM 
of genipin were prepared in 6 well plates. The stiffness of all 
hydrogels was studied by rheology. The frequency sweep test showed 
that there was no significant difference in elastic modulus between 0 
and 1 mM genipin crosslinking. The 5 and 10 mM genipin crosslinking, 
however, significantly increased elastic modulus (P ≤ 0.001) up to 1.03 
kPa in the 10 mM genipin group (Figure 3.14). 
 
Figure 3.14  Rheological study of genipin crosslinked 1.8 mg/ml 
collagen hydrogels 
The characteristics and colour of genipin crosslinked collagen 
hydrogels (A); Addition of genipin significantly increased the 
elastic modulus in the 5 and 10 mM groups (B). (mean±SD, n=3, 
* P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001, B= storage modulus (G’), C= 
loss modulus (G”), Two-way ANOVA, Tukey’s post hoc test).   
Genipin crosslinking can increase the elastic modulus of collagen 
hydrogels up to > 1 kPa. This is a significant increase, but it is still far 
from the stiffness required for osteogenic induction (25-40 kPa) 
(Engler et al., 2006). Dose and time dependent cytotoxicity was next 
studied.  
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3.4.3.3 Genipin crosslinked hydrogel interferometry  
The surface displacement amplitude of 1.8 mg/ml collagen hydrogels 
crosslinked with 0, 1, 5 and 10 mM genipin were studied during NS. At 
1000 Hz, NS amplitude was significantly reduced in crosslinked 
hydrogels (Figure 3.15A and B). The effect of displacement 
amplification, causing by resonance frequency, was noted at 3000 Hz 
in the softer hydrogel (0, 1 mM genipin crosslinked hydrogel) while 
the stiffer hydrogels (5, 10 mM genipin crosslinked gels) showed less 
resonance (Figure 3.15A and C).  At 5000 Hz, stimulating amplitude 
in all groups was very low (Figure 3.15A and D).   
 
Figure 3.15  Interferometry in genipin crosslinked hydrogels. 
(A) Overview comparison of hydrogel displacement at the centre 
of the hydrogels during NS at 1000, 3000 and 5000 Hz. (B-C) At 
1000 and 3000 Hz, hydrogel displacement amplitude was 
decreased in stiff hydrogels (5 and 10 mM group). (C) At 3000 
Hz, the amplitudes exagerated by resonance phenomenon, in 
particular in the soft hydrogels (0 and 1 mM groups) (mean±SD, 
n=3, * P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001, One-way ANOVA, Tukey’s 
post hoc test).  
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3.4.3.4 Genipin crosslinked hydrogel and cell viability studies   
To investigate the effect of genipin on cell viability, 0,1, 5 and 10 mM 
genipin crosslinked hydrogels were prepared. The Alamar blue test 
and microscopy were performed. Microscopic images showed that 
cells were poorly spread after genipin crosslinking (Figure 3.16 A-D). 
The Alamar blue test at 2 week and 4 weeks showed a decreasing 
trend of viability with increased genipin concentration (Figure 3.16 
E-F). 
This study showed that genipin crosslinking adversely affected cell 
viability. Genipin crosslinking can increase the elastic modulus up to 
1 kPa using 10 mM concentration (Figure 3.14). However, microscopic 
images showed rounded and poorly spreading cells after exposure to 
higher concentrations of genipin. Using low concentration of genipin 
may reduce the cytotoxicity but the advantage of hydrogel stiffness 
improvement was insufficient. Therefore, the use of genipin 
crosslinking strategy was discontinued.   
 
Figure 3.16  Microscopy and Alamar blue study in genipin 
crosslinking hydrogel 
At 2 week, A-D) microscopic images showed poor MSCs spreading 
in genipin crosslinking groups. E-F) At 2 and 4 week, percentage 
of Alamar blue reduction was significantly decreased compare 
to control group (mean±SD, n=3, * P≤ 0.05, ** P≤ 0.01, *** P≤ 
0.001, One-way ANOVA, Tukey’s post hoc test). 
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3.5 Discussion 
3.5.1 Ring in gel: what can we learn? 
The concept of ring-in-gel was originated based on our previous 
publication that, cells were grown in 3D hydrogel provided with NS 
gave osteogenic response (Tsimbouri P.M., 2017). However, when we 
switched from commercial to Stro-1 MSCs, gel contraction suddenly 
became a problem. The ring-in-gel strategy focused on changing 
hydrogel supporting structure while preserving hydrogel property.   
The first ring design provided an unsatisfactory result. Initially, it was 
expected that PLA ring inside hydrogel may resist the contraction 
force at gel-container area. However, the first ring design did not 
reduce cell pulling force inside the ring (ring-gel surface). Moreover, 
the PLA ring (in particular without surface treatment such as plasma 
polymerization) may provide inadequate adhesion between the ring-
gel contact surface.  
The second-generation of scaffold was designed based on the 
hypothesis that increasing the ratio of gel-material (ring) contact 
surface (junction) could possibly dissipate the cell pulling force, in 
turn, preventing the gel contraction. In order to rebalance cell pulling 
force and scaffold-gel interface bonding, the internal shape structure 
was changed to a cross-hair design (Figure 3.3B).  
To explain this hypothesis mathematically; the inner circumferential 
length of PLA ring was calculated using the formula:   
𝐿 = 2𝜋𝑟 
L1 = inner circumferential length of ring 
r  = radius of ring 
  = 3.14 
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Thus, the ratio (R1) of volume of “cell in hydrogel” (V1) per contact 
surface length of material-gel junction (L1) of first ring-gel composite 
was: 
𝑅1 =  
𝑉1
2𝜋𝑟
 
𝑅1 =
𝑉1
6.28𝑟
 
In the cross-hair design, the contact junction length (L2) of each “cell 
in hydrogel” area was the sum of a quarter of the inner 
circumferential length of the ring plus with 2 radii, therefore:  
𝐿2 =
2𝜋𝑟
4
+ 2𝑟 
L2 = 3.57r 
The volume of “cell in hydrogel” was divided into 4 areas, thus:  
𝑉𝑜𝑙𝑢𝑚𝑒 𝑝𝑒𝑟 𝑒𝑎𝑐ℎ 𝑎𝑟𝑒𝑎 (𝑉2) =  
𝑉1
4
 
Therefore, the ratio (R2) of volume of “cell in hydrogel” (V2) per 
contact surface length (L2) of cross hair PLA ring was:  
𝑅2 =  
𝑉1
4
3.57𝑟
 
𝑅2 =
𝑉1
14.28𝑟
 
In conclusion, the new design PLA ring increases the contact length of 
the gel-material interface up to 4 folds (R1/R2). Mechanically, this 
design possibly shares the cell pulling force in the hydrogel, in turn, 
reducing hydrogel contraction. Our experiment showed that the 
second-generation PLA ring can indeed prevent further hydrogel 
contraction (Figure 3.3C). However, our preliminary study showed 
that the ring in gel composite was difficult to remove from tissue 
culture using the ring holder, in particular in short term culture 
Chapter 3: Hydrogel optimisation  94 
 
hydrogels. Moreover, the “ring in gel” composite was difficult to use, 
for example, when dividing the hydrogels into small pieces to fill small 
bone defect in clinics. The ring-in-gel concept was, therefore, 
discontinued as it was considered not suitable for clinical application.  
3.5.2 Increasing collagen concentration strategy 
Collagen concentration had an effect on viscoelasticity. It is known 
that high concentration of collagen increases viscoelasticity while low 
concentration decreases (Swift et al., 2013). Increasing collagen 
concentration increases fibre density and reduces the pore size of ECM 
(Wolf et al., 2013) and this reduces syneresis (Chieh et al., 2010; Y. 
K. Zhu et al., 2001). To solve the hydrogel contraction issue by 
increasing collagen concentration, hydrogels were gelated at slightly 
alkaline (approximately pH 7.5-8) and 37°C which is a physiological 
condition of MSCs. Furthermore, MSCs were not exposed to 
cytotoxicity of crosslinking chemicals, rendering this technique safe 
for MSCs.  
From our results, the storage modulus of 1.8 mg/ml collagen hydrogel 
was 161 Pa (Figure 3.10) indicating that the hydrogel is soft but 
handleable (Figure 3.9). The 1.8 mg/ml collagen hydrogel allows 
reliable NS force transmission (Figure 3.12). This soft hydrogel is 
insufficient to drive osteogenic differentiation (Engler et al., 2006), 
therefore it can be extrapolated that osteogenic expression after NS 
was only driven by the effect of NS. Moreover, the storage modulus of 
this hydrogel is compatible with the stiffness of hematomas at fracture 
site. Thus, it could mimic 3D niche of the initial phase of  bone healing 
process (Ryan, Mockros, Weisel, & Lorand, 1999). 
Considering hydrogel contraction, increase collagen concentration 
from 0.8 mg/ml to 1.8 mg/ml can extend the starting date of hydrogel 
contraction significantly in tissue culture which allows an adequate 
stimulating time to induce MSCs osteoblastic commitment, transfer 
composite to clinics and possibly maintain their shapes during bone 
healing process (Claes et al., 2012; Einhorn & Gerstenfeld, 2015) 
(Figure 3.11). Therefore, the concept of cells-gel-sponge composites 
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were proposed to improve hydrogel structure that suit surgical 
purposes (see details in chapter 6).   
3.5.3 Genipin-crosslinking collagen hydrogel  
Genipin had been widely used as a crosslinker for biomaterials and 
soft tissue grafts such as bovine cardiac tissue (Yoo, Kim, Kim, & Choi, 
2011), tracheas (F. Sun et al., 2016), sclera (S. Q. Zhu, Pan, Zheng, 
Wu, & Xue, 2018; S. Q. Zhu et al., 2016) and scaffolds. However, in 
most of the literature reporting cell seeded genipin crosslinked 3D 
scaffolds, cells were seeded after the scaffold crosslinking process (Bi 
et al., 2011; Campos et al., 2018). In our study, MSCs were mixed with 
collagen solution before allowing gelation to create 3D cellular niche. 
Genipin crosslinking was then performed afterwards. MSCs were 
therefore directly exposed to genipin in the 3D hydrogel. Our result 
corresponded to the published literature reporting cytotoxicity of 
genipin (Figure 3.16) (Fessel et al., 2014). Genipin affected cell 
viability by dose- and time-dependence as has been reported 
previously (Fessel et al., 2014). Furthermore, considering signaling 
pathways, the literature shows that genipin can activate MAPK 
pathways and p53 (H. Cao et al., 2010; E. S. Kim, Jeong, & Moon, 
2012; X. Yang et al., 2013) as well as promote reactive oxygen species 
production (B. C. Kim et al., 2005) which, in turn, may activate 
apoptotic pathways.  
Considering the crosslinking mechanism of genipin, genipin possibly 
crosslinks collagen fibrils at amine groups (Butler et al., 2003). 
Increasing genipin concentration increases the density of crosslinked 
sites, in turn, improves hydrogel stiffness (S. Lin & Gu, 2015). 
Theoretically, crosslinked scaffold may extend the scaffold syneresis 
(Guo et al., 2019) and reduce scaffold degradation (McGann et al., 
2015).  
From Figure 3.15, the relationship between displacement amplitude 
and hydrogel stiffness at 1000 and  3000 Hz stimulation possibly was 
explained by oscillation theory (Garrett, 2017; Kett, 1982). Hydrogel 
displacement was assumed as moving in a simple harmonic motion and 
Chapter 3: Hydrogel optimisation  96 
 
hydrogel oscillation frequency was equal to stimulated frequency 
without damping following Hooke’s law:  
F =-kX   (1) 
F  = force action 
k   = constant factor characteristic of gel (act as spring) 
X  = displacement from equilibrium position  
 
Following Newton’s second law (F = ma) for a hydrogel moving under 
gravity (g). Thus, at maximum amplitude (Xa): 
      mg = -kXa    (2) 
−
𝑚𝑔
𝑘
= 𝑋𝑎      (3) 
From equation (3), hydrogel stiffness (k) is inversely proportional to 
amplitude (Xa). Correlating to Figure 3.15-3.16, the 5 and 10 mM 
genipin crosslinked hydrogels had high stiffness (k). Therefore, 
displacement amplitude was decreased. This trend was departed from 
at 3000 Hz due to resonant frequency (value was nearly 3000 Hz).  
3.6 Conclusion  
The first PLA ring design showed an unsatisfactory result. Hydrogel 
contraction still occurred at the ring-gel junction of both commercial 
plates. The second-generation ring reduced hydrogel contraction 
without using chemical crosslinking. In long term culture, hydrogel 
attached to the ring and thus this composite was transferable (Figure 
3.3C). However, removing the composite in short term culture was 
challenging. The ring cut through the hydrogel during lifting with the 
holder. In clinical application, the design would be difficult to use. 
The handle removal process is difficult and can also cause composite 
damage.  
To improve hydrogel handleability, the 1.8 mg/ml collagen hydrogel 
can be prepared in 12 well plates without disturbing NS. Increasing 
collagen concentration can extend the starting date of collagen 
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hydrogel contraction without reducing NS, thus, potentially allow long 
term NS within the NS bioreactor. Following the results in this 
chapter, the 1.8 mg/ml collagen prepared in 12 well plate was the 
best strategy to deal with hydrogel contraction, therefore, this 
strategy is then used in the following chapters for biocompatibility 
testing, phenotype-pathway studies as well as developing cell-
hydrogel-sponge composites.  
Genipin crosslinking can increase collagen hydrogel stiffness up to 1 
kPa. Biologically, genipin significantly increases cytotoxicity in 3D 
hydrogels. Therefore, this strategy is not suitable for developing 3D 
hydrogels for NS. 
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Chapter 4 The effect of high amplitude 
nanovibrational stimulation on 
phenotype and related pathways 
4.1 Introduction 
In chapter 3, the 1.8 mg/ml collagen hydrogel was proposed as a 
suitable extracellular matrix (ECM) for mesenchymal stem cells (MSCs) 
on the nanovibrational bioreactor. However, no previous study 
investigated in the effect of NS amplitude in 3D osteogenesis. In this 
section, a study of the effects of amplitude in 3D was performed. 
Theories of osteogenic differentiation and phenotype expression were 
also reviewed. Since Tsimbouri et al recently showed the success of 
NS induced 3D osteogenesis via transient receptor potential vanilloid 
type 1 (TRPV1) - protein kinase C (PKC) - extracellular signaling-
regulated kinase 1 and 2 (ERK1/2) - β-catenin pathways (Tsimbouri 
P.M., 2017), understanding of calcium signaling and channels, as well 
as interplays between calcium signaling, mitogen-activated protein 
kinase (MAPK) and Wnt signaling may help to unlock the basis of 
nanovibrational stimulation. 
4.1.1 Nanovibrational stimulation; rational for amplitude control.  
It has been shown that mechanical stimulations, such as vibration and 
mechanical strain by stretching, affect cell differentiation. However, 
the proposed intensities and stimulating durations are diverse and 
inconclusive in both 2D and 3D culture systems (B. McClarren & R. 
Olabisi, 2018; Sen et al., 2011).  
Based on the concept that if the size of mechanical stimuli is 
compatible with cellular membrane receptors, it has been proposed 
that Nanovibrational stimulation (NS) possibly triggered specific 
mechanotransductive pathways driving osteogenesis. Recently, NS 
had successfully enhanced 2D and 3D osteogenesis in MSCs using high 
frequency at 1000 Hz (Nikukar et al., 2013; Tsimbouri P.M., 2017). 
Nikukar H. and Pemberton G. had studied the osteogenic induction 
effect of stimulating frequencies. They proposed that NS with 30 nm 
at 1000 Hz can promote 2D osteogenesis (Nikukar et al., 2013; 
Pemberton et al., 2015). Following that, Tsimbouri et al again 
elucidated the success of  3D osteogenesis in MSCs-seeded 0.8 mg/ml 
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collagen by stimulating at 30 nm (Tsimbouri P.M., 2017). However, 
most of these studies focused on frequency rather than amplitude. 
Considering the cytoskeletal tension effect on MSCs in 2D culture, 
strain can promote cell spreading and thus in turn switches on 
osteogenic gene expression (Cui et al., 2015). However, excessive 
strain reduces actin fiber formation and cell spreading (Cui et al., 
2015). In 2D culture, cells spread asymmetrically and interact with 
the uniplanar ECM (Baker & Chen, 2012). However, in 3D culture, cells 
spread in 3D multiplanar manner from the centre (nucleus), thus their 
cellular structure is more symmetrical than that of 2D culture 
(Beningo, Dembo, & Wang, 2004; Jiang & Grinnell, 2005). Considering 
these observations, it was hypothesized that MSCs in a 3D niche, 
where MSCs have lower cytoskeletal tension than that in 2D niche, 
may require higher NS amplitude to tune cytoskeletal tension. This 
tension is crucial to reach the threshold level of osteogenic induction 
in order to trigger mechanotransduction pathways driving gene 
transcription. Moreover, the new collagen hydrogels in which 
concentration was increased for gaining higher stiffness were used. 
Thus, revalidation of NS in the new hydrogels was required. 
4.1.2 Progression of the osteoblast phenotype. 
Osteogenic genes / proteins provide specific functions at specific time 
points driving MSC osteocommitment. For example, Runt-related 
transcription factor 2 (RUNX2) and osterix (OSX) drive osteogenic 
commitment at the early stage, while osteocalcin (OCN) and 
osteopontin (OPN) enhance ECM mineralization at late stage (Lian & 
Stein, 1992; Lian et al., 1991; Stein et al., 1991). Thus, disorder of 
phenotypic expression may hint at differentiation problems and 
pathological conditions (W. Liu et al., 2018; Philipp J. Thurner et al., 
2010). Temporal study of phenotype correlated to MSCs 
differentiation stage is illustrated in Figure 4.1. 
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Figure 4.1  Osteogenic differentiation and phenotypes 
A) Osteogenic differentiation from MSCs towards osteoblastic 
differentiation.  
B) Temporal phenotypic expression and ECM development. In 
summary, in the early phase (week 1), RUNX2 mainly commits 
MSCs to the osteogenic lineage; RUNX2 expression inhibits 
adipogenesis. After RUNX2 expression, OSX then plays a role 
to drive immature osteoblast at week 2. Alkaline phosphatase 
(ALP) and ON promote ECM maturation (week 2 - 3) while OCN 
and OPN enhance mineralization (week 3 - 4) (Komori, 2010, 
2019; Lian & Stein, 1992; Lian et al., 1991; Stein et al., 1991).   
In the early phase, RUNX2 and OSX commit MSCs to the osteogenic 
lineage. RUNX2 is a major transcription factor in early osteogenesis. 
RUNX2 levels peak at day 5-7 (Hassan et al., 2006; J. L. Yang et al., 
2014). RUNX2 is detected in pre-osteoblasts and immature osteoblasts 
(Komori, 2010) and can regulate OCN, OPN as well as collagen type 
I1 (Col1A1) expression (Bruderer, Richards, Alini, & Stoddart, 2014). 
Via bone morphogenetic protein 2 (BMP2) stimulation, RUNX2 links to 
SMAD (Rahman et al., 2015) and non-SMAD pathways (such as the 
MAPK pathway (Rodriguez-Carballo et al., 2016)). OSX is another 
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transcription factor that contributes to later stage osteogenesis and 
bone matrix deposition (Nakashima et al., 2002). OSX levels peak 
approximately at day 9-14 (J. L. Yang et al., 2014; C. Zhang, 2010). 
OSX is typically regulated in dependence of RUNX2 (Matsubara et al., 
2008). The BMP-2 pathway can also induce osterix expression via 
Distal-less homeobox 5 (Dlx5) and MSh homeobox 2 (Msx2) 
transcription factors (M. H. Lee, Kwon, Park, Wozney, & Ryoo, 2003; 
Matsubara et al., 2008). 
Osteonectin (ON; or SPARC) is a bone-specific protein linked to 
collagen type I and hydroxyapatite. ON is highly upregulated at week 
1 (Ardeshirylajimi, Soleimani, Hosseinkhani, Parivar, & Yaghmaei, 
2014). ON promotes ECM assembly and collagen fibril formation 
(Rosset & Bradshaw, 2016). ON may initiate mineralization (Termine 
et al., 1981) and also support osteoblast differentiation and survival. 
Kessler et al showed increase of the Notch1 gene (transmembrane 
receptor regulating adipogenesis and osteogenesis) in ON-null 
osteoblasts. They also proved that Notch1 is regulated by cAMP, and 
proposed that increase of Notch1 relates to the decrease of coupling 
of G proteins to activate adenylyl cyclase (AC) displaying aging 
phenotypes such as osteopenia and increased adipose deposits 
(Kessler & Delany, 2007). 
Alkaline phosphatase (ALP) promotes matrix maturation and reaches 
its peak at 2 weeks (Lian & Stein, 1992). ALP is an ectoenzyme found 
in liver, bone and kidney. ALP plays an important role in 
mineralization. Chondrocytes or osteoblasts bud matrix vesicles which 
contain intravesicular calcium (influxed through the annexin channel) 
and phosphate (influxed by type III Na/Pi cotransporter and PHOSPHO 
I) (Orimo, 2010). These ions interact with the phosphatase enzyme 
and in turn produce PO4 resulting in the deposition of CaPO4 
(Anderson, 1995; Orimo, 2010).  
In the late phase, OPN and OCN enhance mineralization and peak at 
week 3-4 (Lian & Stein, 1992; Lian et al., 1991). OPN is a nonspecific 
glycoprotein secreted by bone, kidney and the epithelial lining. OPN 
is expressed in osteoblasts and osteoclasts playing the role in bone 
remodeling by inhibiting the formation of hydroxyapatite (Mazzali et 
al., 2002). Furthermore, OPN also plays an important role by 
regulating immune cells during inflammation (Lund, Giachelli, & 
Scatena, 2009). OCN is an osteoblast specific protein. OCN is defined 
as a hormone which can control insulin secretion and is thus related 
to glucose metabolism (J. Wei & Karsenty, 2015). Absence of OCN 
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increases bone formation in in vivo study (Ducy et al., 1996). OCN can 
bind to hydroxyapatite as well as recruit osteoblasts and osteoclasts 
for bone resorption and mineralization (Hoang, Sicheri, Howard, & 
Yang, 2003). OCN is found in mature osteoblasts while OPN is 
expressed in immature osteoblasts (Komori, 2010). Transitionally, 
OCN can be found in immature osteoblasts expressing RUNX2 and OPN 
(Komori, 2010). 
4.1.3 Potential mechanism from NS to drive osteogenesis. 
To investigate the related pathways of NS and increased/high 
amplitude NS, understanding the related pathways in NS is important.  
In this section, the previous NS-induced 3D osteogenesis results 
(Tsimbouri P.M., 2017) are focussed on to give hints the potential 
areas to be investigated when the amplitude is increased. Calcium 
signaling, MAPK and wnt are also reviewed.  
4.1.3.1 NS induced 3D osteogenesis 
Tsimbouri et al proposed that the success of NS induced 3D 
osteogenesis was mainly through ion channel activation. At the gene 
level, NS promoted BMP2, ALP, OPN and OCN in the early phase 
(Figure 4.2A). In the early phase (day 5-7, Figure 4.2B), NS activated 
ions channels such as piezo1/2 (tension) and TRPV1 (temperature, 
pain) (Tsimbouri P.M., 2017). Data suggested that TRPV1 is possibly 
indirectly activated by a cytoskeleton dependent pathway as TRPV1 
was effected by ROCK and myosin inhibition (Tsimbouri P.M., 2017). 
However, ROCK and myosin did not affect osteogenesis (Figure 4.2C) 
(Tsimbouri P.M., 2017). Next, the related pathways were investigated 
at the protein level, and, again, no evidence of cytoskeletal tension 
(FAK, myosin, ERK1/2) and BMP2 (SMAD1/5) pathways involvement 
was found for 3D osteogenesis; this is different to 2D NS osteogenesis 
where tension has been implicated (Nikukar et al., 2013). However, it 
is known that the ion channel TRPV1 can act via protein kinase C (PKC) 
to effect β-catenin (canonical Wnt) (Tsimbouri P.M., 2017). It was 
shown that inhibition of TRPV1 (and PKC) reduced active β-catenin 
and reduced osteogenesis in 3D NS (Tsimbouri P.M., 2017) (Figure 4.3 
D-E). 
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Figure 4.2   Previous study of NS induced 3D osteogenesis 
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Figure 4.3  Previous study of NS induced 3D osteogenesis (continue) 
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Figure 4.2-4.3 Previous study of NS induced 3D osteogenesis   
(continue) 
A) qRT-PCR temporal gene study showed osteogenic gene 
upregulation (BMP2, ALP, OPN, OCN) at day 7. B) At day 5-7, 
piezo1/2 and TRPV1 respond to NS. C) TRPV1 links to ROCK and 
myosin pathways with no effect on osteogenesis (BMPR1a, 
RUNX2 and ALP). D) NS activated β-catenin through PKC and 
TRPV1 showing by the decrease of β-catenin after PKC and TRPV 
inhibition. E) TRPV1 affected on osteogenesis (showing in 
RUNX2, ALP and OSX) F) Diagram showed the pathways of NS 
induced osteogenesis (With permission of Tsimbouri et al., 2017 
(Tsimbouri P.M., 2017)) 
4.1.3.2 Calcium homeostasis and signaling 
Calcium ions are essential for many cellular activities (Stojilkovic, 
Tomić, Koshimizu, & Van Goor, 2000). Intracellular calcium is a key 
signal in modulating proliferation, differentiation or apoptosis 
(Humeau et al., 2017). Intracellular calcium concentration [Ca2+]i  is 
maintained within physiological levels for normal cellular functions. 
All sources of calcium, including [Ca2+]i, extracellular calcium 
concentration [Ca2+]o and calcium ions in endoplasmic reticulum 
([Ca2+]e) (Carafoli, 2002; Humeau et al., 2017; Nowycky & Thomas, 
2002), are well-regulated through ion channels/transporters on the 
cell membrane.  
In the resting stage, [Ca2+]i (concentration~100 nM) is lower than 
[Ca2+]o (concentration~2 mM). Na+/Ca2+ exchangers (NCX) and 
Na+/Ca2+-K+ exchangers (NCKX) play roles in maintaining Ca2+ at the 
cellular membrane. At endoplasmic reticulum (ER) (such as myocyte 
and cardiocyte), where is the cellular calcium storage, 
sarco/endoplasmic reticular Ca2+-ATPase (SERCA) pumps Ca2+ into the 
ER while plasma membrane Ca2+ATPase (PMCA) control the outflow 
(Clapham, 2007). However, in bone, osteoblast may use pannexin 3 
(gap junction which locates at ER) to regulate intracellular calcium 
ions released from ER (Masaki Ishikawa et al., 2011; M. Ishikawa & 
Yamada, 2017). 
In the excited state, which requires an increase of [Ca2+]i , calcium is 
initially released from the ER via ryanodine receptors (RyR). On 
cellular membrane, the stimuli such as hormones, neurotransmitters, 
etc activate G protein coupled receptors (GPCRs) and in turn activate 
phospholipase C (PLC) to hydrolyse phosphatidylinositol 4,5-
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bisphosphate (PIP2) to diacylglycerol (DAG) and inositol-1,4,5-
triphosphate (IP3). IP3 binds to IP3 receptor at ER resulting release 
Ca2+ into cytosol (Humeau et al., 2017). Ca2+ and DAG activated PKC 
(K.-P. Huang, 1989). PKC subsequently activates voltage-gated 
(Raifman et al., 2017) (e.g. L-VGCCs), ligand-gated channels 
(Breitinger et al., 2018) and TRP channels (Bhave et al., 2003)) to 
allow influx of [Ca2+]o. [Ca2+]i interacts with proteins in the cytoplasm 
in particular calmodulin and forms calcium-calmodulin complexs. In 
turn, these complexes activate many enzymes including calmodulin-
dependent protein kinase (CaMKs) (Majd Zayzafoon, 2006). Ca2+-
Calmodulin dependent kinase II (CaMKII) plays a role in osteblast 
differentiation (Y. H. Choi, Choi, Oh, & Lee, 2013; Majd Zayzafoon, 
2006). CAMKII promotes phosphorylation of ERK via Ras-Raf-1(Illario 
et al., 2003) and enhances osterix expression (Y. H. Choi et al., 2013) 
(Figure 4.4).   
Furthermore, calcium signaling between cells through gap junctions 
is also important for cell function. In MSCs, pannexin 3, intercellular 
gap junction, activates intracellular calcium driving osteogenesis (M. 
Ishikawa & Yamada, 2017). Thus, understanding the calcium 
homeostasis among intra- and extracellular- and ER can help 
identifying the NS activated pathways.  
 
Figure 4.4  Calcium homeostasis 
In the resting state, [Ca2+]i is maintained at low level by ion 
channels on the cellular membrane (such as  Na+/Ca2+ 
exchangers; NCX, Na+/Ca2+-K+ exchanger; NCKX and plasma 
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membrane Ca2+ATPase PMCA) and endoplasmic reticulum (e.g. 
sarcoendoplasmic reticular Ca2+-ATPase; SERCA). In the excited 
state, stimuli or agonists activate G-protein-coupled receptors 
(GPCRs; sensing to pain, itch and inflammation) (Geppetti, 
Veldhuis, Lieu, & Bunnett, 2015), which in turn, activate 
phospholipases (e.g. PLCβ, PLA2). PLC cleaves PIP2 into 
diacylglycerol (DAG) and 1,4,5-inositol triphosphate (IP3).  IP3 
diffuses in the cytosol and binds to IP3 receptor on the ER, 
subsequently, allowing calcium ion release into the cytoplasm 
and resulting in the increase of [Ca2+]i (Clapham, 2007; Geppetti 
et al., 2015). [Ca2+]i activate kinases (e.g. PKC, tyrosine 
kinases). DAG binds to intracellular calcium and activates PKC. 
PKC then phosphorylates calcium ion channels e.g. TRPV1, 4 and 
transient receptor potential ankyrin1 (TRPA1) (Geppetti et al., 
2015). 
4.1.3.3 Mechanical stimulation induced calcium signaling. 
From the literature, mechanical stimulation can increase intracellular 
calcium (Demer, Wortham, Dirksen, & Sanderson, 1993; Sharma et al., 
1995). However, some literature reported that mechanical 
stimulation alone may not increase the influx of extracellular calcium 
due to the rigorous control of ions transportation through ion channels 
(Chabbert, Geleoc, Lehouelleur, & Sans, 1994). Theorectically, 
mechanical stimulation may affect ion chanels directly (e.g. piezos) 
or indirectly through changes in cytoskeletal tension. For example, in 
airway smooth muscle, integrin formation activates myosin light chain 
(both kinase and phosphatase) phosphorylation and in turn increases 
intracellular calcium (Tran & Teoh, 2014). If NS was considered as a 
mechanical stimuli driving osteogenesis through calcium signaling 
activation, mechanosensitive ion channels (on cellular membrane) 
would be the target to study. 
Calcium ion channels are important sites controlling intracellular 
calcium by allowing extracellular calcium ion influx as well as calcium 
storing and releasing from ER (Clapham, 2007; Monteith, Prevarskaya, 
& Roberts-Thomson, 2017). There are many types of calcium ion 
channels on cellular membrane such as stretching ion channels, 
voltage-gate channels, etc. Therefore, understanding calcium ion 
channels functions is crucial for regulating intracellular calcium 
concentration. Calcium ion channels which potentially link to 
osteogenesis are summarized in Table 4.1. 
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If NS is considered as a “force” (stretching or tethering), two 
hypotheses can be raised. Firstly, ion channels may be directly 
controlled by NS. The NS force possibly opens the channels by itself 
through applying force to the lipid membrane (Martinac & Poole, 
2018) e.g. piezo1/2 channels. Secondly, NS may be indirectly 
controlled via cytoskeleton (Martinac & Poole, 2018) e.g. TRPV 
channels. The change of cytoskeletal tension, in turn, may increase 
the stretching force to the ion channels. If NS was considered as other 
form such as pain, itch or heat, then the NS may modulate through 
the TRP-GPCR axis. GPCRs can activate TRPs via phospholipases 
(PLC/PLA-PIP2-TRPagonist) or kinases (PKC/PKA-pTRP) (Figure 4.5). 
Table 4.1 Current evidences of calcium ions related to 
osteogenesis 
Calcium ion 
channels types 
Examples of 
channels 
Stimuli References 
Voltage sensitive 
calcium channels; 
VSCC 
L-types, CaV 1.2 
 
Depolarized 
membrane 
potential 
(C. Cao et al., 2017; J. 
Li, Duncan, Burr, & 
Turner, 2002; Y. Z. Tan 
et al., 2019) 
TRP channels 
TRPP 
(polycystin1,2) 
pH, voltage, 
phosphorylation 
(Dalagiorgou, Basdra, & 
Papavassiliou, 2010; 
Dalagiorgou et al., 
2017; Grieben et al., 
2016; H. Wang et al., 
2014) 
TRPV1 Nanovibration (Tsimbouri P.M., 2017) 
TRPV4 
Oscillatory fluid 
shear (primary 
cilia) 
(Michele A. Corrigan et 
al., 2018; H.-p. Lee, 
Stowers, & Chaudhuri, 
2019) 
TRPM7 
Membrane 
tension 
(Xiao et al., 2015) 
Piezos Piezo1 
Hydrostatic 
pressure 
(A. Sugimoto et al., 
2017) 
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Figure 4.5  G-protein couples receptor and TRP receptors 
GPCRs activate phospholipases or kinases. For phospholipases, 
GPCRs activate PLA2-AA-PUFAs while PLC links to PIP3-DAG-
PKC. For kinases, GPCRs stimulate AC-cAMP-PKA.(AA; 
arachidonic acid, AC; adenylate cyclase, cAMP; adenyl cyclase 
pathway, PUFA; polyunsaturated fatty acid) (With permission of 
Geppetti et al., 2015 (Geppetti et al., 2015)).   
In the next section, mechanosensitive ion channels and non-
mechanosensitive channels are reviewed.  
4.1.3.4 Calcium ion channels  
4.1.3.4.1 TRP channels  
Transient receptor potential (TRP) is a calcium and sodium ions 
channel, sensitive to temperature and pain (Caterina et al., 1997). 
TRP consists of 7 subfamilies of ion channels including canonical 
(TRPC), melastatin (TRPM), vanilloid (TRPV), polycystin (TRPP), 
Ankyrin (TRPA), mucolipin (TRPML) and (NomPC-like (TRPN). Focusing 
only on TRPV, TRPV consists of 6 members (TRPV1-6) (Table 4.2). 
TRPV1-4 are nocireceptors. TRPV1 is highly expressed in normal cells 
(but reduced in cancer cells). TRPs can be regulated by protein kinase 
A, C and G (Ramsey, Delling, & Clapham, 2006) e.g. PKC affects 
sensitization of TRPV1 (Premkumar & Ahern, 2000) and TRPV4 (Peng 
et al., 2010). TRP is not a mechanically sensitive channel. However, 
stretching-induced actin polymerization can enhance calcium influx 
through the channels found in TRPV2 and 4 (S. Ito et al., 2010). 
Considering Tsimbouri et al’s paper (Tsimbouri P.M., 2017), the result 
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showed that NS involved TRPV1 and TRPV1 did not link to ROCK nor 
myosin. Thus, it suggested that NS induced TRPV1 is possibly activated 
through GPCRs (this was not investigated in the paper).  
4.1.3.4.2 TRPA1 channel 
TRPA1 is member of TRP channels sensing irritants causing pain 
(García-Añoveros & Nagata, 2007). TRPA1 can be activated by 
inflammatory cytokines such as IL1β, IL6, Nitric oxide (NO), H2O2 , 
prostaglandin and ROS through cysteine residues at the amino N 
terminus of TRPA1 (Hinman, Chuang, Bautista, & Julius, 2006; 
Nummenmaa et al., 2016; N. Takahashi et al., 2008; C. Xu, Luo, He, 
Montell, & Perrimon, 2017). Currently,  there is no evidence showing 
that mechanical force directly activates TRPA1 in MSCs (García-
Añoveros & Nagata, 2007). However, in hair cells, TRPA1 is considered 
as one of the mechanosensitive transduction channels (Corey et al., 
2004).  
Table 4.2 TRPVs family; types of channels 
TRP 
family 
Types 
Mechanical stimulation 
/Functions 
References 
TRPV1 Thermosensitive Temperature and pH (Huynh et al., 2014) 
TRPV2 Thermosensitive Heat, innate immunity 
(Huynh et al., 2014; Link 
et al., 2010) 
TRPV3 Thermosensitive 
Temperature, sense to 
Ca2+/CaM 
(Hasan & Zhang, 2018; 
Huynh et al., 2014) 
TRPV4 Thermosensitive 
Oscillatory fluid shear 
Mechanical stimulation 
(M. A. Corrigan et al., 
2018) 
TRPV5 
Epithelial 
calcium 
homeostasis 
Calcium reabsorption in 
kidney 
(Hughes et al., 2018; 
Huynh et al., 2014) 
TRPV6 
Epithelial 
calcium 
homeostasis 
Parathyroid hormones and 
Vitamin D3 
(Hasan & Zhang, 2018; 
Huynh et al., 2014) 
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4.1.3.4.3 Piezo1 and 2 ion channels.  
Piezo1 and 2 are more sensitive to stress than TRPV1 (Bavi et al., 
2017). Piezo1 responded to stretching, cell indentation, shear fluid, 
stiffness, etc (Nourse & Pathak, 2017). While Piezo2, found at nerve 
endings, was sensitive to light touch and sensed rapidly-adapting 
mechanical activated stimulation (Coste et al., 2010). Piezo1 is 
sensitive to stretch and interacts with the cytoskeleton which allows 
calcium influx into cytoplasm (Miyamoto et al., 2014; Nourse & 
Pathak, 2017). Increase of intracellular calcium potentially, in turn, 
modulates or coactivates Yes-associated protein (YAP) nuclear 
translocation (Franklin, Ghosh, Shi, & Liphardt, 2019). Accumulation 
of YAP can drive cell differentiation (Dobrokhotov, Samsonov, Sokabe, 
& Hirata, 2018; Elosegui-Artola et al., 2017; Y. Sun, Shao, Xue, & Fu, 
2016). Mechanical stimulation through the Piezo1 channel can induce 
osteogenesis in MSCs. For example, hydrostatic pressure stimulation 
modulated piezo1 expression and enhanced BMP2 production driving 
osteoblast differentiation (A. Sugimoto et al., 2017).  
4.1.3.4.4 Calcium sensing receptor (CaSR) 
CaSR is a G protein-coupled receptor responding to calcium regulatory 
hormone (e.g. parathyroid hormone) to maintain calcium homeostasis 
(extracellular calcium) (Theman & Collins, 2009). CaSR is sensitive to 
extracellular calcium, however, the mechanism of CaSR sensing 
extracellular calcium is unknown (Dvorak et al., 2004). CaSR can be 
activated through GPCRs-PLC-DAG-PKC (Rodland, 2003); it is not a 
mechanosensitive channel. However, if NS can modulate CaSR sensing 
to extracellular calcium, it might regulate intracellular calcium 
concentration.  
4.1.3.5 Interplay among calcium signaling, MAPK and β-
catenin pathways 
Calcium signaling relays signals from various first messengers and also 
modulates abundant intracellular pathways. Based on our current 
evidence of NS induced 3D osteogenesis (Tsimbouri P.M., 2017), 
interaction between calcium signaling-ERK1/2, calcium signaling-β-
catenin and β-catenin-ERK1/2 pathways were discussed in order to 
predict the possible route of NS effect (Figure 4.6).   
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Figure 4.6  Interaction among calcium signaling, MAPK and 
Wnt/β-catenin pathway 
The diagram showing the interaction among calcium signaling, 
MAPK and β-catenin. Considering calcium ion channels, CaSR 
and TRP channels involve PKC, thus, link to NC/Ca2+. TRP-
Piezo1/2 can be tethered/stretched by cytoskeletal tension 
changes thus MAPK is co-activated. In the MAPK pathway, JNK is 
involved in both NC/Ca2+ and NC-PCP. All canonical and non-
canonical-Wnt signaling can crosstalk (Y. Zhang, Pizzute, & Pei, 
2014) (NC; Noncanonical, C; Canonical, PCP; planar-cell 
polarity). 
4.1.3.5.1 Calcium signaling and ERK1/2 pathway 
Calcium signaling can mediate various cellular pathways including the 
ERK1/2 (member of MAPK) cascade (Chuderland & Seger, 2008). 
Calcium signaling can be coactivated by hormones, transcription 
factors through many receptors e.g. G protein receptor (Gq/11-coupled 
receptors) (Gudermann, Grosse, & Schultz, 2000). Calcium signaling 
interacts with proteins of the ERK1/2 pathways e.g. Ras proteins 
(Chuderland & Seger, 2008). Calcium is also involved in cell cycle 
regulation via the ERK1/2 dependent NFκB pathway (Sée, Rajala, 
Spiller, & White, 2004).  
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4.1.3.5.2 Calcium signaling and β-catenin pathway  
Wnt pathways play an important role in cell growth, differentitation 
and apoptosis (Krishnan et al., 2006). Wnt pathways are important in 
driving MSCs into osteogenesis (J. H. Kim et al., 2013; G. Liu et al., 
2009). Wnt also affects BMP2 induced osteogenesis (Y. Chen et al., 
2007). Wnt/β-catenin consists of three pathways; canonical (β-catenin 
related regulation of gene transcription) and 2 non-canonical routes. 
These are non β-catenin related and Wnt planar cell polarlity (PCP) 
regulating cell polarity, cytoskeleton and Wnt/calcium which links to 
intracellular calcium signaling (Y. Zhang et al., 2014). Canonical Wnt 
can sense mechanical stimulation by coactivation of low density 
lipoprotein-related receptor-5 and -6 (LRP5, LRP6) (K. S. Kang & 
Robling, 2015). It is known that mechanical stimulation can, via 
Wnt5a, induced the Wnt canonical pathway (H.-D. Fu et al., 2016; Gu 
et al., 2018).  For Tsimbouri et al, (Figure 4.1) (Tsimbouri P.M., 2017), 
Wnt canonical pathway (β-catenin related) thus was hypothesized to 
be modulated by the NS effect. 
4.1.3.5.3 Canonical β-catenin and ERK1/2 crosstalking  
Wnt canonical (β-catenin related) pathway affects transcription and 
interacts with MAPK. Focusing only ERK1/2, Wnt itself can activate 
ERK1/2. For example, Wnt3a activates ERK1/2 through Raf1-MEK-ERK 
cascade (M.-S. Yun, Kim, Jeon, Lee, & Choi, 2005; Zeller, Hammer, 
Kirschnick, & Braeuning, 2013). On the other hand, ERK1/2 also 
affects Wnt pathway. MAPK (ERK1/2, JNK, p38) can phosphorylate 
PPPS/TP clusters of LRP6 which promote canonical Wnt expression 
(Červenka et al., 2011).  
4.1.3.6 NS and other possible pathways driving osteogenesis 
4.1.3.6.1 BMP2-SMAD1/5 pathways 
Mechanical stimulation can enhance BMP2 production. BMP2 promotes 
RUNX2 via Smad1/5 (Javed et al., 2008), osterix via Msx2-RUNX2 
(Matsubara et al., 2008), OCN via RUNX2 mediated Atf6 (Jang et al., 
2012), OPN via ERK1/2 (X. Yang et al., 2009) and also ALP expression 
(L. Wang et al., 2010). In previous publication, Tsimbouri et al 
illustrated the upregulation of BMP2 during 3 week NS (Tsimbouri 
P.M., 2017). Thus, it is interesting that NS possibly enhances BMP2 
secretion driving osteogenic phenotypes.   
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4.1.3.6.2 Adhesion-cytoskeletal tension  
It has been shown that cytoskeletal tension regulation promotes 
osteogenesis (McBeath et al., 2004). NS enhances 2D osteogenesis 
linking to cytoskeletal tension regulation via the Rho-ROCK pathway 
(Nikukar et al., 2013). However, it seems less dependent in 3D culture 
(Tsimbouri P.M., 2017). Investigating the roles of cytoskeleton in NS 
induced 3D osteogenesis (starting at ECM synthesis, focal adhesion 
formation and the ROCK pathway) could help to clarify the NS 
mechanism. Most osteogenic induced signaling, such as TGFβ (Creely, 
DiMari, Howe, & Haralson, 1992; Sato, 2006) and  BMP2 (Takuwa, 
Ohse, Wang, Wozney, & Yamashita, 1991) pathways, enhance collagen 
synthesis. Integrins form focal adhesion complexes and transfer 
mechanical signal through actin into the nucleus. RhoA-ROCK 
activation crosstalks with ERK1/2 driving subsequent RUNX2 
phosphorylation (Dalby et al., 2014; Khatiwala et al., 2009). Thus, if 
NS enhances Col1A and integrins production as well as involves ROCK 
pathway, it suggests that NS potentially regulates cytoskeletal tension 
for 3D osteogenesis.  
4.2 Aims and objectives 
1. To identify the NS stimulating amplitude which can induce 3D 
osteogenesis in 1.8 mg/ml collagen hydrogel. 
  
2. To investigate the effect of high amplitude stimulation (90 nm, 
N90) in mechanical and biological aspects.  
 
3. To further study the biological pathways activating by high 
amplitude NS (N90).  
4.3 Methodology and experimental design 
4.3.1 Interferometry 
The 1.8 mg/ml collagen type I hydrogels (2.5 ml) with 1.5 ml media 
were prepared 2 days before the measurement. T5000 model was used 
to study the relationship between frequency-voltage and voltage-
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surface displacement amplitude. The measurement technique was 
explained in Chapter 2, section 2.4. 
4.3.2 Alamar Blue assay  
Stro1 selected MSCs seeded in 1.8 mg/ml collagen hydrogels with 4 
x104 cells/ml density were prepared. NS was stimulated with 30 nm 
and 90 nm for 2 weeks. The technique and calculation of percentage 
of alamar blue reduction was shown in Chapter 2, section 2.6 
4.3.3 qRT-PCR and ROCK inhibition study 
Stro1 selected MSCs seeded collagen hydrogels with 4 x104 cells/ml 
density were prepared and stimulated with NS. The RNA purification 
using Trizol and chloroform, RNA isolation, cDNA synthesis and qRT-
PCR techniques were explained in chapter 2, section 2.8. To study the 
ROCK pathway, 10 μM of Y-27632 (Tocris) in media was prepared. 
Changing media with inhibitor was started on day 2 and then every 2 
days. Details were shown in chapter 2, section 2.12.  
4.3.4 Western blot 
To study protein expression, 4 x 104 cells/ml of Stro1 selected MSC in 
1.8 mg/ml collagen hydrogel were prepared and NS for 7 days. After 
culture for 7 days, all samples were digested. Protein extraction and 
western blot technique were shown in Chapter 2, section 2.9. 
4.3.5 Protein antibody microarrays 
The 4 x 104 cells/ml of Stro1 selected MSC in 1.8 mg/ml collagen 
hydrogel were prepared and stimulated for 7 and 14 days. After the 
samples were digested with collagenase, the total protein was 
quantified using micro BCA kit (Pierce, ThermoFisher). The technique 
was explained in chapter 2, section 2.13.   
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4.4 Results 
4.4.1 Frequency and amplitude selection 
To study the effect of amplitude and frequency on osteogenesis, 
hMSCs seeded in 1.8 mg/ml collagen hydrogels were stimulated with 
various frequencies and amplitudes of NS. At 1000 Hz and (19.69 Vpp), 
measured amplitudes of all 24 wells (both 12 well plates) were 
grouped as N17 (N = nanodisplacement, mean 17.37 nm: SD 8.21 nm), 
N30 (mean 30.12 nm, SD 6.58 nm), N44 (mean 43.08 nm, SD 3.12nm), 
and N90 (mean 90 nm, SD 16.21). All hydrogels were then stimulated 
for 2 weeks and studied for phenotypical changes by qRT-PCR. After 
2 weeks stimulation (Figure 4.7), qRT-PCR showed some evidence of 
RUNX2 and osteonectin upregulation with a trend of PPAR and nestin 
suppression in N90 while other tested frequencies and amplitudes 
showed more generalized gene upregulation patterns. Therefore, N90 
was selected for further studies. 
 
Figure 4.7  The selection of NS amplitude driving for 3D 
osteogenesis by qRT-PCR 
RT-PCR after 2 weeks stimulation. Gels were exposed to 1000 
Hz (average 17, 30, 44 and 90 nm), 3000 Hz and 5000 Hz 
(stimulated with 19.69 Vpp). Upregulation of RUNX2 and ON, as 
well as PPARɣ and nestin suppression was seen in N90 group 
Chapter 4: High amplitude stimulation, phenotypes and pathways 118 
(mean±SD, n=2-4, * P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001, Two-way 
ANOVA, Tukey’s post hoc test). 
4.4.2 Mechanical response of hydrogel to nanovibrational 
stimulation 
In order to study the effect of high amplitude stimulation (N90), the 
efficacy of bioreactors generating amplitude required validation, 
including the precision of amplitude (section 4.4.2.1), the reliability 
of amplitude control by voltage (section 4.4.2.2) and investigating the 
resonant frequency of the culture plate system (section 4.4.2.3). 
4.4.2.1 High amplitude (N90) bioreactor validation 
To examine the reliability of the stimulating amplitude generated by 
the bioreactor, the standard (NTB 4003) 30 nm amplitude bioreactor 
and the N90 (T5000) 90 nm amplitude bioreactor were used for 
validation. Displacement amplitudes were measured by the 
interferometer at the centre area on the surface of wells and gels. 
The results showed that amplitude of gel was significantly higher than 
that of the well plate, but within expected ranges. The mean value of 
gel displacement amplitude of N30 was 35.83 nm (SD 1.77 nm) while 
mean value of amplitude of N90 was 93.94 nm (SD 13.06 nm) (Figure 
4.8).  
 
Figure 4.8  NS-amplitude validation of NS bioreactor 
Comparing N30 and N90 on the NTB 4003 vs T5000 bioreactors. 
Both bioreactors generated reliable amplitudes. The 
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displacement amplitude of the hydrogel was significantly 
increased compared to the well plate in both N30 and N90 
(mean±SD, n=24, * P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001 Mann-
Whitney test).  
4.4.2.2 Effect of increasing amplitude and hydrogel 
displacement 
To validate the stimulating voltage for high amplitude stimulation, 1.8 
mg/ml hydrogels were prepared. The surface displacement of 5 wells 
(2D) and 5 hydrogels (3D) were measured at the same point by 
interferometer using the N90, T5000 bioreactor. The graph of surface 
displacement and stimulating voltage was plotted. The displayed 
graph of AC signal pattern on oscilloscope was observed during 
increasing the stimulating voltage. Considering the AC signaling 
pattern shown by the oscilloscope, distortion of the output signal was 
noted at 31.64 Vpp indicating the saturaturation point of amplitude 
by the bioreactor system. Thus, N90 (stimulation by using 19.69 Vpp) 
can be used as high amplitude stimulation due to having a normal AC 
signal pattern (Vpp was less than 31.64 Vpp and AC signal pattern is 
normal). In Figure 4.9, the relationship between stimulating voltage 
and surface amplitude is a linear pattern upto 30 Vpp. Therefore, the 
bioreactor can generate precise- and reliable-high amplitudes (at 
19.69 Vpp).  
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Figure 4.9  The effect of increasing stimulating voltage on NS 
amplitude 
The linear correlation of voltage-amplitude was found upto 
31.64 Vpp. Thus, N90 (at 19.69 Vpp) is reliable and precise 
(mean±SD, n=5, W; well, P; platform, G; hydrogel).   
4.4.2.3 Resonance frequency and hydrogel-12 well plate 
system on nanvibrational bioreactor 
The relationship between frequency and amplitude was measured on 
the surface of 1.8 mg/ml hydrogels at the centre and edge points in 
12 well plates. The resonant frequency ranged approximately 2,250-
2,750 Hz. Thus, it confirmed that there was no resonance effect 
during the stimulation at 1000 Hz. There was no significant difference 
of amplitude between the centre and edge of the gels at 1000 Hz 
(Figure 4.10).  
  
Chapter 4: High amplitude stimulation, phenotypes and pathways 121 
 
Figure 4.10  Relationship between frequency and amplitude in 
12 well plate 
At 1000 Hz, hydrogel displacement is reliable and precise. 
Effect of resonance (at 2500 Hz) amplified the stimulating 
amplitudes resulting in high variation (high SD value) in both the 
centre and edge areas (mean±SD, n=5, T5000, 19.69 Vpp, * P≤ 
0.05, ** P≤ 0.01, *** P≤ 0.001, Two-way ANOVA, Sidak post hoc 
test, W; well, C; centre, E; edge).  
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4.4.3 Biological response of MSCs to high amplitude 
nanovibrational stimulation 
Biological effects of high amplitude NS were investigated for viability, 
effect on osteogenic differentiation induction in gene and protein 
levels and the involved cellular pathways. 
4.4.3.1 High amplitude and cell viability  
After 2 weeks of NS, alamar blue study was peformed. Both standard 
(N30) and high amplitude (N90) showed no difference to unstimulated 
control and osteogenic media (Figure 4.11).  
 
Figure 4.11  Alamar blue assays in N30 and N90 at 2 week 
Alamar blue study showed no significant difference between all 
groups indicating that high amplitude stimulation (N90) was safe 
for MSCs (mean±SD, n=3-4, Stro1+ MSCs, NS= no significant 
difference, One-way ANOVA, Tukey’s post hoc test, C; control, 
O; osteogenic media, N30; 30 nm, N90; 90 nm).   
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4.4.3.2 Nanovibrational stimulation enhance 3D osteogenesis 
The effect of high amplitude nanovibrational stimulation in osteogenic 
induction were then studied in Stro1+ MSCs seeded in hydrogels. To 
study the effect of N90 on gene expression, qRT-PCR was investigated 
at day 7 and 9. At day 7, osteogenic gene expression was not obviously 
presented, and only OSX upregulation was found. At day 9, N90 
induced osteogenic gene expression including RUNX2 (major 
transcription factor for osteogenesis), OSX, ON, ALP, OPN and OCN. 
PPAR (fat gene expression) increased from day 7 to 9 but there was 
no change compared to control (Figure 4.12). Therefore, day 9 is the 
suitable time point showing the obvious NS effect and was selected to 
study a single time point in gene expression.  
 
Figure 4.12  Gene expression comparing between day7 and 9 in 
N90 
After stimulation with N90 at 1000 Hz for 7 days, only OSX was 
significantly increased. Interestingly, at day9, N90 enhanced 
osteogenic gene expression. PPARɣ (fat) suppression was noted. 
(mean±SD, n=4, * P≤ 0.05, Stro1+ MSCs, green asterix; 
comparing between day7 and 9 using Mann-Whitney test, black 
asterix; comparing to control using Mann-Whitney test). 
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Comparing between N30 and N90 after stimulating for 9 days, N90 
promoted greater osteogenic gene expression (RUNX2, OSX, ON, OPN, 
OCN) than N30. Adipogenesis suppression was found in both N30 and 
N90 (Figure 4.13).  
 
Figure 4.13  Osteogenic gene expression comparing between 
N30 and N90 at day 9 
The qRT-PCR at day 9 comparing N30 and N90. High amplitude 
stimulation (N90) significantly increased RUNX2, OSX, ON, OPN 
and OCN while N30 showed less osteogenic induction (mean±SD, 
n=4, * P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001, One-way ANOVA, Tukey’s 
post hoc test, Pt1-2; patient 1-2). 
4.4.3.3 Protein expression 
To study protein level osteogenesis, western blot and densitometry 
were performed at day7. Again, N90 significantly enhanced 
pRUNX2/RUNX2 upregulation greater than N30 (Figure 4.14A-B). 
Interestingly, this result corresponded to gene level (Figure 4.12- 
4.13). 
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Figure 4.14  RUNX2 protein expression comparing between N30 
and N90 at day 7 
Western blot after 1 week stimulation; A. Phospho RUNX2 was 
upregulated in N30 and N90 (representative blot). B. Western 
blot densitometry showed significant upregulation of 
pRUNX2/RUNX2 for N90 comparing to control (mean±SD, 3 
patients, n=3, * P≤ 0.05, Mann-Whitney test, Pt1-3; patient1-3). 
4.4.3.4 Temporal gene study  
To investigate whether NS may change the osteogenic gene expression 
pattern, a temporal gene study by qRT-PCR was performed at day 7, 
14 and 21. These results elucidate that N90 provides greater enhanced 
osteogenic gene expression than N30. The pattern of N90 induced 
osteogenic gene expression corresponded to normal osteogenic gene 
expression pattern (Lian & Stein, 1992; Stein et al., 1991; Stein et al., 
2004; J. L. Yang et al., 2014). RUNX2 and OSX were found at 1-2 week, 
playing a role in committing preosteoblasts to immature osteoblasts 
(J. L. Yang et al., 2014). OPN and OCN increased at week 2 and 3 for 
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mineralization (Lian & Stein, 1992; Stein et al., 1991). ALP and ON 
expression increased at week 1-2 (Figure 4.15).  
 
Figure 4.15  Temporal gene analysis comparing between N30 
and N90 during  day 7-21 
A) N90 showed greater osteogenic gene expression over N30. 
RUNX2 increased at week 1. OSX and ON tended to increase 
and reached a peak at week 2. OPN and OCN increased at 
week 2 and 3. ALP was maximal at week 1. Overall, NS 
induced osteogenic gene expression pattern which 
corresponded to normal osteogenic gene pattern (mean±SD, 
3 patients, n=4, * P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001, One way-
ANOVA, Tukey’s post hoc test, asterix; blue= significant 
difference of N30, red=significant difference of N90, black= 
significant difference comparing between N30 vs N90, Pt1-
3; patient1-3).  
B) Diagram showing trends of the temporal gene study for N90.    
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4.4.4 Nanovibrational stimulation and related pathways 
Understanding the NS induced 3D osteogenesis is crucial. As 
aformentioned, Tsimbouri et al proposed that NS drives 3D 
osteogenesis mainly through TRPV1, PKC and β-catenin (Tsimbouri 
P.M., 2017) while Nikukar et al showed that NS induced 2D 
osteogenesis via ROCK-ERK1/2 pathway (Nikukar et al., 2013). Thus, 
in this section, NS related osteogenic pathways including calcium 
signaling, BMP2- and cytoskeletal related pathways were investigated.  
4.4.4.1 Investigating in calcium-, BMP2-and cytoskeletal-
related pathways in gene expression  
Osteogenesis pathways including BMP2-SMAD5, ion channels (including 
TRPV1, Piezos, CasR protein receptors), as well as ERK1/2 (which is 
MAPK member) were studied by qRT-PCR at day 9. The results showed 
that BMP2-SMAD1, TRPV1-Piezo2-CaSR and ERK1 expression was 
significantly upregulated, indicating that N90 potentially induced 3D 
osteogenesis through BMP2 and calcium signaling pathways (Figure 
4.16).  
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Figure 4.16  Gene expression of NS activated pathways 
compared between N30 and N90 at day 9 
RT-PCR at day 9 showed N90 activated BMP2-SMAD1, calcium 
signaling (TRPV1-Piezo2) and ERK1 pathways (mean±SD, n=4, * 
P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001, One-way ANOVA, Tukey’s post 
hoc test, Pt1-2; patient 1-2). 
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4.4.4.2 ROCK pathways and osteogenesis in 2D vs 3D 
nanovibrational stimulation  
The previous study by Nikukar et al demonstrated that NS enhances 
2D osteogenesis via ROCK pathway (Nikukar et al., 2013). To study the 
effect of N30 vs N90 on ROCK pathway, MSCs were cultured in 2D for 
7 day. The ratio of pRUNX2/RUNX2 was studied by In-Cell western 
assay. The 10 μM of Y-27632 (ROCK inhibitor) was added at day 2 and 
day 5. At day 4, pRUNX2/RUNX2 significantly decreased in N90, 
indicating that ROCK pathway links to RUNX2 expression. However, no 
significant difference was noted at day 7. Therefore, ROCK pathway 
might influece 2D osteogenesis, especially for N90, in the very early 
stages of committment (day4) (Figure 4.17).  
 
Figure 4.17  RUNX2 protein expression with ROCK pathway 
inhibition in 2D culture 
In-Cell Western assay of pRUNX2/RUNX2 with ROCK pathway 
inhibition for 2D osteogenesis. At day 4, the ROCK pathway was 
significantly involved in osteogenesis in the early phase (day 4). 
Effect of ROCK pathway was reduced at day 7 (Mean±SD, n=4, * 
P≤ 0.05, ** P≤ 0.01, *** P≤ 0.001, One-way ANOVA, Tukey’s post 
hoc test).  
To investigate the role of ROCK pathways in 3D osteogenesis, 10 μM 
of Y-27632 (ROCK inhibitor) supplemented in the media was changed 
every 2 days (starting from day 2), and qRT-PCR was performed at day 
9. The decrease of the RUNX2 ratio between with and without 
inhibitor (less than 1) was noted in N90, indicating that ROCK pathway 
may also tend to enhance to RUNX2 expression in 3D NS osteogenesis. 
Moreover, a significant ROCK-linked decrease of OSX expression was 
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noted in the N30 group (but not in N90), indicating that the ROCK 
pathway is involved in N30 driven osteogenesis (Figure 4.18).  
 
Figure 4.18  Osteogenic gene expression with ROCK pathway 
inhibition in 3D culture 
qRT-PCR with Y-27632 (ROCK inhibition) was performed at day 
9. ROCK pathways significantly involved in OSX gene expression 
in N30 group at day 9. No significant change was found in RUNX2 
and OPN gene expression (mean±SD, n=4, * P≤ 0.05, ** P≤ 0.01, 
*** P≤ 0.001, One-way ANOVA, Tukey’s post hoc test). 
4.4.4.3 Protein expression by protein arrays 
To further investigate the NS induced pathways at protein level, a 
protein array was performed. MSCs were stimulated with standard 
(N30) and high amplitude stimulation (N90) for 7 days. N30 activated 
cellular membrane receptors such as integrins and BMP2. Increase of 
collagen protein production was also noted. High stimulating 
amplitude (N90), however, showed the activation of ion channel 
proteins on cellular membranes such as TRPA1, TRPV1, Piezo1,2, and 
L-type calcium channel. (Figure 4.19). Interestingly, protein array 
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results corresponded to qRT-PCR showing the upregulation of TRPV1 
and piezo2 in gene level (Figure 4.16A).  
 
Figure 4.19  Protein expression of NS activated pathways at day 7 
From protein array at day 7, standard NS amplitude (N30) 
activated ECM proteins including integrins and collagens. 
Interestingly, High amplitude NS (N90) not only triggered ECM 
protein production but also activated stretching ion channels 
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proteins such as TRPV1, Piezo1, 2, and L-type calcium ion 
channels.  
4.5 Discussion 
4.5.1 High amplitude nanovibration stimulation enhances 
osteognesis and pathway activation 
At day 9, osteogenic genes (RUNX2, OSX, ALP, OPN and OCN) were 
significantly upregulated in the N90 group (Figure 4.12). Regarding 
the gene expression in N90, it might be implied that stimulated MSCs 
are committed to preosteoblasts (by the effect of RUNX2 and osterix) 
and became immature osteoblasts (by the evidence of RUNX2, OPN 
and OCN upregulation at day 9). At the protein level, the evidence of 
pRUNX2/RUNX2 upregulation (Figure 4.14), again, affirmed that N90 
provided a better osteogenic induction effect than N30 which 
coresponded to activated pathways at the gene level for N90 (Figure 
4.16). The activation of N90-induced calcium ion-related (TRPV1, 
Piezo1, ERK1) and BMP2-related (BMP2, SMAD1) genes and proteins 
indicated that N90 may link to calcium signaling and BMP2 pathways.  
In a temporal gene study (Figure 4.15), again, N90 showed better 
osteogenic induction during 3 weeks of stimulation. The temporal 
gene study of N90 corresponded to Yang et al who studied the 
temporal gene expression for nanotopography induced osteogenesis 
(J. Yang et al., 2014). RUNX2 and OSX upregulation was found in week 
1-2 for osteogenic commitment of MSCs. OCN and OPN were then 
increased at week 2-3 for ECM production and mineralization. 
However, the early increase of ALP at week 1 was noted which 
correlated to Tsimbouri et al’s study showing the upregulation of ALP 
and OPN in 1 week by N30 induction (Tsimbouri P.M., 2017). The early 
upregulation of ALP in N90 was observed and possibly relate to 
mineralization initiation (Stefkova, Prochazkova, & Pachernik, 2015). 
In a physiologically-relevant osteogenic gene expression pattern, ALP 
was produced in low levels at week 1 and progressively increase at 
week 2-3 (Hoemann, El-Gabalawy, & McKee, 2009). To explain why 
the early upregulation of ALP and OPN was found in week 1, three 
hypotheses were drawn. Firstly, NS may directly activate calcium 
channels such as TRPV1, Piezo1/2, and L-type calcium channels 
especially in week1 resulting in the influx of extracellular calcium. 
The increase of intracellular calcium may induce OPN (You et al., 
Chapter 4: High amplitude stimulation, phenotypes and pathways 133 
2001) and possibly enhance ALP secretion (Iannotti, Naidu, Noguchi, 
Hunt, & Brighton, 1994).  
BMP2 secretion in week1 could be another cause. NS possibly 
promotes BMP2 secretion in the early phase (shown in (Tsimbouri 
P.M., 2017) and Figure 4.2A, 4.16B), and may increase intracellular 
calcium and ALP expression (W. Xu et al., 2016). This hypothesis 
coresponded to Tsimbouri’s study reporting that the effect of NS links 
to calcium signaling (Tsimbouri P.M., 2017). Morover, NS also induce 
BMP2 as well as links to TRPV1 and PKC which is the mediator of the 
calcium signaling pathway (Figure 4.3 D-E).  
Another hypothesis could be drawn based on the metabolomic data, 
NS may induce low grade oxidative stress e.g. reactive oxygen species 
(ROS). This stress, in turn, induced endoplasmic reticulum (ER) stress 
(J. K. Kim et al., 2016) in early phase (day 7), thus, enhancing ALP 
upregulation (Furmanik & Shanahan, 2018). NS induced ROS 
hypothesis possibly linked to calcium ions. ROS can control calcium 
homeostasis and affects on mitochondria and ER functions. ROS 
induces ER to release calcium ions from ER into the cytosol (Görlach, 
Bertram, Hudecova, & Krizanova, 2015). ROS may generally enhance 
ion channels upregulation in protein arrays such as TRPV1 (Chuang & 
Lin, 2009), TRPA1(Nicholas, Yuan, Brookes, Spencer, & Zagorodnyuk, 
2017; C. Xu et al., 2017), L-type Ca2+ channels (L. Yang et al., 2013) 
and, furthermore, it may enhance collagen synthesis (Boin et al., 
2014) showing in protein array (Figure 4.19). Effect of ROS on MSCs 
is a double-edged sword, low level of ROS suits for osteogenesis and 
proliferation (C. H. Byon et al., 2008; Choe et al., 2012). However, 
high doses of ROS reduce differentiation (Atashi et al., 2015; C. H. 
Lin, Li, Cheng, & Yen, 2018; J. Tan et al., 2015). Further discussion 
of ROS and osteogenesis are discussed in chapter 5.  
4.5.2 The hypothesized pathways and crosstalk activated by NS; 
possible interaction between calcium signaling-BMP2-
cytoskeleton.  
It is difficult to conclude that NS directly activate calcium ion 
channels or that calcium ion channels are the secondary responders 
from other activated pathways. The possible pathways, activated by 
NS, are summarized in Figure 4.20. NS is potentially involved in 
calcium ion channel expression/function (directly activated or 
indirectly activated by cytoskeleton or by reducing channel 
sensitization by ROS and inflammatory cytokines) or involves GPCRs 
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which might be overlooked as mechanosensor (Connelly et al., 2015). 
Increased intracellular calcium activate PKC (K.-P. Huang, 1989) in 
turn phosphorylates TRPV1 allowing calcium influx (Studer & 
McNaughton, 2010). Cacium/CAM complex might then activate CaMKs  
promoting differentiation (Y. H. Choi et al., 2013; Illario et al., 2003). 
NS also enhanced BMP2 signalling via SMAD1/5 pathway driving 
osteogenesis. BMP2 also increases intracellular calcium promoting 
osteogenesis (W. Xu et al., 2016). Cytoskeletal tension appears to play 
a role in 3D osteogenesis via integrins-ROCK pathway. ERK1/2 was 
possibly mediated by cytoskeleton, crosstalking of calcium signaling 
as well as crosstalking between canonical and non-cannonical Wnt. 
Joining the dots on all of these pathways remains to be done. 
 
Figure 4.20 Extended hypothesis of NS induced 3D osteogenesis  
(refer to section 4.5.2)   
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4.6 Conclusion 
NS with high amplitude stimulation (90 nm) was safe for MSCs and 
enhanced 3D osteogenesis in gene and protein levels. In a temporal 
gene study, N90 induced 3D osteogenesis corresponding to an 
osteogenic gene expression pattern. N90 appeared to drive 3D 
osteogenesis through multiple biological pathways including BMP-
smad1/5, calcium signaling (through TRPV1, piezo2, CaSR) and ROCK 
pathways.
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Chapter 5 The effect of high amplitude 
nanovibrational stimulation on MSC 
metabolomics and inflammatory 
response 
5.1 Introduction 
5.1.1 Metabolic changes in MSC status 
It is known that metabolomic changes reflect cellular status such as 
proliferation, differentiation, oxidative stress or apoptosis (Wanet, 
Arnould, Najimi, & Renard, 2015). Thus, understanding the 
metabolomic changes, during proliferation, differentiation and 
exposure to external stimuli, could help to interpret how MSCs 
respond to NS. 
In physiological conditions, MSCs require bioenergy from glycolysis and 
fatty acid -oxidation for maintaining self-renewal (K. Ito & Suda, 
2014). During differentiation, MSCs develop different metabolic 
patterns. For example, chondroblastic differentiation mainly uses 
glycolysis under hypoxic conditions (Pattappa, Heywood, de Bruijn, & 
Lee, 2011). However, osteoblastic differentiation likely requires 
energy from oxidative phosphorylation (OXPHOS) in normoxic 
conditions; reactive oxygen species (ROS) are thus produced at low 
levels (Shum, White, Mills, Bentley, & Eliseev, 2016). Adipogenic 
differentiation requires OXPHOS for differentiation from pre-
adipocyte to adipocyte; ROS is produced at high levels (Shyh-Chang et 
al., 2013). It is noted that the Phosphoinositide 3-kinase/Protein 
kinase B/mammalian target of rapamycin (PI3K-AKT-mTOR) pathway 
is important for bioenergetic regulation maintaining cellular 
homeostasis (K. Ito & Ito, 2016). 
5.1.1.1 Glycolysis, oxidative phosphorylation: from 
quiescence to differentiation  
MSCs require high energy to maintain functions such as differentiation 
or proliferation. Glucose metabolism plays an important role in 
undifferentiated and differentiated cells. The oxygen niche is another 
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key regulator for glycolysis and oxidative phosphorylation (Ziello, 
Jovin, & Huang, 2007).  
It had been known that HIF1 regulates glycolysis and oxidative 
phosphorylation in responding to oxygen concentration. HIF1 
activates pyruvate dehydrogenase kinase 1 (PDK1) in turn inactivating 
pyruvate dehydrogenase (PDH). A decrease in PDH reduces the 
conversion of pyruvate to acetyl-CoA, thus, suppressing tricarboxylic 
acid cycle (TCA) cycle (J.-w. Kim, Tchernyshyov, Semenza, & Dang, 
2006).  HIF1 is increased in the hypoxic niche resulting in activation 
of glycolysis and reduction of OXPHOS. High levels of HIF1α are found 
in undifferentiated cells in the niche (Shum et al., 2016). In normoxic 
conditions, where MSCs are e.g. osteogenically induced, HIF1 is 
downregulated and thus OXPHOS is activated (Palomaki et al., 2013) 
(Figure 5.1). HIF1 is thus a determinant of stem cell fate along 
osteogenic, angiogenic or chondrogenic lineages. Moreover, HIFs also 
crosstalk with many signaling pathways such as TGF/Smad and 
Wnt/Catenin pathways (Ozturk, Hobiger, Despot-Slade, Pichler, & 
Zenobi-Wong, 2017; S. M. Watt, Tsaknakis, Forde, & Carpenter, 2009). 
In hypoxic condition, HIF1 is best known to promote angiogenesis 
through vascular endothelial growth factors (VEGFs) signaling result 
(Drager et al., 2015). However, VEGF-D also regulates osteoblast 
maturation via VEGF receptor 3 (VEGFR3) (Orlandini et al., 2006). 
5.1.1.2 Lipid metabolism in MSCs  
Lipid metabolism is essential for cell homeostasis maintaining the 
equilibrium between anabolism (lipogenesis) and catabolism 
(generating ATP) (Kuo & Ann, 2018); lipids are important sources of 
ATP. In quiescent stem cells, fatty acids are catabolized by -
oxidation into acetyl-CoA then used to generate ATP via TCA cycle. In 
proliferative stem cells, Acetyl-CoA is used to synthesize 
polyunsaturated fatty acids or complex fatty acids such as the 
phospholipid membrane (Folmes, Park, & Terzic, 2013).    
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5.1.1.3 Amino acid metabolism; role of glutamine in MSCs 
Glutamine metabolism is important for cell survival as it is the main 
nitrogen source for nucleotide synthesis. During cell differentiation 
which requires high energy, reactive oxygen species (ROS) are 
produced. Glutamine balances cellular redox acting as an antioxidant 
(Mates, Perez-Gomez, Nunez de Castro, Asenjo, & Marquez, 2002). In 
hypoxic conditions, the TCA cycle is limited in generating ATP by HIF1-
. HIF1- reduces pyruvate dehydrogenase (PDH), thus reduces the 
conversion of pyruvate to acetyl-CoA. Subsequently, glycolysis is the 
main source of energy in hypoxia. Glutamine is converted to 
glutamate and -ketoglutarate which in turn enters TCA cycle for ATP 
production (Michalak, Mackowska-Kedziora, Sobolewski, & Wozniak, 
2015) (Figure 5.1).  
 
Figure 5.1  Glycolysis, oxidative phosphorylation and HIF1-α 
In hypoxic conditions, HIF1- α activates pyruvate dehydrogenase 
kinase 1 (PDK1) to inhibit PDH reducing the conversion of 
pyruvate to Acetyl-CoA. Glycolysis therefore is mainly used 
during the quiescent state. In normoxic conditions, HIF1- α is 
degraded by prolyl hydroxylases (PHDs), factor inhibiting HIF-1 
(FIH) and Von Hippel-Lindau ubiquitin ligase complex (VHLs). 
Pyruvate from glycolysis is converted to Acetyl-CoA which, in 
turn, enters TCA cycle and oxidative phosphorylation (K. Ito & 
Suda, 2014; Y. Liu & Ma, 2015; Mahon, Hirota, & Semenza, 
2001).  
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5.1.2  Can NS-induced osteogenesis with low grade oxidative 
stress?  
From current evidence, mechanical stimulation can induce 
osteogenesis (P. L. Fu et al., 2017; X. Huang et al., 2018) but it may 
also produce oxidative stress (Chapman et al., 2005; Sharifpanah, 
Behr, Wartenberg, & Sauer, 2016). Optimal reactive oxygen species 
(ROS) drive differentiation (Choe et al., 2012) while over stimulation 
(high level of ROS) can suppress differentiation and may affect cell 
survival (Chang Hyun Byon et al., 2008; Jufri, Mohamedali, Avolio, & 
Baker, 2015; J. Tan et al., 2015). There are many studies that show 
that mechanical stimulations may link to oxidative stress (Chapman 
et al., 2005; J. J. Cheng, Wung, Chao, & Wang, 1998; Hong et al., 
2015; Schmelter, Ateghang, Helmig, Wartenberg, & Sauer, 2006; 
Sharifpanah et al., 2016). For example, cyclic stretch produces ROS 
at the plasma membrane (by NADPH oxidase) or via the mitochondrial 
respiratory chain. ROS is involved in multiple cell functions including 
cellular contraction (via ion channels), cell growth, cellular apoptosis 
(via cyclins, CDK) and inflammation (via e.g. NFB) (Birukov, 2009). 
NS can be considered as a mechanical stimulus, thus, it possibly 
generates oxidative stress. Thus, if ROS is found during NS, this 
possibly hints the clue of NS induced osteogenesis.  
5.1.3 ROS: sources and REDOX balance 
ROS are oxygen free radicals e.g. peroxides, superoxide, etc., 
produced by cellular metabolism (Murphy, 2009). ROS metabolites 
maintain redox homeostasis (Droge, 2002). ROS are mainly produced 
by mitochondria from the electron transport chain (Murphy, 2009) but 
can also be produced at the cellular membrane where external stimuli 
such as bacteria or mechanical stimulation (e.g. cyclic stretch (Liang 
et al., 2019)) act. At the cellular membrane, NADPH oxidase (NOX) 
plays important roles in ROS generation (Bigarella, Liang, & Ghaffari, 
2014). 
ROS is controlled by antioxidative responses in cells. In acute 
response, ROS is counterbalanced by enzymes. For example, 
superoxide dismutase (SOD) can convert ROS to H2O and O2 (Mittal, 
Siddiqui, Tran, Reddy, & Malik, 2014).  Glutathione also scavenges 
ROS by oxidation (Droge, 2002). Chronic ROS production triggers the 
nuclear factor erythroid 2-related factor2 (Nrf2) gene for antioxidant 
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response (Ma, 2013). This activates MAPK, p53 and NFκB for cell 
survival in a long-term response (Martindale & Holbrook, 2002).  
At the physiological level, ROS enhances stem cell proliferation and 
differentiation. In high oxidative stress conditions, ROS can lead to 
mitochondrial dysfunction, induce DNA damage and apoptosis 
(Maryanovich & Gross, 2013). ROS is also directly involved in redox 
signaling and protein functions such through NFB, HIF1, FOXO, 
mTOR, AKT which in turn, regulate glycolysis and oxidative 
phosphorylation (Bai et al., 2005; Bigarella et al., 2014; Murphy, 
2009).  
5.1.4 Metabolomic changes of MSCs in oxidative stress 
conditions 
As aforementioned, MSCs maintain in vivo potency using glycolysis 
under hypoxic niche conditions. In osteogenically differentiating 
MSCs, OXPHOS is activated (Shyh-Chang et al., 2013). SOD and 
catalase are increased to control ROS (C. T. Chen, Shih, Kuo, Lee, & 
Wei, 2008). In the early differentiation stage, ROS is produced at 
physiological levels, enhancing molecular signaling to help driving 
differentiation and proliferation (Droge, 2002). In high energetic 
process such as proliferation, ROS can temporally increase but it then 
reverts to normal levels (Droge, 2002; Shyh-Chang & Ng, 2017).  
In oxidative stress conditions where ROS accumulation can damage 
cellular organs, cells scavenge ROS using enzymes and redox signaling 
as sentinel mechanisms maintaining normal cellular functions and 
reduce ROS. Glycolysis is also shifted to pentose phosphate pathway 
(PPP).  
5.1.4.1 The shift of OXPHOS to glycolysis and pentose 
phosphate pathways in oxidative stress conditions 
In oxidative stress conditions, cells use a redox balancing system to 
reduce mitochondrial injury from high levels of ROS. Cells reduce ATP 
production from the TCA cycle by diverting  glycolysis to PPP (Kuehne 
et al., 2015). The PPP generates NADPH, pentoses and ribose from G-
6 phosphate; ribose-5-phosphate is a precursor for DNA, RNA synthesis 
and NADPH formation (Perl, Hanczko, Telarico, Oaks, & Landas, 
2011). By redox balancing, PPP reduces oxidative stress by converting 
H2O2 to H2O using glutathione peroxidase (Bigarella et al., 2014). Some 
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literature mentions that shifting to PPP may be an early sign of 
tumorigenesis before shifting to aerobic glycolysis-dependent 
mechanisms (Warburg effect) (E. S. Cho, Cha, Kim, Kim, & Yook, 2018; 
Kuehne et al., 2015). 
5.1.4.2 Effect of ROS on amino acids and lipids  
ROS oxidizes proteins causing hydroxylation of aromatic amino acids 
as well as nitration, nitrosylation and sulfoxidation, in turn, resulting 
in protein degradation and dysfunction (Stadtman & Levine, 2003). 
Moreover, L-glutamine also links with ROS. L-glutamine is a precursor 
of glutathione (GSH). GSH plays role in redox balance reducing ROS. 
GSH is oxidized to glutathione disulfide (GSSG) by converting H2O2 to 
H2O (Mailloux, McBride, & Harper, 2013). Aspartate, a non-essential 
amino acid, is another source of ATP from mitochondrial oxidation (Pi 
et al., 2014). Aspartate is a known antioxidant. However, evidence 
and mechanism of aspartate on ROS reduction is scarce and remains 
unclear (J. Duan et al., 2016). 
Considering lipids, LC-PUFAs are important as they are ATP sources 
and precursors of phospholipids (Maulucci et al., 2016). LC-PUFAs are 
also antioxidants (via Nrf-2/HO-1 pathway) (Kusunoki et al., 2013; 
Richard, Kefi, Barbe, Bausero, & Visioli, 2008). However, in oxidative 
stress conditions, ROS can peroxidize PUFAs, lipoproteins and damage 
oxidative membrane (H. Arai, 2014; Ayala, Muñoz, & Argüelles, 2014).  
5.1.5 mTOR-AMPK-Akt pathway regulates metabolism in 
oxidative stress conditions.  
It has been shown that the mTOR-AMPK-Akt pathway links to cellular 
metabolism, redox balancing, autophagy and cell survival (Y. Zhao et 
al., 2017). Zhao et al contributed a good summary of the interaction 
between mTOR-AMPK-Akt and ROS as illustrated in Figure 5.2 A-B.  
In low (physiological) stress conditions (with glucose deprivation), 
AMP-activated protein kinase (AMPK) pathway plays a catabolic role 
to produce energy together with anti-oxidant production (via 
Forkhead box class O; FOXO) as well as reduce anabolism (Y. Zhao et 
al., 2017). AMPK acts as an energy sensor for cells. AMPK suppresses 
protein synthesis (by inhibiting mTOR), fatty acid catabolism (by 
activating adipose triglyceride lipase; ATGL) and lipid synthesis (via 
inhibition of HMG-CoA reductase and acetyl-CoA-carboxylases; ACC1 
Chapter 5: Metabolomics, oxidative stress and inflammation during Ns 143 
and 2). AMPK increases glucose uptake (by TBC1D1 activate via GLUT1 
and 4) and inhibits glycogen synthesis (inhibiting glycogen synthase) 
(Herzig & Shaw, 2018). AMPK also plays role in autophagy (via ULK1) 
(Mihaylova & Shaw, 2011). Interestingly, some studies have shown 
that AMPK may promote osteogenesis and mineralization (E. K. Kim et 
al., 2012; Yi Li, Su, Sun, Cai, & Deng, 2018).  
In high stress conditions (shown by ROS accumulation), the Akt 
(protein kinase B) pathway plays a role by initiating cell survival and 
anti-apoptotic pathways as well as promotes anabolism (Y. Zhao et 
al., 2017). mTOR (considered as a nutrient sensor) is a member of PI3K 
kinase family (Saxton & Sabatini, 2017). mTOR is regulated by both 
AMPK (inhibitory effect) and Akt (stimulating effect) thus balancing 
between catabolism and anabolism (Hahn-Windgassen et al., 2005; 
Saxton & Sabatini, 2017). Akt activation provides anti-apoptotic 
function and increases glucose uptake (Y. Zhao et al., 2017) as well 
as resists an oxidative stress (L. Wang, Chen, Sternberg, & Cai, 2008).  
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Akt activated-mTOR increases protein synthesis and decreases 
autophagy (Saxton & Sabatini, 2017).   
 
Figure 5.2   mTOR mTOR-AMPK-Akt signaling pathway and 
oxidative stress 
A) AMPK, Akt, mTOR and FOXO interaction. In summary, AMPK 
promotes energy production by increasing catabolism 
(increase fatty acid oxidation, glycolysis) and reducing 
anabolism (reduce protein and fatty acid synthesis). Akt 
activation increases anabolism such as glycogen and protein 
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synthesis and promotes anti-apoptosis. mTOR is activated by 
Akt but inhibited by AMPK. FOXO is controlled by AMPK and 
Akt.   
B) mTOR-AMPK-Akt pathways and ROS regulation; Akt-AMPK 
affects on mTOR (AMPK inhibits while Akt activates mTOR). 
Activated mTOR promotes protein synthesis and decrease 
autophagy. AMPK-FOXO promotes anti-oxidants synthesis 
and shift glycolysis to PPP in order to reduce ROS  
(With permission of Zhao., 2017 (Y. Zhao et al., 2017),  
licensed under Creative Common Attribution License; CC; 
https://creativecommons.org/licenses/by/4.0/). 
5.1.6 Oxidative stress and interaction among lipid rafts, NAPDH 
oxidase and ROS on the cellular membrane 
It has been proposed that NS may ‘flutter’ cellular membranes (Childs 
et al., 2016). Theoretically, ROS can also be generated at the cellular 
membrane by NADPH oxidase (NOX). Indeed, much signaling 
emanating from the cellular membrane is linked to lipid rafts. Thus, 
understanding the lipid raft-oxidative stress relationship is important. 
Lipid rafts (LR or membrane rafts) are microdomain clusters on the 
cellular membrane which consist of phospholipids, sphingolipids and 
sterols. LRs interact with proteins (e.g. receptors) providing biological 
functions such as redox signaling. LR functions depend on the major 
proteins in rafts e.g. calcium channel rafts (functioned as ion channels 
activity), GPCR rafts (GPCR cellular signaling), and raft-cytoskeleton 
(Fas signaling) (Jin, Zhou, Katirai, & Li, 2011).  
LR also plays crucial roles on NOX controlling redox signaling by 
forming NOX-lipid rafts platform (Ushio-Fukai, 2006). At the cellular 
membrane, ROS can be generated by NADPH oxidase (NOX) which can 
be found in physiological and pathological conditions (Bedard & 
Krause, 2007). NOX-dependent ROS oxidises cysteine residues 
activating many transcription factor such as NFkB and Ras as well as 
inducing TNFα and TGFβ1 (Bedard & Krause, 2007). Moreover, NOX 
can be activated by calcium signaling. NOX can regulate calcium 
channels (L-type channels, stored-operated calcium channels, Ca2+ 
ATPase pump) resulting in increased intracellular calcium (Bedard & 
Krause, 2007).   
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5.1.7 Interplays between ROS and inflammatory pathways 
Inflammation is a major cause of oxidative stress (Chatterjee, 2016) 
and, as has been discussed, ROS can induce inflammation (Biswas, 
2016) Thus, It is difficult to specify whether ROS or inflammation 
firstly triggers these inflammation-ROS signals. If the process is 
started with inflammation induced ROS production, the inflammation 
may be initiated as MSCs are exposed to stimuli such as bacteria or 
tissue injury. These inflammasomes, in turn, activate ROS production 
from mitochondria and the cellular membrane (via NADPH oxidase) 
together with inducing ER stress and calcium influx. These signals then 
activate thioredoxin-binding protein and NLRP3 to produce IL-1β 
(Abais, Xia, Zhang, Boini, & Li, 2015). However, oxidative stress can 
also induce inflammation by itself. Chronic ROS exposure can activate 
NFκB which is a sensor of oxidative stress that links cell survival 
pathways (Morgan & Liu, 2011; Oliveira-Marques, Marinho, Cyrne, & 
Antunes, 2009; T. Wang et al., 2002), it also activates TNFα (Blaser, 
Dostert, Mak, & Brenner, 2016), IL-1β (via NLRP3) (Abais et al., 2015; 
Chang Hyun Byon et al., 2008), caspases (Higuchi, Honda, Proske, & 
Yeh, 1998) as well as activator protein 1 (AP-1; links to cell growth or 
apoptosis) (Ferreira Mendes, Caramona, Carvalho, & Lopes, 2003). 
These signals explain why inflammatory cascades are activated 
(Lugrin, Rosenblatt-Velin, Parapanov, & Liaudet, 2014; Reuter, 
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Gupta, Chaturvedi, & Aggarwal, 2010). The cycle of ROS-inflammation 
is illustrated in Figure 5.3.  
 
Figure 5.3 Vicious cycle of ROS and inflammatory response 
ROS can induce inflammation. However, inflammation also 
enhances ROS production. Uncontrolled inflammasomes or 
oxidative stress, drive this cycle leading to apoptosis. 
5.1.8 MSCs play roles in inflammation 
Theoretically, inflammatory cells exposed to exogenous (pathogen) or 
endogenous (soft tissue damage) stimuli present pathogen-associated 
or damaged associated molecular patterns (PAMPs or DAMPs) which 
can be recognized by pattern recognition receptors (PRRs) e.g. Toll-
like (TLRs on the cell membrane) and NOD-like (NLRs in cytoplasm) 
receptors. Both receptors activate NFB signaling pathway which is a 
major inflammatory regulator producing inflammatory cytokines 
(Lugrin et al., 2014).  
MSCs also have TLRs which can respond to DAMPs (e.g. heat shock 
protein; HSP60, HSP70) and PAMPs (e.g. bacteria) (Shirjang, Mansoori, 
Solali, Hagh, & Shamsasenjan, 2017). Regarding MSC polarization, 
MSCs can express pro-inflammatory or anti-inflammatory phenotype 
depending on environments (Bernardo & Fibbe, 2013). In an 
inflammatory environment, MSCs interact with other MSCs through 
TLR secreting TGFβ, PGE2, NO and indoleamine 2,3-dioxygenase (IDO) 
(Mellor, Lemos, & Huang, 2017; Putra et al., 2018). Moreover, MSCs 
also produce IL-6 to convert monocytes to M2 macrophages which, in 
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turn, produce IL-10 giving anti-inflammatory effects (Bernardo & 
Fibbe, 2013).  
5.1.8.1 Inflammation and metabolomics; role of long chain 
polyunsaturated fatty acids (LC-PUFAs) and 
inflammation  
Long chain polyunsaturated fatty acids (LC-PUFAs), are essential fatty 
acids derived from linolenic and linoleic acid desaturation and 
elongation. LC-PUFAs consist of n-3 and n-6 fatty acids (or omega-3 
and omega-6). Omega-3 is known to be anti-inflammatory while 
omega-6 is pro-inflammatory (Borges, Santos Fde, Telles, Correia, & 
Lanna, 2014).  
Omega-3 and omega-6 require Δ5-desaturase to synthesize LC-PUFAs; 
Omega-6 requires Δ5-desaturase to produce arachidonic acid (AA) 
which synthesizes high grade inflammatory metabolites (e.g. 
thromboxane, prostaglandins) by cyclooxygenase (COX) and 
lipoxygenase (LOX). WhIile omega-3s such as eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA) also use Δ5-desaturase to 
synthesize low grade inflammatory metabolites by COX and LOX (e.g. 
leukotrienes) (Kruger, Coetzee, Haag, & Weiler, 2010). Increased 
levels of n-3 PUFAs competitively use Δ5-desaturase with n-6 PUFAs 
to synthesize eicosanoids. Thus, there is evidence that omega-3 PUFAs 
may indicate a shift of high to low grade synthesis reducing 
inflammation level (Calder, 2001).  
PUFAs might enhance osteogenic differentiation depending on their 
levels (Martinez-Ramirez et al., 2007). Optimal (low) level of PUFAs 
may promote TGFβ1 and insulin like growth factor (IGF) which are 
essential for differentiation (Kruger et al., 2010). However, some 
evidence has shown that DHA could inhibit alkaline phosphatase 
expression but did not involve mineralization studied in MC3T3-1 
osteoblast-like cells (Coetzee, Haag, & Kruger, 2009). Moreover, 
omega-3 also has antioxidative effects (through Nrf2-HO-1) (Giordano 
& Visioli, 2014; Kusunoki et al., 2013; Richard et al., 2008). 
Interestingly, PUFAs can also regulate TRP channels via PKC (Ciardo & 
Ferrer-Montiel, 2017; Sisignano, Bennett, Geisslinger, & Scholich, 
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2014). As NS may activate osteogenesis via TRPV1, thus, the role of 
PUFAs during NS should be investigated. 
5.2 Aims and objectives 
1. To study the metabolomic response of MSCs on high amplitude 
NS. 
 
2. To study the effect of high amplitude stimulation in 3D 
osteogenesis in terms of biological response. 
 
3. To Identify related inflammatory pathways which are involved 
in osteogenic differentiation   
5.3 Methodology and experimental design 
5.3.1 Metabolomics  
Stro1-selected MSCs seeded with 4 x104 cells/ml density in 1.8 mg/ml 
collagen hydrogels were stimulated with N30 and N90. After 1 and 2 
week, NS the gels were homogenized on ice, and metabolites were 
then extracted using a Chloroform/Methanol/water (1:3:1 ratio) 
extraction buffer. Samples were agitated on a shaker at 4C for 1 hour 
and in turn centrifuged at 13,000xg at 4C for 5 minutes. Supernatants 
were transferred to and analysed by the Glasgow Polyomics team. 
Hydrophilic interaction liquid chromatography-mass spectrometry was 
performed (Dionex, UltiMate 3000 RSCL system, Thermo Fisher 
Scientific, Hemel Hempstead, UK) using a ZIC-pHILIC column (150 mm 
x 4.6 mm, 5 m. column, Merck Sequant). The datasets were 
processed using XCMS (peak picking), MzMatch (filter and grouping), 
IDEOM (post processing filtering and identification). Metaboanalyst 
was used to generate heatmaps and PCA analysis. KEGG database and 
Ingenuity Pathway Analysis (IPA) software were used for metabolomic 
pathway analysis.  
5.3.2 qRT-PCR and protein inhibition test 
In all qRT-PCR studies, 4 x104 cells/ml of Stro1-selected MSCs seeded 
in 1.8 mg/ml collagen hydrogels was prepared and stimulated with 
N30 and N90. For the temporal gene study, the samples were 
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harvested at day 7, 14 and 21. The samples were digested with 
collagenase. The techniques of RNA extraction and purification as well 
as cDNA synthesis were mentioned in Chapter 2 section 2.8. For qRT-
PCR with the inhibition test, hydrogels were stimulated for 9 days. All 
inhibitors (ERK1/2, JNK, p38, TNFα, NFκB inhibitors) were mixed with 
basal media which were changed at day 2, 5 and 8. The functional 
concentration of inhibitors in media was shown in chapter 2 section 
2.12. 
5.3.3 In-Cell Western with protein inhibition test   
Stro1-selected MSCs were seeded in 24 well-plates with the density of 
10,000 cells/well. MSCs then were stimulated with N30 and N90 for 7 
days. Culture media was added with ERK1/2, JNK, p38, TNFα, and 
NFκB inhibitors (functional concentration of inhibitors in media was 
shown in Chapter 2, section 2.12). Media was changed at day 2 and 
day 5. In-Cell Westerns were performed at day 7 (technique described 
in chapter 2 section 2.10). 
5.3.4 ROS measurement by DCF-DA with flow cytometry  
Stro1-selected MSCs seeded with 4 x104 cells/ml density in 1.8 mg/ml 
collagen hydrogels were stimulated with N30 and N90 for 7 day. The 
samples were incubated in 2.5 mg/ml collagenase for 1 hour and were 
then centrifuged at 200xg for 4 minutes. Following that, the cell 
pellets were incubated for 1 hour in 2 uM 2’,7’- dichlorodihydrogen-
fluorescein diacetate (H2DCF-DA, Invitrogen) in phenol red free media 
(Sigma, D5030). In the positive control group, 500 uM hydrogen 
peroxide was added. After incubation, the samples were then 
centrifuged and resuspended in 250 ul of flow cytometry buffer (2% 
FBS, 2 mM EDTA in PBS) and transferred to 96 well plates. 
Resuspended MSCs in 96 well plates were incubated for 30 minutes. 
Signal of H2DCF-DA fluorescein was detected by using flow cytometry 
at 492-295 nm of excitation and 517-527 nm of emission.  
5.3.5 Mitotracker  
Stro1-selected MSCs with 4 x104 cells/ml of density in hydrogels were 
prepared. After 7 days stimulation, samples were digested using 
collagenase D. Cells were centrifuged to obtain pellets and 
resuspended with 100 nM final concentration of Mitotracker Green 
(FM, M7514, Invitrogen). The incubation lasted for 45 minutes and the 
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cells were then resuspended in prewarmed flow cytometry buffer (2% 
FBS, 2 mM EDTA in PBS). Flow cytometry was done immediately to 
detect fluorescence emission at 490 nm of excitation and 516 nm of 
emission.  
5.3.6 Mitochondrial activity measurement (JC-1) 
To study the mitochondrial activity, Stro1-selected MSCs with 4 x104 
cells/ml of density in hydrogels were stimulated with NS for 7 days. 
The samples were harvested at day 7 and digested in collagenase D 
for 1 hour. After centrifuging the cell pellets were treated with 2 uM 
(final concentration) of 5’,6,6’-tetrachloro-1,1’,3,3’-tetraehyl-
benzimidazolylcarbocyanine iodide (JC1, M34152, Molecular probes) 
for 30 minutes at 37C. In the control group, 50 uM (final 
concentration) of CCCP was added and incubated at 37C for 5 
minutes. The mitochondria membrane potential was detected by flow 
cytometry. The fluorescence emissions were measured at green (529 
nm) and red (590 nm) channels.  
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5.4  Results and discussion 
5.4.1 Metabolomic assessment  
In this study, metabolomics was used to search the NS-induced 
activation of bioenergetic-based pathways. Overall, metabolomic 
changes were firstly analysed broadly in order to scope out where 
more specific study should be focused. Then, interesting metabolites 
related to energy synthesis and oxidative stress pathways were 
selected and analysed in more depth. To correlate metabolomic 
results with biochemical signaling, the IPA software was used to 
create predicted activated networks from total metabolite data vs 
control.  
5.4.1.1 Clustered metabolite assessment 
To identify associated metabolites of MSCs responding to NS, major 
nutrient metabolisms including carbohydrate, amino acid and lipid 
metabolism were studied. Metaboanalyst was used to identify overall 
metabolomic changes. Heatmaps showed that N30 and N90 increased 
the activated metabolites, especially in lipid metabolism (Figure 5.4 
and 5.5). Principle component analysis (PCA) showed the most 
obvious changes. There is clear clustering of the samples into 
different, isolated groups in lipid metabolism at week 2, suggesting 
discrete metabolite phenotypes for each sample at this time point. 
However, amino acid metabolome of N90 was still clustered together 
(Figure 5.6 and 5.7). 
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Figure 5.4  Heatmap at week 1 of NS 
Amino acid, carbohydrate and lipid metabolism after 1 week of 
Stro1 selected MSCs being seeded in 1.8 mg/ml collagen 
hydrogels analysed by Metaboanalyst. Although there was only 
a small change in carbohydrate and amino acid metabolism in 
response to N30 and N90, the lipid metabolism demonstrated 
the greatest changes particularly in N90 group (n=3-4; red and 
blue representing up and down regulation respectively, 
C=control, N30= 30 nm amplitude N90= 90 nm amplitude).  
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Figure 5.5  Heatmap at week 2 of NS 
The lipid metabolism showed an increase in metabolite 
abundance in response to N90. No obvious change in amino acid 
and carbohydrate metabolites (n=3-4; red and blue representing 
up and down regulation respectively, C=control, N30= 30 nm 
stimulating amplitude N90= 90 nm stimulating amplitude). 
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Figure 5.6  3D Principle component analysis 
3D Principle component analysis of carbohydrate, amino acid 
and lipid metabolism at 1 and 2 week time points; Lipid showed 
the most discrete metabolome in response to N90 at 1 and 2 
weeks. Only minor changes in carbohydrate and amino acid 
metabolism (n=3-4).  
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Figure 5.7 2D Principle component analysis of lipid metabolites 
Considering only lipid metabolites at week 1, the lipid 
metabolites of all groups remain clustered together. At week 2, 
the N90 metabolites showed a clear separation from the control 
group indicating that NS (especially N90) involved lipid 
metabolism (n=3-4).  
5.4.1.2 Metabolomic profile assessment  
In order to spotlight specific metabolite pathways linking to 
osteogenesis, the selection of metabolites involving glycolysis, 
pentose phosphate pathway, TCA cycle, oxidative phosphorylation 
(OXPHOS), L-, and L-aromatic amino acid, Long-chain polyunsaturated 
fatty acids (LC-PUFAs) and -oxidation was performed. These 
metabolites were selected from the IDEOM file. Metaboanalyst 
software was used to generate the heatmaps.  
At week 1, the heatmap in figure 5.8 displayed that the metabolites 
of N90 group are an increased PPP product (ribose) with decreased 
pyruvate indicating that MSCs responded to oxidative stress by 
controlling redox balancing. Active metabolites of TCA cycle were 
found suggesting that MSCs required rapid energy through amino acid 
(via glutamine), lipids (via β-oxidation) and glycerol-3-phosphate 
(G3P) shuttle. The increase of LC-PUFAs was found only in N30 group. 
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Thus, it was hypothesised that N30 may synthesised LC-PUFAs possibly 
aiming for anti-inflammatory effect (Figure 5.8).  
Overall, from week1-2 (Table AII.1), N90 slightly increased pentose 
phosphate pathway products (Figure AII.2 and AII.3), LCPU-FAs 
(precursor of inflammatory metabolites; Figure AII.8), β-oxidation 
(lipid catabolism; Figure AII.9), L-amino acid (linking to calcium 
sensing receptor; Figure AII.6) as well as glycerol-3-phosphate shuttle 
(relating to rapid ATP production) and OXPHOS (linking to reactive 
oxygen species and osteogenesis; Figure AII.5). Further details are 
shown in Appendix II. 
 
Figure 5.8  Heatmaps at week 1 of main nutrient pathways. 
At week 1, active metabolites in TCA cycle were found 
indicating that N90 is an energetic process. MSCs required rapid 
energy from β-oxidation and G3P shuttle. Increased PPP 
suggested that redox balancing was involved to reduce oxidative 
stress (N=3).  
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Figure 5.9  Metabolomic change during high amplitude 
stimulation at week 1 and 2 
N90 activated energetic pathways such as OXPHOS, glycerol-3-
phosphate shuttle and β-oxidation.  Metabolic pathways were 
potentially slightly modulated to reduce oxidative stress 
(indicated by activation of PPP).   
5.4.1.3 Predicted activated networks after 1 week stimulation  
The IPA software was then used to link metabolomics to biochemical 
pathways through prediction analysis. After 1 week stimulation 
(Figure 5.10), N30 was predicted to enhance ERK1/2 and superoxide 
dismutase (SOD) indicating that N30 produced slight oxidative stress 
which was counterbalanced by SOD.  In the N90 group, the activation 
of SOD, phosphatidylinositol-3 kinase (PI3K or Akt) and NFκB were 
indicated. SOD, Akt (antiapoptotic function), and NFκB (cell survival 
signaling) are linked to antioxidant function (C. T. Chen et al., 2008; 
L. Wang et al., 2015). These data indicate that N90 possibly provides 
higher levels of oxidative stress compared to N30 and required higher 
level of counterbalance mechanism to reduce cellular stress 
maintaining cell survivals.  
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Figure 5.10  Networks with predicted activation at week 1 
NS, both N30 and N90, activate the ERK1/2 pathway which is 
crucial for osteogenesis. Stimulation with 30 and 90 nm both 
generated controllable cellular stress. N30 and N90 activated 
SOD for ROS reduction. Increasing stimulating amplitude (N90) 
also triggered Akt and NFκB. This can be interpreted that N90 
produced the higher level of counterbalance system such as 
NFB, SOD, Nitric oxide synthase (NOS) and Akt aiming for anti-
apoptosis. (n=3-4, Networks were merged from the top 4 
pathways of N30 and N90; scores/focus molecules were 47/24, 
47/24, 45/23, and 42/22 respectively).  
 
At 2 weeks, a predicted increased response in antioxidant mechanism 
was found in both N30 and N90. In the N30 group, IL-1β and Akt 
activation was noted compared to week1. The degree of NFκB and Akt 
activation in N90 were increased at 2 weeks (Figure 5.11). This result 
indicated that increased duration of stimulation possibly enhanced 
oxidative stress as a function of time.  
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Figure 5.11  Predicted activated networks at week 2 
Compared to week1, an increase in antioxidative pathways was 
found. In the N30 group, Akt, ERK1/2 and IL-1β activation was 
newly noted from week1. Predicted activation of NFκB, Akt and 
ERK1/2 was increased compared to week1 in N90 (n=3-4, 
Networks were merged from the top 4 pathways of N30 and N90; 
N30 score/focus molecules were 52/25, 49/24, 38/20, and 
28/16; N90 were 51/25, 49/24, 38/20, and 26/15 respectively). 
5.4.2 Nanovibrational stimulation effect on reactive oxygen 
species and mitochondrial activity  
From the previous section, NS possibly enhances oxidative stress. 
Slight increase of PPP (gluconic acid, ribose) and glycolytic (pyruvate, 
lactate) pathways may link to redox balancing in oxidative stress 
condition (E. S. Cho et al., 2018; Kuehne et al., 2015). Moreover, small 
increases of LC-PUFAs may promote ROS reduction. Therefore, the 
evidence of ROS production was analysed and quantified.  
5.4.2.1 Molecular and functional pathway analysis 
The IPA software was again used to predict and compare molecular 
and functional pathways in aspect of oxidative stress. At 1 and 2 
weeks, heatmaps of activation Z-score showed NS activated 
inflammatory metabolites and reactive oxygen species (ROS). 
Increased stimulating amplitude (N90) showed higher activation of 
ROS production and cellular stress (Figure 5.12).    
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Figure 5.12  Heatmap of activation z-score of molecular and 
cellular function in respect to cellular stress and 
ROS production at weeks 1 and 2 
N90 indicated greater ROS production and cellular stress in both 
1 and 2 week cultures. The heatmap gradient was scaled from 
blue (representing inhibition) to orange (activation) whereas z 
score >2.0, predicted activation Z score <-2.0 predicted 
inhibition (n=3-4). 
To further investigate the ROS-production related metabolites, IPA 
was used to generate the metabolite network of ROS production. 
Interestingly, high amplitude stimulation (N90) increased ROS 
production linked metabolites compared to N30 (Figure 5.13).  
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Figure 5.13  Related metabolites of ROS production in N30 and N90 at week 1 
High amplitude stimulation (N90) increased active ROS production related metabolites compared to N30. (n=3-4, Orange 
representing predicted functional activation while blue showing the predicted inactivation, green and red representing 
increase and decrease measurement respectively).  
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IPA was used to generate heatmaps of metabolites relating to ROS 
production. The increase of the stimulating amplitude (N90) activated 
stronger signals and involved higher number of ROS related 
metabolites such as malonic acid, which has mitochondrial toxicity 
and induces ROS production (Fernandez-Gomez et al., 2005). Palmitic 
acid, which induces oxidative stress by involving intracellular calcium 
balance, was found to be increased at week 2 (Nissar, Sharma, & 
Tasduq, 2015). The increase of uric acid in N90 may play a role as 
antioxidant (Glantzounis, Tsimoyiannis, Kappas, & Galaris, 2005) 
(Figure 5.14).   
 
Figure 5.14  Heatmap metabolites related to ROS at 1 and 2 
week. 
High amplitude stimulation (N90) increased active metabolites 
related to ROS production. (n=3-4, Red; increased 
measurement; green; decreased measurement).   
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5.4.2.2 Reactive oxygen specie measurement 
To measure ROS production, Stro1 selected MSCs in 1.8mg/ml collagen 
were prepared and stimulated with N30 and N90 for 7 days. The 2’-7 
dichlorodihydrofluorescein diacetate (DCF-DA) fluorescein was used 
to quantify ROS production. Flow-cytometry was performed to detect 
the labelled cells at day 7. A significant increase of ROS production 
was noted in N90 compared to control (Figure 5.15).   
 
Figure 5.15  Reactive oxygen species measurement 
By using DCF-DA fluorescein and flow cytometry, high amplitude 
stimulation (N90) was seen to significantly increase cellular ROS 
production corresponding to my previous metabolomic study 
(mean±SD, n=3-4, 3 patients (Pt 1-3), * P≤ 0.5, one-way ANOVA, 
Tukey’s post hoc test, Pt1-3; patient 1-3).  
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5.4.2.3 The effect of Nanovibrational stimulation induced 
reactive oxygen species on 3D ostegenesis 
It is known that controllable ROS enhances osteogenesis but 
uncontrollable ROS suppresses osteogenesis (M. Arai et al., 2007; 
Atashi et al., 2015; C. H. Byon et al., 2008). Therefore, the effect of 
ROS on 3D osteogenesis during NS was studied by qRT-PCR with ROS 
inhibition (N-acetyl cysteine; NAC) for 9 days of culture. The ratio to 
control of qRT-PCR with ROS inhibitor for RUNX2 and OSX were 
calculated. This ratio represented RUNX2 and OSX which are affected 
by the ROS-independent pathways. After that, the ratio to control of 
RUNX2 and OSX without ROS inhibition (thus, representing RUNX2 and 
OSX which were derived from the total pathway; both ROS dependent 
and independent pathways) was also calculated. The effect of ROS on 
RUNX2 (or OSX) expression was calculated from the difference of 
RUNX2 (or OSX) from total pathway to RUNX2 (or OSX) from ROS 
independent pathway. To interpret the results, positive outcomes 
represented enhancing- while negative outcomes mean reducing 
RUNX2 (or OSX) expression. 
In the N30 group, RUNX2 and OSX downregulation was noted after 
inhibiting ROS (Figure 5.16A, right). Together with RUNX2 and OSX 
outcomes in Figure 5.16B showing positive values, N30-induced ROS 
enhanced RUNX2 and OSX expression at day 9. Considering N90, N90 
significantly promoted RUNX2 and OSX expression (Figure 5.16A, 
left). However, an increase of ratio to control of RUNX2 and OSX was 
noted after inhibiting ROS (Figure 5.16, right) as well as ROS effect 
of N90 were noted in negative value (Figure 5.16B). Thus, N90-
induced ROS slightly reduced RUNX2 and OSX expression. Even though 
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ROS negatively affected RUNX2 and OSX expression, N90 still highly 
induced RUNX2 and OSX expression (Figure 5.16A, left).  
 
Figure 5.16  The effect of ROS on RUNX2 and OSX expression 
by qRT-PCR with ROS inhibition at day 9. 
A) N90 significantly induced RUNX2 and OSX expression (left). 
After inhibiting ROS with N-acetyl cysteine, an increase of 
ratio to control of RUNX2 and OSX indicated that ROS slightly 
reduced RUNX2 and OSX expressions. In N30 group, RUNX2 
and OSX expression was reduced  after inhibiting ROS, which 
indicated that N30-induced ROS was important for RUNX2 
and OSX expression (mean±SD, n=4, * P≤ 0.05, ** P≤ 0.01, *** 
P≤ 0.001, one way ANOVA, Tukey’s post hoc test). 
B) The effect of ROS on RUNX2 and OSX; positive value of N30 
and negative value of N90, suggested that N30-induced ROS 
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enhanced while N90-induced ROS reduced osteogenesis 
(mean±SD, n=4, * P≤ 0.05, Mann-Whitney test).  
5.4.3  NS and mitochondrial activity  
Metabolomic studies showed that NS involved β-oxidation metabolites 
(Figure 5.8 - 5.9). Thus, investigating mitochondrial activity may 
indicate whether MSCs require high energy for differentiation. 
Mitotracker and JC1 fluorescein dye were used to quantify 
mitochondrial activity measured by flow cytometry. At day 9, no 
significant changes were found indicating that mitochondrial activity 
is normal during NS (Figure 5.17A-B). Therefore, it was hypothesized 
that N90 may affect nutrient sources for energy production. MSCs may 
require more energy from fatty acids by increasing catabolism (β-
oxidation) through the AMPK pathway (Herzig & Shaw, 2018; Lipovka 
& Konhilas, 2015). 
 
Figure 5.17 Mitochondrial mass and activity studied by 
mitotracker and JC1 fluorescein dye.  
A. Mitotracker stain showed no difference in mitochondrial mass 
(mean±SD, n=3-4, 1 patients, One-way ANOVA, Tukey’s post 
hoc, negative control was induced by CCCP, positive control was 
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induced by H2O2) B. JC1 staining showed no difference in 
mitochondrial activity (mean±SD, n=3-4, 2 patients, Pt1-2; 
patient 1-2, one-way ANOVA, Tukey’s post hoc test). 
5.4.4 NS induced inflammation in 3D osteogenesis 
To investigate the hypothesis that NS-induced inflammation is 
essential for bone healing. qRT-PCR was used to investigate the 
inflammatory gene expression at day 9 (Figure 5.18). Interestingly, 
qRT-PCR showed the first clues of NS induced inflammation by the 
increased expression of TNF and IL-6 transcripts. Concomitantly, 
increased NFB expression indicated that cell survival pathways were 
also potentially activated.  
IL-1 which is a coupled inflammatory cytokine to TNF (Oppenheim, 
Matsushima, Yoshimura, Leonard, & Neta, 1989) and commonly found 
in the bone healing process was then investigated using ELISA. The 
level of IL-1, however, was unable to be detected. It is thus likely 
that transcript changes are not fully reflected at protein level and it 
is undetectable; it could be postulated that this indicatives very low 
levels of inflammation that may help in bone healing. 
Next, the BMP2-induced osteogenesis signaling pathway was also 
investigated based on the hypothesis that IL-6 mediated inflammation 
may induce BMP2 secretion, in turn, activates SMAD1/5 to enhance 
osteogenesis (M. Sun et al., 2017; W. Yang et al., 2013). As postulated, 
the result showed evidence of increased BMP2 (between N30 and N90) 
and SMAD1/5 gene upregulation (compared to control). The MAPK 
signaling pathway study provided evidence of ERK1/2 and JNK 
activation. This clue hinted that NS not only activated osteogenic gene 
expression but also relayed the signals for basic cellular regulation 
(proliferation, differentiation or apoptosis) responding to 
extracellular stimuli, however, it did not produce large amounts of 
cytokines at the protein level.  
  
Chapter 5: Metabolomics, oxidative stress and inflammation during Ns 171 
 
Figure 5.18  Inflammatory gene response in 3D-N90. 
qRT-PCR at day 9 showed IL-6 (between NS groups) and TNF 
(compared to control for N90) gene upregulation which are 
inflammatory cytokines. NFB upregulation was also noted 
suggesting that MSCs produced NFB reducing death signaling 
pathways. Upregulation of BMP2 and SMAD1/5 gene expression 
may imply that N90 enhances osteogenesis through a BMP2-
SMAD1/5-mediated pathway. Activation of MAPK pathway gene 
expression including ERK1/2, JNK1/2 can be interpreted that NS 
signal was regulated by MAPK signaling hubs in order to select 
the appropriate cellular response such as differentiation or 
inflammation (Mean±SD, n=4, * P≤ 0.5, ** P≤ 0.01, *** P≤ 0.001, 
Mann-Whitney test).   
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5.4.5 NS-induced Inflammation may affect 2D osteogenesis in the  
early phase 
To determine the effect of inflammation on 2D osteogenesis, In-Cell 
Western assay was used. Protein inhibition tests, which are associated 
to inflammation-related osteogenesis pathways, were investigated 
including MAPK pathways (ERK, JNK, p38), TNF and NFB. All 
inhibitors were added at day 2 and day 4. The ratio of phosphorylated 
RUNX2 to total RUNX2 was quantified at day 4 and 7 respectively. 
While this is not a particularly sensitive test, it was chosen as it is 
quantitative and at the protein level. It can determine activated 
osteogenesis and it fits with the time course in which we could use 
the inhibitors. The result showed that NS successfully induced 2D 
osteogenesis at day 7 while there was no increase in pRUNX2/RUNX2 
at day 4 (Figure 5.19). This could be explained as day 4 was a very 
early time point to detect RUNX2 expression under NS.  
 
Figure 5.19  Nanovibrational stimulation in 2D osteogenesis 
NS showed the success of 2D osteogenic induction at day 7 by 
In-Cell Western study. The significant increase of 
pRUNX2/RUNX2 in N90 group was noted (Mean±SD, n=4, * P≤ 0.5, 
** P≤ 0.01, *** P≤ 0.001, one-way ANOVA, Tukey’s post hoc test). 
Next, protein inhibition analysis was used to identify which pathways 
linked to osteogenesis determed by the pRUNX2/ RUNX2 expression. 
The pRUNX2/RUNX2 was used to calculate the ratio (R) of group with 
inhibitor to group without inhibitor. Therefore, if R > 1 
(pRUNX2/RUNX2 expression in inhibitor group is > than in the non-
inhibited group), representing that pathways suppress osteogenesis as 
the inhibition increased pRUNX2/ RUNX2 expression. If R=1 or close to 
1 (the inhibitor group is the same as the non-inhibited group), it means 
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that the pathways investigated did not affect pRUNX2/RUNX2 
expression. However, if R<1 (inhibited group < non inhibited group) 
the inhibition of the pathway reduced pRUNX2/RUNX2 expression. 
Thus, it could be interpreted that the studied pathway promotes 
osteogenesis. 
At day 4 (Figure 5.20), the only effect the assay was sensitive enough 
to detect was that NFB inhibition significantly decreased 
pRUNX2/RUNX2 protein expression representing that NFB was 
important for 2D osteogenesis with N90 stimulation. This result may 
be interpreted as that NFB is potentially important for RUNX2, 
perhaps by optimizing inflammatory response to improve 
osteogenesis; this ties in with increased NFB expression (Figure 
5.17).  
At day 7 (Figure 5.20), as interpreted from the inhibition studies the 
MAPK pathway (ERK1/2, JNK, p38) and NFB negatively affected 
RUNX2 expression in all groups. NS provided an increase of 
osteogenesis trend via ERK1/2 (R trend towards to 1 in N90 group).  
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Figure 5.20. Effect of inhibition of inflammation pathways on 2D 
osteogenesis. 
In-Cell Western study of pRUNX2/RUNX2 expression in the 
presence of inhibitors at day 4 and day 7. A) At day 4, very early 
phase, NFB significantly affected osteogenesis in the N90 group 
(R <1). No other pathway changed with inhibition (Mean±SD, 
n=4, * P≤ 0.5, ** P≤ 0.01, *** P≤ 0.001, one-way ANOVA, Tukey’s 
post hoc test).  
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5.4.6 Nanovibrational stimulation also involved inflammatory 
pathways in 3D osteogenesis 
From the 2D inhibition study, the results showed that MAPK, TNF and 
NFB expression during osteogenesis were dynamically changed at 
different time points. To study the relationship of inflammation and 
nanovibration induced 3D osteogenesis, qRT-PCR with MAPK (ERK1/2, 
JNK and p38), TNFα and NFκB inhibitors was performed at day 9. The 
ratio of the group with inhibitor to that without inhibitor (R) was 
calculated based on 2ΔΔct technique (Livak & Schmittgen, 2001). Thus, 
R >1 representing pathways that reduce osteogenesis. On the other 
hand, R<1 meant that pathway promotes osteogenic gene expression.  
In Figure 5.21, JNK, p38 and NFκB inhibition showed the decreased 
trend of RUNX2 gene expression in N90 group. The ratio being less 
than 1 of p38 in all group indicated that p38 promoted RUNX2 
expression and NS possibly enhanced RUNX2 expression via p38 
showing in the decrease trend after inhibiting p38. Reduction of 
RUNX2 expression in NS comparing to control group was also found 
after inhibiting JNK and NFκB. The results indicated that JNK and NFκB 
played positive roles for RUNX2 expression. 
MAPK (ERK1/2, JNK and p38), TNFα and NFκB pathways; all of these 
pathways tended to enhance OSX gene expression. However, the 
effect of NS was not obviously seen linking to OSX expression. 
Considering the NS effect on OPN, NS seemed to link to NFκB and p38 
in OPN expression by showing the decrease trend of OPN expression 
in the NS group.  
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Figure 5.21 The effect of nanovibrational stimulation induced 
inflammation in 3D osteogenesis 
qRT-PCR with inhibitors at day 9 indicated that JNK, p38 and 
NFκB promote RUNX2 expression. MAPK, TNFα and NFκB 
promote OSX expression (R<1). However, no obviously NS effects 
involved OSX gene expression. OPN is possibly enhanced by p38 
and NFκB (Mean±SD, n=4, * P≤ 0.5, ** P≤ 0.01, *** P≤ 0.001, one-
way ANOVA, Tukey’s post hoc test).  
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To simply identify the roles of pathways of interest (POI; MAPKs, NFκB, 
and TNFα) on osteogenesis, RT-PCR data with inhibitors at day 9 was 
re-calculated. The difference between total pathways and POI-
independent pathways was calculated for the effect of POI on RUNX2 
and OSX expression. Positive value means enhancing while negative 
means suppressing osteogenesis (Figure 5.22A). Corresponding to 
Figure 5.21, JNK, p38 and NFκB were positive thus enhancing- while 
TNFα and ROS were negative values thus suppressing osteogenesis 
(Figure 5.22A). These results can possibly be explained by the 
response of NFκB in oxidative stress (J. L. Luo, Kamata, & Karin, 2005; 
T. Wang et al., 2002). In oxidative stress condition or inflammation, 
it is known that TNFα can activate NFκB to produce signals in order to 
reduce oxidative stress (ROS and TNFα) and also involved MAPK via 
JNK and p38 (Lingappan, 2018; Nakano, 2004; L. Wang et al., 2012). 
These survival pathways aim to reduce apoptotic signals (Nakano, 
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2004). Simple diagram of mechanotransduction with NFκB and MAPK 
involvement under oxidative stress were shown in Figure 5.22B.  
 
Figure 5.22  Role of MAPKs, NFκB and TNFα on RUNX2 and OSX 
expression 
A. The effect of POI graph showed that JNK p38 and NFκB promote 
RUNX2 and OSX expression while TNFα and ROS reduced RUNX2 
and OSX expression. (Mean±SD, n=4, * P≤ 0.5, ** P≤ 0.01, 
paired-t-test)  
B. Simple diagram showed the effect of NFκB on TNFα and ROS in 
oxidative stress during mechanical stimulation.  
To investigate whether inflammation is controllable, a temporal gene 
study of IL-6 and NFκB by qRT-PCR was performed at day 7, 14 and 21. 
IL-6 and NFκB levels in N90 were higher than those in N30. IL-6 and 
NFκB expression peaked at week 2 and tended to reduce at week 3 
indicating that inflammation was controllable (Figure 5.23). 
Correlating this data with the temporal study of phenotype showing 
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successful osteogenic induction (Figure 4.15), we propose that NS 
induced inflammation is controllable and suitable for osteogenesis.   
 
Figure 5.23  Temporal gene analysis of IL-6 and NFκB 
Temporal study of IL-6 and NFκB showed that NS possibly 
produces inflammation, but that it is controllable. IL-6 and NFκB 
expression peaked at week 2 and tended to decrease at week 3 
(Mean±SD, n=4, 3 patients, 4=replicates, * P≤ 0.5, ** P≤ 0.01, *** 
P≤ 0.001, one-way ANOVA, Tukey’s post hoc test, Pt1-3; patient 
1-3, blue asterix; compared N30 to control, red Asterix; 
compared N90 to control, black Asterix; compared N30 to N90).   
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5.4.7 The balance between osteogenesis and inflammation in NS 
induced 3D osteogenesis 
Occasionally, we found a non-responding patient sample (approx. 1 in 
20 according to whole lab data). If NS can produce inflammation, thus, 
prestimulating the inflammatory status of MSCs could affect NS 
outcomes. To prove this hypothesis, qRT-PCR in a non-responding 
patient was performed at day 9. Initial phenotype after NS showed 
the expected no change in osteogenic gene expression in NS group 
(N30 and N90); RUNX2 was even significantly downregulated in N30 
(Figure 5.24).  
 
Figure 5.24  Failure of NS induced 3D osteogenesis 
qRT-PCR at day 9, showing data from a non-responding patient 
(Mean ± SD, n=4, * P≤ 0.5, ** P≤ 0.01, *** P≤ 0.001, one-way 
ANOVA, Tukey’s post hoc test). 
To investigate the cause of osteogenic induction failure in the patient 
whose cells did not respond to NS, qRT-PCR with cultures grown using 
MAPK, TNFα and NFκB inhibitors was performed at day 9. Considering 
the significant decrease of RUNX2 expression in the N30 group (Figure 
5.25), JNK and NFB were seen to be repressing RUNX2 expression, 
and hence osteogenesis. ERK 1/2 was also seen to inhibit osteogenesis 
through OSX expression. Inhibition of p38 MAPK appeared to increase 
osteogenesis as seen by repression of pRUNX with p38 inhibition 
(Figure 5.25).  
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Figure 5.25  3D NS and inflammatory pathway studies with 
inhibition of biochemical pathways in a non-
responding patient 
qRT-PCR at day 9, the inhibition of MAPK pathway (ERK1/2, JNK, 
p38), TNF and NFB increased the RUNX2 expression in the N30 
group. R>1 indicates that MAPK, TNF and NFB pathways are 
inhibiting RUNX2 expression at this time point. Considering the 
OPN response, only NFB inhibition significantly increased OPN 
gene expression. The OSX expression slightly differed from 
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RUNX2 and OPN. ERK1/2 and NFB were seen to significantly 
reduce expression while p38 is indicated to enhance OSX gene 
expression (Mean ± SD, n=4, * P≤ 0.5, ** P≤ 0.01, *** P≤ 0.001, 
one-way ANOVA, Tukey’s post hoc test). 
To determine the level of NFB gene expression as it had strong effect 
in reducing osteogenesis for N30 (RUNX2) and N90 (OPN and OSX) in 
this non-responding patient, qRT-PCR for NFB with/without NS and 
together with/without inhibitor (TPCA-1) compared to non-stimulated 
control without inhibitor were investigated at day 9. Surprisingly, a 
significant reduction of NFB gene expression was found in both the 
N30 and N90 groups with expression of NFB reduced below that of 
the inhibitor on the control group (Figure 5.26). It was hypothesized 
that the suppression of NFB gene expression was affected by the 
negative feedback loop (Renner & Schmitz, 2009). In the NS group, 
long term exposure of higher level of NFB may result in significantly 
greater suppression of NFB gene expression. Moreover, inflammation 
could also affect on level of NFκB. Stimulating with low magnitude 
stimulation (such as NS) may inhibit NFB signaling pathways in cells 
with pre-existing low inflammation (Agarwal et al., 2003; 
Dossumbekova et al., 2007; Madhavan et al., 2007; J. Nam et al., 
2009).  
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Figure 5.26  NFB level was controlled by negative feedback 
loop in failure of nanovibration-induced 
osteogenesis 
RT-PCR at day 9 showed that NFB of stimulated group (N30 and 
N90) was less than that of non-stimulated control group. 
Addition of NFB Inhibitor in N30 and N90 did not change the 
gene expression as it was already very low. (Mean ± SD, n=4, * 
P≤ 0.5, ** P≤ 0.01, *** P≤ 0.001, one-way ANOVA, Tukey’s post 
hoc test). 
5.5 Discussion 
5.5.1 Nanovibrational stimulation: what we have learnt from 
metabolomics 
From clustering metabolome analysis, NS mainly affected lipid 
metabolism after 1 and 2 weeks of stimulation (Figure 5.4 - 5.7). 
Smaller metabolome shifts from N30- and N90-NS were noted in amino 
acid and carbohydrate metabolism compared to control. Lipid 
metabolism is pivotal for stem cell differentiation due to its  
bioenergetic roles through fatty acid catabolism as well as producing 
precursor metabolites which are necessary for diverse cytokine 
synthesis such as arachidonic acid and prostaglandins (Burke & Weiler, 
2002). 
Carbohydrate metabolism, specifically glycolysis, is important for 
stem cell self-renewal and maintenance. In the process of osteogenic 
differentiation of MSCs, the role of glycolysis remains inconclusive. 
Some evidence indicates that the role of glycolysis is reduced in 
differentiated cells (C. T. Chen et al., 2008; Fillmore et al., 2015; 
Pattappa et al., 2011; Shyh-Chang et al., 2013). However, Shum et al 
shows that there is no difference in glycolysis level between 
osteogenic differentiated cells and undifferentiated cells (Shum et 
al., 2016). In our results, pyruvate tended to increase at 2 weeks but 
there was no significant difference of pyruvate level at both 1 and 2 
weeks. The upregulation of lactate was noted at 1 week but was 
decreased by 2 weeks. All data indicated that NS did not obviously 
change the glycolysis pathway. Theoretically, increase of lactate may 
indicate aerobic glycolysis, explained by the Warburg effect (H. Lu, 
Forbes, & Verma, 2002). Even though the cues from glycolysis-related 
metabolites might not reveal the stage of cell development, the 
success of NS induced osteogenesis as shown in chapter 4 has 
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supported that nanovibration induced MSCs differentiate from 
preosteoblast to immature osteoblasts by week 2.  
Although NS insignificantly changed carbohydrate metabolism, the 
increase of orthophosphate in N90, as well as the increase of sn-
glycerol-3-phosphate shuttle in N30 and N90 groups (Figure AII.5), 
suggesting that NS driven osteogenesis is an energetic process. 
Activation of the glycerol-3-phosphate shuttle represents that cells 
require expenditure of ATP by shifting complex I of OXPHOS (Mracek, 
Drahota, & Houstek, 2013). Increased activity of OXPHOS is linked to 
greater reactive oxygen species (ROS) production (Huttemann, Lee, 
Samavati, Yu, & Doan, 2007). Furthermore, increased glycerol-3-
phosphate shuttle activity is associated with high ROS production 
(Mracek, Pecinova, Vrbacky, Drahota, & Houstek, 2009). OXPHOS with 
low levels of ROS promotes osteoblastic differentiation while high 
OXPHOS with high ROS promotes adipogenesis (C. T. Chen et al., 2008; 
Shyh-Chang et al., 2013). Our previous gene expression study showed 
the upregulation of osteogenic gene expression over adipogenic gene 
expression (PPARɣ) at day 9 (Figure 4.12 and 4.13). Therefore, it was 
reasonable to hypothesise that N90 affected osteogenesis and 
produced an optimal level of ROS at 1 week.  
The effect of NS is possibly linked to amino acid metabolism. Previous 
literature showed that L-type and aromatic L-amino acids can activate 
the calcium-sensing receptor (CaSR) which controls calcium 
metabolism (Conigrave, Mun, & Lok, 2007). Calcium influx in turn 
actives the ERK1/2 pathway and PKC resulting in osteoblast 
differentiation and proliferation (MacDonell, Hamrick, & Isales, 2016). 
Our results showed the increase of L-type and L-aromatic amino acids 
in N90 corresponded to CaSR gene expression. Generally, CaSR takes 
an important role in intracellular calcium regulation. CaSR responds 
to extracellular calcium ion levels, parathyroid hormone, amino acid 
and pH changes (Theman & Collins, 2009). It was hypothesised that NS 
slightly increased amino acid and may subsequently upregulates CaSR. 
This requires investigation. 
Lipid metabolism is important for cell proliferation and 
differentiation. To explore the relationship of NS and lipid metabolism 
on osteoblast differentiation, firstly, long-chain polyunsaturated fatty 
acids (LC-PUFAs) are considered. LC-PUFAs are derived from essential 
fatty acids such as linoleic acid and alpha-linolenic acid (omega-3 
fatty acid) desaturating to eicosapentaenoic acid (EPA), 
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docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA). These 
PUFAs are precursors of inflammatory metabolites such as arachidonic 
acid (AA), cyclooxygenase (COX), thromboxanes (TXA) which play 
pivotal roles on osteoblast and osteoclast development (Kruger et al., 
2010). Many reports show that PUFAs improve bone synthesis in in 
vitro and in vivo studies (Jeromson, Gallagher, Galloway, & Hamilton, 
2015; Kruger & Schollum, 2005). EPA supplements link to low grade 
inflammatory metabolites synthesis such as leukotriene 5 via 
cyclooxygenase (COX). The use of COX competitively inhibits high-
grade inflammatory metabolite synthesis (such as PGE2, TXA2) from 
AA (Borges et al., 2014). However, some studies show adverse effects 
of long term exposure of AA and DHA in osteogenic gene expression 
(Coetzee et al., 2009). 
In this study, a slightly increase of EPA, DPA and DHA after NS at 1 and 
2 weeks was found (Figure AII.8) meaning that NS could promote PUFA 
synthesis and this might link to the increase of inflammatory 
metabolite synthesis. In respect to energy production via lipid 
catabolism, -oxidation-related metabolites were further 
investigated which were found in the experiments including hexanoic 
acid, 4-8 dimethylnonanoylcarnitine and O-propanoylcarnitine. N30 
and N90 showed slightly increases of hexanoic acid and 4-8 
dimethylnonanoylcarnitine levels. However, there was no significant 
change of TCA cycle metabolites (Figure AII.4). Therefore, NS might 
slightly affect ATP production but evidence is week and needs more 
investigation. The current literature of these metabolites is very 
limited. 
5.5.2 Metabolomics perspective; nanovibrational stimulation 
possibly promotes osteogenesis through an inflammation 
process 
The related biological pathways of NS were analyzed by IPA software. 
At 1 and 2 weeks of stimulation, the ERK1/2 pathway (Figure 5.10 - 
5.11) had predicted activation in N90 which corresponded to PCR 
showing gene upregulation (Figure 4.15A). It is likely that ERK1/2 
plays a pivotal role in NS induced osteogenesis (Tsimbouri P.M., 2017).  
Nitric oxide synthase (NOS) also had predicted activation in the N30 
and N90 group at 1 and 2 weeks (Figure 5.10-5.11). NOS is an enzyme 
that produces nitric oxide (NO). Nitric oxide controls intracellular 
homeostasis (Klein-Nulend, van Oers, Bakker, & Bacabac, 2014). NOS 
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can be produced by endothelial cells (eNOS), the central nervous 
system (nNOS) or induced by inflammation (iNOS) (Saura, Tarin, & 
Zaragoza, 2010). Many studies elucidate the importance of NO in 
osteoblast proliferation and differentiation (Fox & Chow, 1998; 
Samuels, Perry, Gibson, Colley, & Tobias, 2001), e.g. NO mediates the 
ERK1/2 pathway resulting in osteogenesis (Saura et al., 2010; S. Wang 
et al., 2006; H. Y. Yun, Dawson, & Dawson, 1999) as well as promoting 
bone healing by increasing blood flow from vasodilation (R. E. 
Tomlinson, Shoghi, & Silva, 2014). However, overproduction of iNOS 
can induce osteoblast apoptosis possibly linked to ROS and 
cytochrome C (Ho, Chen, Chiu, Tai, & Chen, 2005).  
NS could be linked to inflammation through reactive oxygen species 
(ROS). ROS is a product of mitochondrial oxidative phosphorylation. 
Optimal ROS levels directly control MSC osteogenic differentiation (Q. 
Q. Li, Gao, Chen, & Guan, 2017). Excessive ROS production can reduce 
osteogenesis and promote adipogenesis as well as induce cell 
dysfunction and apoptosis (Atashi et al., 2015; Circu & Aw, 2010; 
Wanet et al., 2015). The Akt pathway and superoxide dismutase 
pathway (SOD) take on important roles to counter inflammatory 
metabolites overproduction. Insulin growth factor (IGFs) can activates 
Akt pathway and promotes osteoblast differentiation though BMP2 
(Mukherjee & Rotwein, 2009; Pramojanee, Phimphilai, Chattipakorn, 
& Chattipakorn, 2014). The Akt pathway counterbalances ROS 
overproduction improving inflammation capacity and subsequently 
promoting osteogenesis (L. Wang et al., 2015). Not only does the Akt 
pathway reduce ROS, but also superoxide dismutase (SOD) represses 
inflammatory metabolites. SOD takes a role to convert superoxide 
anions (O2-) to hydrogen peroxide (H2O2) and then H2O and O2 by 
catalase and glutathione peroxidase (C. T. Chen et al., 2008).  
At 1 week stimulation (Figure 5.10), IPA indicated that the Akt 
pathway seemed to be activated, potentially to counterbalance 
inflammation in N90, while SOD was activated in N30 and N90. 
Therefore, NS could promote osteogenesis together with increasing of 
oxidative stress. In N90 group, Akt and NFκB were activated in N90 but 
not N30 suggesting that N90 can switch on survival pathways (Akt and 
NFκB) resulting in increase intracellular signaling. Thus, it was  
hypothesised that stimulation with high amplitude NS (N90) possibly 
provides osteogenic induction over that of N30 due to activation of 
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the Akt pathway which could enhance osteogenesis by itself while N30 
activated only SOD.  
At 2 weeks, N30 started to trigger Akt and interleukin-1β while greater 
levels of activation of Akt, ERK1/2 and NFκB were noted in N90. The 
results indicated that NS effect may be accumulated with time. The 
effect of NFB on osteogenic differentiation is not well known. 
Activation of NFκB seems to provide negative effect on osteogenesis 
(Boyce, Yao, & Xing, 2010; Chang et al., 2013). However, from our 
results, NFκB tended to provide positive effect on RUNX2 expression 
during NS (Figure 5.21).  
Overall, NS promoted osteogenesis shown through gene, protein and 
metabolomic studies. Lipids showed the highest change responded to 
NS. Oxidative stress was slightly generated during NS but it was 
controllable. The conclusion of metabolite changes is illustrated in 
Figure 5.27.  
 
Figure 5.27  Summary of metabolomic change during NS 
Lipid metabolism showed the greatest change possibly linked to 
PUFA synthesis which produces inflammatory metabolites as 
well as slightly enhanced -oxidation producing energy. PPP 
may be involved in redox balancing. Oxidative phosphorylation 
was increased in parallel with glycerol-3-phosphate shuttle 
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activation and possibly, in turn, produced ROS. ROS may also be 
produced on the cell membrane by NAPDH oxidase. ROS was 
counterbalanced by SOD. ROS activated NFκB and Akt to 
maintain cell survival. NS also increased L-type amino acid 
which may subsequently upregulated calcium signaling receptor 
(CaSR), allowing calcium influx. (G3P= glycerol-3-phosphate 
shuttle) 
5.5.3 Inflammation in normal bone healing process vs 
nanovibrational stimulation 
NS induces osteogenesis mimicking the normal bone healing process. 
In the normal bone healing process, inflammation is the first phase 
that occurs at the fracture site. Neutrophils produce cytokines such 
as TNF to recruit inflammatory cells to eliminate the pathogens, 
prepare the fracture niche and recruit osteoprogenitor cells pooling 
at the fracture site (F. Loi et al., 2016). Pro-inflammatory cytokines 
including IL-1, IL-6 and BMP2 trigger MSCs to become osteoblasts (F. 
Loi et al., 2016). NFB and RANKL can activate osteoclast 
differentiation (through RANK) thus preparing for the remodeling 
phase (Abu-Amer, 2013). However, in tissue engineering, high levels 
of inflammation are critical hurdles for stem cell differentiation 
controlled by mechanical induction or prosthesis (Gibon, Lu, Nathan, 
& Goodman, 2017). Thus, mimicking the mechanical stimuli which can 
directly enhance osteogenesis with low level activation of 
inflammation is challenging. Considering the results, NS promoted 
inflammatory cytokines corresponding to the normal bone healing 
process (Figure 5.28). In this study, Stro1-selected human MSCs were 
used which are osteoblast precursors (Dennis et al., 2002). NS induced 
inflammatory cytokines to be produced by the MSCs (Kyurkchiev et 
al., 2014) as other inflammatory cell types were not present in the 
culture.  
In normal bone healing, bone fractures produce an inflammation 
triggerring healing process (F. Loi et al., 2016). NS promoted 
inflammatory modulators at an early time point, day 7. The 
inflammatory cytokines were then suppressed by intracellular 
signaling pathways which may corresponded to normal bone healing 
stage (F. Loi et al., 2016).  
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Figure 5.28 Conclusion of N90 effect on phenotype and 
inflammatory pathway 
N90 promoted osteogenesis which corresponded to normal 
osteogenic pathway. In early phase (day 9), JNK, p38 and NFκB 
enhanced while TNFα and ROS slightly reduced osteogenic 
induction. Inflammatory response (IL-6 and NFκB), peaking at 
week 2, may help promoting mineralization. 
5.5.4 Osteogenic pathway in nanovibrational stimulation; 
mechanotransduction-metabolite-inflammation  
Based upon our knowledge, NS potentially enhances osteogenesis via 
multiple pathways. From this studies, the effect of NS-induced 
osteogenesis can be placed into mechano-transduction, inflammation 
and metabolite ‘bins’. These major pathways all work downstream of 
the MAPK signaling hub which determine the appropriate cellular 
responses to these stimuli such as proliferation, differentiation and 
apoptosis.  
5.5.4.1 Mechanotransduction perspective 
Considering the mechanotransduction aspect, our previous 
publication (Tsimbouri P.M., 2017) showed that NS induced 
osteogenesis through 1) ion channels TRPV1-PKC--catenin pathway, 
2) BMP2-SMAD1/5 and 3) Integrin-ROCK pathway. These pathways 
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operate through ERK1/2 to trigger RUNX2 phosphorylation and 
osteogenesis. 
5.5.4.2 Inflammation perspective  
As aformentioned, NS induced low levels of MSC driven inflammation 
during early culture (week1-2). The inflammation subsided by week 3 
suggesting that it was a well-controlled inflammatory response and 
thus enhanced osteogenesis. Inflammation is a double-edged sword 
for osteogenesis. Low grade inflammation is essential for 
mineralization. Inflammation induces MSCs to produce OPN which, in 
turn, promotes mineralization via binding to the growing apatite 
mineral (F. Kahles, H. M. Findeisen, & D. Bruemmer, 2014). While high 
grade inflammation suppresses osteogenesis, and promotes 
osteoclastogenesis (Knapik et al., 2014). In this study, NS induced IL-
6 and TNF production. IL-6 can induce osteogenesis via the BMP2-
SMAD1/5 pathway (M. Sun et al., 2017) whose gene upregulation was 
noted in Chapter 4 (Figure 4.12 and 4.14).  
The effect of TNF on osteogenesis varies by dose, duration and 
starting phase. Short-term exposure with a low dose of TNF can 
enhance osteogenesis while long-term exposure of TNF inhibits 
mineralization (Daniele et al., 2017; H. Huang et al., 2011). Hess et 
al., showed that the addition of TNF enhances ALP expression (Hess, 
Ushmorov, Fiedler, Brenner, & Wirth, 2009). TNF can stimulate IL-6 
secretion that, in turn, can induce bone activating BMP2 production 
(De Cesaris et al., 1998). TNF does not effect on differentiation in 
pre-committed MSCs but does promote mineralization and 
osteogenesis in committed MSCs (Croes et al., 2015). Daniele et al., 
also confirmed that TNF did not affect proliferation and 
differentiation in undifferentiated cells but that it is involved in early 
phase of osteogenic differentiation (Daniele et al., 2017). High levels 
of TNF, however, suppress osteogenesis. In this study, TNF was 
produced in the early phase only suggesting a role in enhancing 
osteogenesis. 
The MAPK signaling pathway plays an important role in cell response 
and is activated by extracellular stimuli such as adhesion, stress, 
growth factors and cytokines. The MAPK pathway regulates cellular 
responses such as proliferation, differentiation, inflammation and 
apoptosis (W. Zhang & Liu, 2002; Y. Zhang et al., 2014). MAPK 
signaling requires to be balanced in optimal levels for enhancing 
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osteogenesis while higher levels suppress osteogenesis (Rodriguez-
Carballo et al., 2016). 
Intracellular ERK1/2 is involved in many cellular functions. ERK1/2 
and mechanically-induced osteogenesis may associate with 
differentiation stages. Prolonged mechanical stimulation might 
desensitize ERK1/2 and thus reduce phosphorylated, active, ERK1/2 
(Jansen et al., 2004). ERK itself can also activate osteoclast function 
thus promoting osteoclastogenesis (Rodriguez-Carballo et al., 2016). 
Considering the effect of NS, it was previously shown that NS can 
induce ERK1/2 related osteogenic pathway through 1) TRPV1-PKC-
ERK1/2 –-catenin and 2) Integrin-FAK-ROCK-ERK1/2 pathways 
(Tsimbouri P.M., 2017). On the other hand, NS may also activate 
ERK1/2 through TNF induced inflammation. Thus, 3D osteogenesis 
required the great balancing harmony of osteogenic enhancing signals. 
The role of JNK in osteogenesis is less clear. JNK can be activated by 
TNF (Papa, Zazzeroni, Pham, Bubici, & Franzoso, 2004) and NFB (A. 
Lin, 2003). In our study, N90 activated only JNK1 during osteogenesis 
(Figure 5.18) which tended to enhance osteogenesis (Figure 5.21). 
However, in our non-responding patient, JNK significantly suppressed 
RUNX2 expression (Figure 5.25). This implies that pre-inflamed cells 
with high levels of TNF, JNK and NFB suppress osteogenesis.  
P38 is also known to have roles in osteoblast differentiation 
(Rodriguez-Carballo et al., 2016). In this inhibition study (Figure 
5.22), p38 significantly enhanced not only RUNX2 but also OSX gene 
expression in 3D osteogenesis of N90. This result corresponded to 
Wang et al affirming p38 mediated OSX for osteogenic differentiation 
(X. Y. Wang, Goh, & Li, 2007). Activation of p38 can phosphorylate 
various osteogenic transcription factors. Interestingly, signaling axis 
such as 1) BMP/TGF-p38--catenin or 2) WNT-p38–-catenin 
(Rodriguez-Carballo et al., 2016) could worth further investigation. 
NFB pathway is crucial for cell survival. NFB can be activated by 
inflammatory cytokines such as IL-1, IL-6 and TNF through classic 
and alternative pathways (Lawrence, 2009). The activation of NFB 
counterbalances the cell death pathway for cell survival (J. L. Luo et 
al., 2005). NFB can also function as an antiproliferative protein, thus 
determining growth arrest, differentiation or cell death (Imran & Lim, 
2013). NFB pathways result in antioxidant (e.g. Mn SOD, catalase) 
and oxidant (e.g. iNOS, COX2, LOX2) production (Morgan & Liu, 2011). 
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Moreover, NFB can crosstalk with ROS. NFB can mediate RANK 
ligand induced osteoclastogenesis (Abu-Amer, 2013). Thus, the 
upregulation of NFB in early phase by NS probably promoted 
osteoclast differentiation preparing for bone remodeling in later 
phase. This osteoclastogenesis hypothesis may be worth further study. 
5.5.4.3 Metabolomic perspective  
Our metabolomics study indicated that NS produced low grade 
inflammation. The evidence of long chain polysaturated fatty acid 
synthesis (LC-PUFAs) and reactive oxygen species (ROS) production 
were found. TCA cycle showed a slightly increase trend of TCA 
metabolite in NS group. Interestingly, NADPH oxidase was also found 
in N90 group. It is known that NADPH oxidase is related to ROS 
production at the plasma membrane (Fisher, 2009). Thus, it could be 
hypothesized that NS may directly affect the plasma membrane e.g. 
by fluttering the cell membrane. Considering the predicted activated 
network, the network showed the activation of NADPH oxidase, 
ERK1/2, Akt, NFB, NOS, SOD with N90 stimulation; these signals were 
predicted at much lower levels with N30 stimulation (Figure 5.10 - 
5.11). This could be interpreted that stimulating amplitude 
(approximate range from 40-100 nm) may involve or activate the 
inflammatory signal or ROS product at the cellular membrane. This 
activation then induces the counterbalance signaling. The “switch on” 
of counterbalance signaling may concomitantly activate the 
osteogenic differentiation pathway as well. 
5.5.5 Cellular Yin-yang; the balance between osteogenesis and 
inflammation in nanovibrational stimulation. 
The balance between osteogenesis and inflammation at each time 
point appears to be the key to stimulate osteogenesis by mechanical 
stimuli. Adequate duration and intensity of stimuli will commit MSC 
differentiation to osteoblasts and produce slight inflammation (with 
benefit for mineralization). Over inflammatory response reduces 
osteogenesis and, in the literature, has been linked to increased 
adipogenesis or suppressed differentiation or apoptosis. The pathways 
enhancing or suppressing osteogenesis which might be induced by NS 
are summarised in Table 5.1. 
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Table 5.1 Summary of potential NS pathways 
 Pathways/ Effects References In this thesis 
Enhanced 
osteogenesis 
1) Cytoskeletal involvement 
Integrin-FAK-ROCK-ERK1/2 
(Tsimbouri P.M., 2017) ✓ 
2) BMP2 
BMP2-SMAD1/5 
(Tsimbouri P.M., 2017) ✓ 
3) Stretching ion channels 
TRPV1-PKC--catenin 
(Tsimbouri P.M., 2017) ✓ 
4) Inflammation 
IL-6-BMP2-SMAD1/5 
TNF- NFB? -(BMP2-OSX-
RUNX2) 
(Hess et al., 2009; Osta, 
Benedetti, & Miossec, 2014; 
M. Sun et al., 2017) 
✓ 
5) ROS (controllable) (Atashi et al., 2015) ✓ 
6) Others such as 
- Fluid flow (questionable) 
(PC-1-JAK2/STAT3-RUNX2) 
- Heat activation 
(Dalagiorgou et al., 2017) 
(E. Chen, Xue, Zhang, Lin, & 
Pan, 2015; Ota et al., 2017) 
- 
Suppressed 
osteogenesis 
1) NFB degraded -catenin 
(Chang et al., 2013; N. 
Wang et al., 2016). 
- 
2) MAPK inhibits SMAD1/5 
(R. L. Huang, Yuan, Tu, Zou, 
& Li, 2014; Mao et al., 2016) 
- 
3) TNF 
(R. L. Huang et al., 2014; 
Lencel, Delplace, Hardouin, 
& Magne, 2011; Osta et al., 
2014) 
✓ 
4) ROS (high level) (Atashi et al., 2015) ✓ 
To simplify the interaction of NS related pathways, the 
mechanotransduction-metabolite-inflammation theory was used to 
illustrate signaling maps caused by mechanical stimulating cues, 
inflammation and metabolites. The example of signaling pathways in 
optimal stimulation and in high oxidative stress are shown in Figure 
5.29-5.30 
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Figure 5.29 The hypothesis of NS involved pathway with optimal intensity of NS. 
Inflammation effect on osteogenesis is greater than its negative effects (contributing by inflammation, TNF, ROS and NFB 
(Red line = high level expression, Orange line = low level expression, dense line = proved pathways, dot line = theorectical 
pathway, blue line = phenotype/ result expression). 
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Figure 5.30 The hypothesis of NS involved pathway in high oxidative stress condition 
Over stimulation or poor cell quality (resulting in high level of NFB and TNF baseline level), these conditions suppress 
osteogenesis (Red line = high level expression, Orange line = low level expression, dense line = proved pathways, dot line 
= theoretical pathway, blue line = phenotype/ result expression). 
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5.6 Conclusion 
Nanovibrational stimulation involved lipid metabolism and produced 
controllable ROS which enhance osteogenesis. NS also induced 
controllable inflammatory response (IL-6 and TNF) promoting 3D 
osteogenesis. A good balance between osteogenic enhanced niche and 
oxidative stress-inflammation is crucial to achieve the osteogenic 
induction.  
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Chapter 6 Composites for nanovibrational 
stimulation using in bone tissue 
engineering  
6.1 Introduction  
Natural hydrogels, such as collagen, are widely used for tissue 
engineering (Antoine, Vlachos, & Rylander, 2015). However, 
improving the mechanical properties of natural hydrogel such as 
collagen, gelatin, etc for bone tissue engineering is challenging. In 
chapter 3, it was shown that soft collagen hydrogels were unable to 
resist cell traction forces resulting in hydrogel contraction. Moreover, 
the degradation time of soft collagen hydrogels do not correspond to 
bone regeneration (Helary et al., 2011). Crosslinking techniques can 
improve physical properties (Sundararaghavan et al., 2008) and 
extend the degradation time of hydrogels (Lang, Spousta, & 
Lyubovitsky, 2015; McGann et al., 2015). However, these techniques 
provide cytotoxicity issues for MSC culture (Fessel et al., 2014; J. C. 
Lee et al., 2011; X. Yang et al., 2013).  
Rigid scaffolds provide better mechanical properties than hydrogels. 
However, nutrient and oxygen transfer in hydrogels is superior than in 
dense, rigid scaffolds (Zohreh Izadifar, Xiongbiao Chen, & William 
Kulyk, 2012; Rouwkema et al., 2010). There are many techniques to 
produce rigid collagen scaffolds such as electrospinning (Jha et al., 
2011; Law et al., 2017), freeze drying (Kane & Roeder, 2012; Kane et 
al., 2015; Schoof, Apel, Heschel, & Rau, 2001), etc. However, loading 
cells into these rigid scaffolds are inevitably performed after the 
scaffolds were prepared. Thus, it is difficult to achieve homogenous 
cell distribution together with 3D cellular response within 3D scaffolds 
(Weilun Sun et al., 2012). 
To combine advantages of rigid scaffold and hydrogel together, 
biphasic scaffold is composed of rigid constructs inside hydrogels 
providing composite architecture while the MSCs reside in the 
hydrogel component as a 3D cellular niche. From the current 
evidence, many techniques have been proposed using the biphasic 
scaffold concept. For example, Tanaka et al proposed combination of 
a hydrogel and rigid internal construct by compositing Poly L-lactic 
acid (PLLA) scaffolds into atelocollagen for cartilage tissue 
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engineering (Y. Tanaka et al., 2010). Furthermore, the concept of a 
combination between gel phase and rigid phase were also integrated 
into a 3D printed bioprinting scaffolds approach. Hydrogels were used 
as the ECM for stem cells in the 3D bioprinting process. PCL was also 
printed as a rigid component for maintaining scaffold shape (H. W. 
Kang et al., 2016). 
Considering a different issue, it is questionable whether MSCs can 
maintain their osteogenic phenotype after NS is finished. Moreover, it 
is known that materials can regulate cell fate. Stiff materials promote 
osteogenesis while soft materials enhance adipogenesis (Engler et al., 
2006). Therefore, loading MSCs in soft collagen hydrogel may reverse 
NS induced osteogenic phenotype. Theoretically, adequate dose and 
duration of mechanical stimulation allows MSCs to differentiate and 
memorize their fates without phenotypic reversibility after stimuli is 
terminated (C. Yang et al., 2014). 
In this chapter, biphasic scaffold compositing of collagen hydrogels 
with freeze dried collagen sponge was introduced. This composite 
combined the advantage of hydrogel and sponge together. The 
hydrogel allows nanovibrational force transmission and nutrient 
transfer, while the collagen sponge supports the composite structure, 
preventing hydrogel contraction and improves handleability 
(important for clinic). Mechanical properties, hydrogel contraction 
and mechanical response of cell-hydrogel-sponge composite (CHSC) 
during N90 stimulation were optimised. Biological responses including 
viability and phenotype expression were investigated. Finally, the 
optimal NS duration for osteogenesis and phenotypical memory was 
also studied.   
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6.2 Aims and objectives. 
1 To develop a CHSC that suits the NS bioreactor 
2 To investigate mechanical properties of CHSCs and study how 
CHSCs responded to NS. 
3 To evaluate the biological responses of MSCs to CHSCs as well as 
investigate the phenotype expression of MSCs in CHSCs after NS.  
4 To optimise the NS duration and dose for MSCs in CHSCs which 
can induce osteogenesis as well as maintain phenotype after NS 
was removed.  
6.3 Methodology and experimental design 
6.3.1 Freeze dried collagen sponge preparation  
To prepare the collagen sponges, 5% weight of bovine tendon powder 
(Collagen solution, UK) was used. The 0.001 M of HCl with pH 3 was 
added and then homogenized with homogenizer (TissueRuptor, 
Qiagen) on ice. The mixed composites were then molded in 
polystyrene cell culture inserts (0.4 m Polyethylene terephthalate; 
PET, membrane, 12 well plate diameter, Greiner bio-one, Austria) and 
in turn frozen at -80C for 10 hours. Freeze drying was done at -110C, 
Vapor pressure at 0 mBar, for 20 hours (VirTis, SP industries, USA). 
Freeze dried collagen sponges were sterilised by UV light exposure for 
1 hour. 
6.3.2 Cell-hydrogel-sponge composite preparation 
To prepare the CHSCs, sponges were placed at the centre of 12 well 
plates and were weighted down by placing a screw nut on top of the 
sponges. 1.8 mg/ml collagen hydrogels were prepared by using rat-
tail collagen type I (5mg/ml, First Link, UK). 10xDMEM (First link, UK) 
and Fetal bovine serum (Fisher Scientific) was used as cell medium 
supplement. 0.1M sodium hydroxide (Fluka, UK) was added for pH 
titration by phenol red indicator and pH paper. After the pH titration, 
MSCs were added in the hydrogel mixture and 2.5 ml of MSCs-hydrogel 
mixture was decanted around the sponges. Gelation was allowed at 
pH 7.7 - 8.0 and in a 37°C incubator. Following the cell-hydrogels 
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gelation, 0.5 ml of secondary hydrogels (1.8 mg/ml) without cells 
were aliquoted on top the composite. The CHSCs were then 
transferred for stimulation on the NS bioreactor. When the stimulation 
time ended, the CHSCs were detached from the culture wells by 
spatula allowing CHSC contraction before removed for further analysis 
(Figure 6.1). 
 
Figure 6.1  Cells-hydrogel-sponge composite preparation 
To prepare CHSC, sponges were placed at the centre of wells. 
Cells were mixed with 1.8 mg/ml collagen hydrogel and then 
aliquoted into wells. After gels were set, hydrogels were then 
aliquoted on top to cover the composite. 
6.3.3 CHSC contraction and time lapse microscopy 
To observe the CHSC contraction, top view images of gel-sponge 
composite were taken every 1-2 days. The surface area of the gels 
was measured using ImageJ software. To evaluate cell migration, 
CHSCs were cultured for 6 and 10 days. CHSCs were imaged using a 
10x objective lens at 120 sec intervals for 24 hours at 37°C. Cell 
velocity and migration directions were analysed using imageJ plugin 
(manual tracking) and Chemotaxis and Migration tool (Ibidi).  
6.3.4 Compression test 
The collagen sponges (5% of dry weight) were prepared (sample height 
4 mm, radius 5.5 mm) and placed on the base of the compression 
testing machine (Zwick-Roell, Z2.0, Germany). Compression velocity 
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was set at 1mm/min. Samples were compressed for 2 mm distance.  
Stress-strain graphs were plotted to identify the linear range which 
represented the elastic property of the collagen sponges. The elastic 
modulus was then calculated by Microsoft Excel software using data 
within the elastic range (Figure 6.2).  
 
Figure 6.2  Compression test of collagen sponge 
Collagen was placed on the base of the compression testing 
machine. Compression test was performed for 2 mm with 1 
mm/min velocity.   
6.3.5 Cryosection  
After CHSCs were stimulated with NS, the samples were fixed in 4% 
formadehyde and infused in 30% sucrose in PBS for cryoprotection, 
overnight at 4C. The samples were then transferred to embedding 
molds and O.C.T. (Tissue-Tek, Sakura) was aliquoted to cover the 
samples. The samples were then frozen in liquid nitrogen and kept at 
-80C. The frozen samples were then sliced into 60 mm thickness and 
attached onto adhesive slides (9597, Tissue-Tek, Sakura, 
Netherlands). Immunofluorescent staining was then carried out. 
Techniques were explained in chapter 2 section 2.11.     
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6.3.6 Scanning electron microscopy (SEM) 
The samples were prepared for SEM using the sputter coating 
technique. The samples were mounted onto SEM stubs using double 
sided conductive tape and silver paint. They were then coated with 
Gold/ Palladium (approximately 10-20 nm) using a SEM coating system 
(Q150T ES, Quorum, UK). The samples were viewed on a JEOL6400. 
SEM running at 10 kV and Tif image captured using Olympus Scandium 
Software. Porosity diameter was analysed by ImageJ software. 
6.4 Results 
6.4.1 Mechanical validation  
The studies of porous characteristics (by SEM), mechanical properties 
of CHSCs, as well as reproducibility of CHSC composite preparation 
were conducted. The pattern of CHSCs responding to NS was also 
studied.  
6.4.1.1 Characteristics, SEM and CHSC 
The 5% weight of freeze dried collagen sponges were prepared in order 
to study the effect of NS on biphasic scaffolds. The average pore size 
was 227.74 mm (SD 72.93) (Figure 6.3 A-D), and the average elastic 
modulus of the dry collagen sponge was 1.08 MPa (SD 0.29) measured 
by compression testing (Zwick-Roell, compression rate 1 mm/min) 
(Appendix III). CHSC was lift up with spatula for a simple inspection. 
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CHSC was maintained its shape and handleable in both pre- and post- 
contraction (Figure 6.3 E).  
 
Figure 6.3  Sponge characteristics, SEM and CHSC 
The 5% weight freeze-dried collagen sponges were prepared (A-
B). SEM showed the homogeneous porosity of the collagen 
sponge (magnification c; 200x, d; 10,000x) (C-D). CHSC was 
maintained its shape (E).   
Chapter 6 : Cells-hydrogel-sponge composite  205 
 
6.4.1.2 Hydrogel contraction 
Initially, the “one-week NS protocol” was developed to evaluate the 
reproducibility of CHSC contraction. To study CHSC contraction 
progression, Stro1-selected MSCs were mixed in collagen hydrogels at 
different cell concentrations (4x, 10x and 20x104 cells/ml) and 
prepared as CHSCs. After NS for 7 days, the hydrogel component was 
detached from the wells and cultured for a further 14 days (Figure 
6.4). At day 9, all CHSCs in all groups started to contract until the 
gels touched the sponge. Increasing the number of cells seeded had 
some effect on hydrogel contraction, but no effect of NS on CHSC 
contraction was found (Figure 6.5).  
 
Figure 6.4  Diagram of hydrogel contraction study 
To test the “one-week NS protocol”, three different cell 
concentration groups (4x, 10x and 20x104 cells/ml) were 
stimulated with N30 and N90 for 7 days. At day 7, CHSCs were 
detached and continuously cultured until day 14.  
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Figure 6.5  CHSC contraction observation 
CHSC contraction was observed between day 7 and 14. At day 
7, CHSCs were detached from the culture plates. All CHSCs 
started to contract at day 9; the hydrogels were significantly 
contracted in the 10x and 20x104 cells/ml groups comparing to 
the 4x104 cells/ml group. This result implies that the high cell 
numbers possibly increased the cell pulling force (mean±SD, 
n=4, *= P≤ 0.05; ** = P≤ 0.01; *** = P≤ 0.001, Two-way ANOVA, 
Tukey’s post hoc test).  
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6.4.1.3 Displacement amplitude in hydrogel-sponge 
composite  
To confirm that the cells would feel the vibrations in the hydrogel-
sponge composite during NS, the hydrogel displacement amplitudes 
were measured at the centre of the hydrogel (at the sponge area) and 
hydrogel periphery (where MSCs were seeded). Figure 6.6A shows 
that the NS bioreactor generated reliable CHSC displacement 
amplitudes within the elastic range of the hydrogel; increasing voltage 
increased the CHSC surface displacement in a linear manner. The 
CHSC surface amplitude at the sponge area (centre of CHSC) was 
always slightly higher than the gel area (peripheral area) (Figure 6.6 
B-C). A graph of frequency (Hz) - amplitude validation was plotted in 
order to study the resonance phenomenon of hydrogel-sponge 
composite (Figure 6.7). A reduction of CHSC resonance frequency was 
noted (at 1,250 Hz) when comparing to hydrogels without sponge (at 
2,250 Hz).  
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Figure 6.6  Amplitude validation of CHSC during NS 
Voltage (peak to peak)-amplitude validation (A); Linear pattern 
of the relationship between amplitude-voltage represented that 
nanovibrational stimulating bioreactor was reliable and desired 
frequency was tunable within the elastic range of the hydrogel.  
Hydrogel displacement along vertical (B) and horizontal (C) lines 
showed that the peak of amplitude located at the centre of 
hydrogel-sponge composite (C; centre, D; distal, G; gel area, I; 
interface between gel and sponge, L; left, P; proximal, R; 
right).  
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Figure 6.7  Frequency-amplitude validation by interferometry 
Frequency-amplitude validation. Decrease of resonance 
frequency in gel-sponge composites (green) comparing to the 
hydrogel without sponge group was noted (red) which followed 
the rule of simple harmonic motion. In both gel and the 
hydrogel-sponge composites, NS still showed a good fidelity at 
1000 Hz stimulation. GS; gel-sponge composite, G; gel area 
(peripheral area), S; sponge area (centre area).  
 
6.4.2 Biological validation of cells-hydrogel-sponge composite 
Next, the biological response of CHSCs as well as biocompatibility 
were carried out. Firstly, the interaction between cells and the 
sponge in the composite was tested. Cell behaviors in the CHSC, such 
as cell migration and velocity were studied. Moreover, 
biocompatibility was also tested by Alamar Blue assay. Utmostly, MSC 
phenotype of NS induced CHSCs was investigated.  
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6.4.2.1 Time lapse microscopy 
To investigate cell viability in pre- and post-contracted CHSC, 4x104 
cells/ml of MSCs were seeded into CHSCs. Time-lapse microscopy 
images were taken at day 6 (pre-contracted) and 10 (post-contracted) 
for 24 hours. Cell migration velocity in the pre-contracted CHSCs was 
significantly higher than that in the post-contracted CHSCs (Figure 
6.8). Chemotaxis plots and rose plots illustrated that cells favored 
migration towards the sponge in both pre- and post-contracted gels 
(Figure 6.9). 
  
Figure 6.8  Effect of CHSC contraction on cell migration 
velocity 
Comparison of cell migration velocity in pre-contracted and post 
contracted hydrogels showing that cell velocity decreased in the 
contracted hydrogels (n=10) (mean±SD, n=10, *= P≤ 0.05; ** = P≤ 
0.01; *** = P≤ 0.001, paired t-test) 
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Figure 6.9  Cell movement direction 
Chemotaxis and rose plots demonstrated that cells tended to 
migrate toward the sponge in non NS-stimulated CHSCs. (n=10, 
red line; counts the upward direction, black line; counts the 
downward direction, +; center of migration, S; collagen sponge 
in CHSCs).  
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6.4.2.2 Cell characteristics at hydrogel-sponge junction   
As MSCs in the CHSCs tended to migrate toward the sponge (Figure 
6.9), it was decided to look closer. Thus, 4x104 cells/ml of MSCs were 
seeded into CHSCs and cultured for 14 days without NS. Microscopy 
showed that MSCs tended to move toward to the sponge in pre-
contracted CHSCs. In contracted CHSCs, MSCs attached onto the 
sponge (Figure 6.10 A-B). Next, CHSC cryosections were studied to 
identify MSCs inside the sponge. The 104 cells/ml of MSCs seeded into 
CHSCs and cultured for 1 week without NS. CHSCs contraction was 
allowed at day 7. At day14, contracted MSC seeded CHSCs were sliced 
by cryosection and immunofluorescence stains (myosin IIa, actin and 
DAPI) were carried out. Microscopy showed that MSCs attached onto 
sponges. Red stained cells (actin) could be seen inside the sponges 
(Figure 6.10 C-D).  
 
Figure 6.10  Microscopy and cryosection of gel-sponge 
A-B Microscopy of the gel-sponge composite. Stro1 selected 
MSCs at day7 (A) in precontracted CHSCs showed that MSCs were 
viable and tended to move toward the sponge (20x 
magnification, scale bar 100 μm). At day 12 (B), in contracted 
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CHSCs, viable MSCs were still seen in the hydrogel (20x 
magnification, scale bar 100 μm).  
C-D Gel-sponge cryosections. Cryosections of the contracted 
CHSCs at day 14 showed MSCs attached onto the sponge. (C; 4x 
magnification; scalebar 300 μm, D; 10x magnification; scale bar 
150 μm, Green; myosinIIa, Red; actin, Blue; DAPI, S; sponge, G; 
hydrogel) 
6.4.2.3 Alamar Blue study  
Stro-selected MSCs seeded with different cell concentrations (4x, 10x, 
20 x 104 cells/ml) into CHSCs were prepared to investigate 
biocompatibility using the alamar blue assay. The 1-week NS was 
performed as in Figure 6.4. The Alamar Blue study (Figure 6.11A-C), 
representing both viability and metabolic activity, emphasized again 
that CHSCs were compatible for MSCs. Interestingly, the percentage 
of alamar blue reduction in the contracted CHSCs was significantly 
higher than in the non-contracted CHSCs (Figure 6.11A). This could 
be interpreted that MSCs in the contracted CHSCs are more active 
than cells in non-contracted CHSCs. During NS (day 6), the increase in 
the percentage of alamar blue reduction compared to non-stimulated 
controls indicated that NS enhanced cellular metabolic activity 
(Figure 6.11B). This activity remained in the N90 group after stopping 
stimulation (day 11) (Figure 6.11C). Construct loading with a high 
number of cells produced greater metabolic activity than lower 
concentrations.  
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Figure 6.11  Alamar blue study in CHSC 
A) Comparing contracted and non-contracted CHSCs at day 10, 
metabolic activity in the contracted CHSCs was higher than 
that in the non-contracted CHSCs, indicating that MSCs are 
more active in the contracted CHSCs. (mean±SD, n=4, *= P≤ 
0.05; ** = P≤ 0.01; *** = P≤ 0.001, pair t test). 
B) Considering NS in pre-contracted CHSCs at day 6, NS 
enhanced metabolic activity compared to control (non-
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contracted CHSC) (mean±SD, n=4, *= P≤ 0.05; ** = P≤ 0.01; 
*** = P≤ 0.001, one-way ANOVA, Tukey’s post hoc test).  
C) After stopping the stimulation at day 7, metabolic activities 
in all groups were reduced at day 10. Interestingly, the 
activity in N90 group was the same compared to control 
(contracted CHSC) (n=4, *= P≤ 0.05; ** = P≤ 0.01; *** = P≤ 
0.001, one-way ANOVA, Tukey’s post hoc test). 
 
6.4.2.4 Temporal gene analysis  
Next, a temporal gene study was performed to select an adequate 
dose of NS which can commit MSCs for osteoblastic differentiation. 
The 4x104 cells/ml of Stro1-selected MSCs/ml in CHSCs was prepared. 
MSCs in CHSCs were stimulated with NS for 7, 14 and 21 days without 
detachment, therefore, there was no hydrogel contraction. RUNX2 
and OSX upregulation were found at week 1 for osteogenic 
commitment. OPN was upregulated in week 2-3. The N90 group 
provided better osteogenic induction than the N30 group (Figure 
6.12A). Considering inflammation, IL-6 upregulation was noted at 
week 1 indicating that MSCs produced an inflammatory response. 
However, the inflammation was reduced in week 2-3. This suggests a 
controllable inflammatory response that is beneficial for 
osteogenesis. NFκB was produced at week 1 and again was reduced by 
week 2-3 corresponding to IL-6 level and supporting the controlled 
inflammation hypothesis (Figure 6.12B). The summary diagram of NS 
induced phenotype and inflammatory response is shown in Figure 
6.12C.  
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Figure 6.12  Temporal gene study at day 7-21 
NS induced osteogenic gene expression. RUNX2, OSX and ON 
were upregulated at week 1 for osteogenic commitment while 
OPN was increased at week 2-3 (A). Inflammation (linked to IL-
6 and NFκB levels) was found at week 1 but decreased at week 
2-3 indicating that inflammation is controllable (B). A diagram 
illustrating the relationship between phenotype and 
inflammatory response (C) (mean±SD, P1-2; patient 1-2, * = P≤ 
0.05; ** = P≤ 0.01; *** = P≤ 0.001, n=3, One way ANOVA, Tukey’s 
post hoc test).  
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6.4.3 Nanovibrational stimulation and phenotypic memory 
Maintaining the osteogenic phenotype of MSCs after NS is important 
for translation into clinics and clinical applications. From the 
temporal gene study above (Figure 6.12), it was shown that 1-2 weeks 
of NS possibly provided an adequate dose triggerring osteogenic gene 
expression. To study whether MSCs can memorize their osteogenic 
commitments or if their phenotypes were reversible, models of 1- and 
2-week NS were created for a phenotypic memory test. CHSCs 
contraction was allowed after 7 or 14 days and phenotypes were then 
tested after an additional week (after 7 days of NS) or 2 weeks (after 
2 weeks of NS) after the end of NS. The outcomes could suggest the 
best process for clinical translation in the future production of a 
handlable, osteogenic scaffold where contraction isues have been 
considered. 
  
6.4.3.1 Gene expression (1 week-NS and qRT-PCR at week 2) 
As the effects of cell seeding number and duration of NS on osteogenic 
phenotype expression and cell fate memory are unknown, three 
different cell concentrations (4x, 10x and 20x104 cells/ml) of Stro1 
selected MSCs seeded in CHSCs were prepared. CHSCs were 
nanovibrated for 1 week. After this stimulation, hydrogels were 
allowed to contract onto the sponge by detaching them from the 
wells. CHSC cultures were then maintained in incubator for a further 
week. At week 2, phenotypic studies were performed by qRT-PCR. 
The increased trend of osteogenic gene upregulation in N90 group 
including osterix, osteonectin, osteopontin and alkaline phosphatase 
were noted but they were not significant. Theoretically, cell-seeding 
concentration can affect differentiation. Bitar M et al, showed a cell 
density of 106-107 cells/ml can increase RUNX2 and osteonectin 
transcriptions (Bitar et al., 2008). However, no significant effect of 
cell seeding concentration on osteogenic induction was noted (Figure 
6.13). As loading MSCs with 4x104 cells/ml in CHSCs used less cell but 
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provided the best osteogenic induction, this was selected to go 
forwards.   
 
Figure 6.13  qRT-PCR at week 2 after 1 week-NS 
qRT-PCR at day 14 showed the trend of osterix, alkaline 
phosphatase, osteonectin and osteopontin gene upregulation in 
N30 and N90 groups. No significant effect of cell concentration 
on osteogenic gene expression was noted. The 4x104 cell/ml 
appeared to provide the best osteogenic induction results 
(mean±SD, n=4, * = P≤ 0.05; ** = P≤ 0.01; *** = P≤ 0.001, Tukey 
post hoc test, Dunn’s post hoc test).   
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6.4.3.2 Gene expression (2 week-NS and qRT-PCR at week 4) 
The previous experiment showed that 1 week-NS can produce only a 
very slight evidence of osteogenesis in CHSCs (Figure 6.13), the next 
experiment was designed to increase duration of stimulation to 2 
weeks. The 4x104 cells/ml of Stro1-selected MSCs seeded in CHSCs 
were used in this study. After 2 weeks of stimulation, hydrogels were 
allowed to contract onto the sponge and then cultured without 
stimulation up to 4 weeks. qRT-PCR at week 4 showed RUNX2 and 
osteonectin (ON) were significantly increased in N90 group (Figure 
6.14). This result indicated that 2 week-NS with N90 triggered 
osteogenic commitment driving MSCs into preosteoblasts. ALP, OPN 
and OCN expression were not changed (Figure 6.14). ALP plays a role 
in hydrolysing organic to inorganic phosphate. Thus, no induction of 
ALP may affect mineralization through inorganic phosphate reduction 
(Orimo, 2010; Siffert, 1951). As the increase trend of OPN was found 
at week 2-3 in previous temporal gene study (Figure 6.12), the lack 
of change in OPN and OCN at week 4 (Figure 6.14) may also affect 
bone remodelling (Icer & Gezmen-Karadag, 2018).  
 
Figure 6.14  qRT-PCR at week 4 after 2 weeks-NS 
Only RUNX2 and ON were significantly upregulated in N90. The 
result indicated that N90 potentially committed MSCs to 
preosteoblasts in this regime. (mean ± SD, n=4, * = P≤ 0.05; ** = 
P≤ 0.01; *** = P≤ 0.001, One way ANOVA, Tukey’s post hoc test).  
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6.4.3.3 Protein expression (2 weeks-NS and western blot at 
week 3) 
As qRT-PCR at week 4 (after 2 weeks-NS) showed low levels of OPN, 
this was investigated further and OPN expression at week 3, after 2 
weeks of NS, was conducted. The 4x104 cells/ml of Stro1-selected 
MSCs seeded in CHSCs was stimulated for 2 weeks. After that CHSCs 
were detached allowing hydrogel contraction onto the sponge and 
cultured for a further week without NS. Western blots were performed 
at week 3. An increased, non-significant, trend of OPN was found in 
the N90 group (Figure 6.15).  
Summarising the NS memory tests, 2 week-N90 stimulation can induce 
osteogenic gene expression showing the successful up-regulation of 
RUNX2 (week 1) and osterix (week 2) (Figure 6.12). This result 
indicates that MSCs are slowed in their progression and are possibly at 
the preosteoblast stage after the stimulation and rest. Summary 
diagram was shown in Figure 6.16.    
 
Figure 6.15  Western blot of osteopontin at week 3 post 
2 week-NS 
After 2 weeks of NS, CHSCs contraction was allowed. Western 
blot study showed a trend of OPN protein upregulation in N90 at 
week 3. The result indicated that after 2 week-NS, MSCs possibly 
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memorized osteogenic expression upto week 3 (mean±SD, n=4, 
One-way ANOVA, Tukey’s post hoc test).  
 
Figure 6.16 The summary of phenotypic memory test after 
stimulating with 1 week- and 2 weeks- N90 protocol 
in CHSC. 
Stimulating with 1 week-N90 was inadequate to induce 
osteogenesis. Interestingly, 2 weeks of N90 stimulation was 
possibly adequate to commit MSCs at preosteoblast stage 
showing by significant upregulations of RUNX2 and ON at week 
4.  
6.5 Discussion 
6.5.1 CHSC; the clinical application model for NS and rationale of 
1-2 week NS protocol.  
Collagen type I hydrogels provide a range of biological advantages 
(Antoine, Vlachos, & Rylander, 2014). Hydrogel stiffness is compatible 
with a hematoma which is formed in the initial phase of fracture 
healing (Ryan et al., 1999). The increase in cell number by collagen 
supporting proliferation (Chinnapaka Somaiah et al., 2015) as well as 
permitting differentiation, increase cell contractile force, known to 
be important for osteogenesis (Darinka D. Klumpers, Xuanhe Zhao, 
David J. Mooney, & Theo H. Smit, 2013; Kumar, Placone, & Engler, 
2017), but that can result in gel contraction. This contraction, at the 
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wrong time can be problematic as once detached, the vibrations do 
not transmit faithfully. 
The CHSC combined the advantages of hydrogel and sponge together. 
Hydrogels provide biological advantages such as allowing the 
distribution of nutrients, growth factors and oxygen, which are 
essential for the cell differentiation process (Hesse et al., 2010). 
Preparing cells in hydrogels can prevent cell sedimentation onto the 
bottom of the tissue culture wells, therefore improving MSCs 
distribution and attachment onto the sponge. On the other hand, the 
rigid sponge improves mechanical property of the scaffold. The 
sponge inside the hydrogel can also act to stop further hydrogel 
contraction, maintaining composite structure and extending the 
degradation time. Thus, control of contraction using the sponge 
results in a more handleable structure. Moreover, gel contraction can 
increase spatial cell-to-cell interaction (D. D. Klumpers, X. Zhao, D. 
J. Mooney, & T. H. Smit, 2013). In our study, the hydrogel creates the 
bonding to the rim of tissue culture wells. This hydrogel-well bonding, 
however, can be overcome by cell traction forces. Therefore, the time 
of hydrogel contraction can be chosen by controlling the force balance 
at the rim of well plate and hydrogel. At 2-3 days after hydrogel 
detachment, the hydrogels had contracted onto the sponges. The 
results showed that CHSC contraction can be made to be controllable 
and reproducible (Figure 6.5).  
Next, the protocol that would allow the stimulated MSCs in CHSCs to 
be used for clinical application, was developed. The “1 week-NS 
protocol” was initially tested by stimulating CHSCs for 1 week with 
high amplitude stimulation (N90; 90 nm). The rationale is based on 
trauma patient scenario and the theory of cell mechanical memory 
after adequate exposure of mechanical stimulation (approximately 10 
days) that results in irreversible phenotype (C. Yang et al., 2014). 
However, only a trend rather than statistical difference at this time 
point was observed. Next, NS duration was extended to 2 weeks. 
Phenotypical study at week 4 showed that MSCs were committed to 
preosteoblasts as shown by enhanced RUNX2 and OSX expression. 
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However, evidence of mineralization (by ALP) and remodelling (by 
OPN) were not obviously found.  
6.5.2 Nanovibrational stimulation and mechanical response of 
CHSCs 
In this study, collagen sponges were produced to study the effects of 
NS in CHSCs. It was demonstrated that the NS bioreactor is reliable 
with CHSCs and generates tunable stimulating amplitude by adjusting 
the voltage (Figure 6.6A). Figure 6.6B and C possibly explained that 
the CHSCs vibrated as circular membrane (e.g. a drumhead) in a 
standing wave pattern with greatest displacement at the centre. It 
was also found that incorporating the sponge into hydrogel changed 
the resonance frequency (Figure 6.7). To explain this phenomenon, 
it can be implied that during NS, the hydrogel is displaced in the 
culture plate well, driven by the stimulating frequency (1,000 Hz) 
without energy loss and thus each hydrogel is displaced with its own 
natural frequency in a simple harmonic motion. The natural frequency 
of hydrogels can be explained by the equation below.  
𝑓 =
1
2𝜋
√
𝑘
𝑚
    (1) 
Therefore, the change of mass (m) or elastic property (spring 
constant; k) results in changes in the hydrogel natural frequency. The 
resonance phenomenon represents that the external stimulating 
frequency (NS) equal to the natural frequency of the system resulting 
in amplification of gel displacement amplitude and showing a high 
peak of gel displacement. From Figure 6.7, the addition of sponge 
into the hydrogel increases mass (m) of the stimulated composite. 
Consequently, it reduces the natural frequency of the CHSC 
representing the reduction of resonance frequency.  
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The change of amplitude in the CHSC during NS can be explained by 
Newton’s second law and Hooke’s law as follows;   
Newton’s second law;  F = ma 
Hooke’s law;    F = -kx 
Therefore,     ma  = -kx   
 (2)  
Regarding equation (2), the increase of mass (m) amplifies the 
displacement of object (x). In a hydrogel without the sponge, the 
stimulation with 19.69 Vpp generated 91 nm average hydrogel 
displacement while in the CHSC (addition of mass [sponge] into the 
system), amplitude was increased to approximately 150 nm at the 
sponge zone (Figure 6.6A). 
As aforementioned, the variation of amplitude due to changing the 
composite can be solved by tuning the stimulating voltage. At 1000 
Hz, amplitude in CHSC was slightly increased compared to hydrogels 
alone, but it is reproducible without random vibrations occurring and 
can be tuned to achieve a 90 nm average. 
6.5.3 Biological response in CHSCs; cell concentration, cell 
differentiation and phenotype memory theory 
In this study, it was demonstrated that CHSCs using the hydrogel 
contraction concept are biocompatible in terms of cell viability. Some 
literature has shown that the effect of gel contraction can provide 
unfavorable results such as cell apoptosis (Y. K. Zhu et al., 2001). 
However, in this study, the contraction was limited using the sponge 
and the effect of gel contraction was tested at three different cell 
concentrations. The Alamar Blue assay indicated that cell activity of 
the contracted CHSCs increased compared to that of the non-
contracted CHSCs (figure 6.11A). It was also noted that MSCs tended 
to migrate toward the sponge in pre- and post-contracted CHSCs 
(figure 6.9 - 6.10).  
During NS, the increase of percentage of Alamar Blue reduction 
indicated that NS is an energetic process. Alamar Blue can be reduced 
by NADPH, FADH and cytochromes (Ehrbar et al., 2011). These 
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cofactors are involved in catabolism and anabolism. Together with the 
data in chapter 5, it was found that NS involved in lipid metabolism 
as well as increased osteogenic phenotype. Thus, we could imply that 
NS in the CHSCs potentially drives the cell differentiation process. 
Again, in this study, the contracted CHSCs had higher cell metabolic 
activity compared to non-contracted CHSCs (Figure 6.11A). It was 
hypothesised that this change was linked to energy consumption of 
MSCs in order to migrate within the higher dense 3D matrix 
(contracted hydrogel). Microscopic images showed cell migration 
velocity in the pre-contracted CHSC was significantly faster than those 
in the post-contracted CHSCs. From the literature, it has been 
previously shown that contracted collagen hydrogels provide a dense 
collagen fiber architecture, driving cells to consume greater ATP 
during migration compared to pre-contracted gels (Zanotelli et al., 
2018). Also in 3D matrices, matrix stiffness and pore size have been 
shown to affect cell differentiation (Petrie & Yamada, 2015). Cells 
form focal adhesions in direct correlation to increasing stiffness and 
transfer mechanotransductive signals to the nucleus. Stiff surfaces 
can induce MSC osteogenesis while soft surfaces direct MSC towards 
adipogenesis (Engler et al., 2006). During cell migration through small 
pores, cells are squeezed and subsequently transfer mechanical signal 
to their nuclei (Fruleux & Hawkins, 2016; Petrie & Yamada, 2015). The 
increase of matrix stiffness could increase the reaction force 
interaction to the cell nucleus enhancing YAP (Yes-associated protein) 
influx (Dalby, Garcia, & Salmeron-Sanchez, 2018). YAP/TAZ is a 
pathway which links to differentiation control by mechanical cues 
(Codelia, Sun, & Irvine, 2014; J. X. Pan et al., 2018; Piccolo, Dupont, 
& Cordenonsi, 2014). This concept triggered our curiosity to further 
study the effect of the contracted CHSCs on MSCs differentiation. It 
was hypothesised that the reduction of pore size in contracted 
hydrogels might modulate cell differentiation by directly deforming 
nuclear shape as well as relatively increasing cytoskeletal tension 
during migration. Moreover, the increase of metabolic activity in the 
contracted hydrogel might be related to the increase of oxygen 
consumption, ROS production and oxidative phosphorylation 
consequently affecting  MSC differentiation e.g. osteogenesis 
(Arakaki, Yamashita, Niimi, & Yamazaki, 2013). Theoretically, the 
matrix stiffness which can drive osteogenesis, is very rigid (25-40 kPa) 
(Engler et al., 2006). However, some literature reports the effect of 
3D collagen hydrogel contraction on driving osteogenesis (D. D. 
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Klumpers et al., 2013). In our study, the effect of hydrogel contraction 
onto the sponge was initially aimed at improving handleability and 
extending the material degradation time.  
From the temporal gene study (Figure 6.12), nanovibration 
sucessfully promoted osteogenic gene expression in CHSCs. However, 
the evidence of osteogenic phenotype was less clear than that of the 
constant NS (Figure 6.13, 6.14). In theory, adequate duration and 
intensity of mechanical stimulation can commit an irreversible 
phenotype and NS is considered to be a mechanical stimulation 
(Tsimbouri P.M., 2017). Cells sense the mechanical environment using 
their cytoskeletons. Mechanical signals are transfered to the nucleus 
via actin and myosin by cytoskeletal tension change (K. H. Vining & D. 
J. Mooney, 2017). YAP/TAZ is important for mechanosensing and 
phenotype memory. YAP transfers mechanical signal via Rho-GTPase-
dependent translocation to the nucleus (Driscoll, Cosgrove, Heo, 
Shurden, & Mauck, 2015). Influx and accumulation of YAP into the 
nucleus initiates the onset of osteogenic differentiation. Force 
intensity and duration link to YAP transport through the nuclear pores. 
Sufficient force allows YAP nuclear translocation into the nucleus 
(Elosegui-Artola et al., 2017; Panciera, Azzolin, Cordenonsi, & 
Piccolo, 2017). Exposure to adequate duration and intensity of 
mechanical stimulation thus results in irreversible phenotype (C. Yang 
et al., 2014) while inadequate force stimulation causes phenotype 
reversibility (Cui et al., 2015). The hypothesis of NS effect on cell 
memory is shown in Figure 6.17. Further studies of NS effect on 
YAP/TAZ pathway would need to be performed in future work. 
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Figure 6.17  Hypothesis of mechanical memory and 
nanovibrational stimulation for 3D osteogenesis 
A) In non-stimulated MSCs, YAP remains in the cytoplasm. B) 
With adequate stimulation amplitude and duration, NS 
potentially increased cytoskeletal tension, in turn, there was an 
enhanced YAP influx into the nucleus thus driving osteogenesis. 
C) During NS, MSCs attach to the ECM via focal adhesions 
including integrins, which then enhance the Rho-ROCK pathway 
for actin polymerization and myosin II activation (Parsons, 
Horwitz, & Schwartz, 2010). The increase of cytoskeletal 
tension could stretch nuclear pores resulting in YAP influx into 
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the nucleus (Elosegui-Artola et al., 2017). Subsequently, YAP 
coactivated with TEA domain-containing sequence-specific 
transcription factors (TEADs) drive osteogenesis 
6.6 Conclusion  
 We are stepping towards translation of NS into a handlable 
format and trying to workout a robust and short NS protocol. Our 
composite is safe for cell viability and allows a controllable 
nanovibrational force transmission. NS enhanced osteogenic gene 
expression in the CHSCs. An extension of the duration of stimulation 
may improve phenotype expression without reversibility. 
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Chapter 7 General discussion and conclusion 
7.1 General discussion 
In this section, interesting issues are discussed to help identifying 
further studies in the future. The ideas and concepts of improving the 
NS protocol and introducing scaffolds into clinics are also proposed.  
7.1.1 Amplitude, frequency or accerelation (g); which parameter 
should be focused on? 
Low-magnitude high-frequency vibration (LMHFV) for osteogenic 
induction is studied with use of a diverse range of stimulating 
protocols (Chapter1, Table 1.4). Considering the literature, 
osteogenic induction has been achieved using 0.3 g of acceleration 
but with varying  frequencies and amplitudes (Lau et al., 2011; 
Marędziak et al., 2017; Mehta et al., 2018; Q. Zhao et al., 2017; Y. 
Zhou et al., 2011) (Chapter1, Table 1.4). Interestingly, in this thesis, 
increasing the NS amplitude from 30 nm (0.12 g at 1000 Hz (Tsimbouri 
P.M., 2017)) to 90 nm (0.36 g at 1000 Hz) showed significantly 
increased osteogenesis where the acceleration corresponded to those 
of other LMHFV protocols. Considering the theory of simple harmonic 
motion (Garrett, 2017; Kett, 1982; "Simple harmonic motion," 2007), 
the relationship between accerelation, stimulating amplitude and 
frequency are shown in the equation below.  
𝐴 = (𝑎)(2𝜋𝑓)2 
Where   A  = acceleration (1g = 9.81 ms-2) 
a = amplitude 
f = frequency 
From the equation, squaring of a slight increase of frequency results 
in a large change of acceleration while an increase of amplitude 
directly corresponds to the acceleration in a linear pattern (when 
using a constant frequency). As shown in the phenotypic and 
metabolomic studies, the change of NS amplitude on the nanoscale 
(from 30 to 90 nm) can display the alteration of cellular response from 
low (by N30) to high levels (by N90) of osteogenesis. Thus, nanoscale 
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amplitude or acceleration is a good parameter to consider for further 
studies.  
7.1.2 Mechanisms and pathways 
This study clearly elucidated that NS induces osteogenesis through 
multiple pathways, not only by a single pathway. It was hypothesised 
that high amplitude stimulation probably generates multiple stimuli 
such as stretching on the cell membrane, fluid shearing or heat, which 
in turn induces osteogenesis through various types of cellular 
membrane receptors. Simultaneously, high amplitude stimulation also 
produces low grade inflammation which is important to promote 
mineralization and recruit precursor cells for enhancing 
osseointegration and vascularization into scaffolds in the in vivo 
phase. The high amplitude stimulation also produces low level of 
controllable ROS. However, the overall outcome of NS favors high 
levels of osteogenesis. 
7.1.3 Oxidative stress and Inflammation  
In chapter 5, it was shown that NS induces oxidative stress and low-
grade inflammation without reducing osteogenesis. However, 
oxidative stress and inflammation are double-edged swords. 
Controllable and low-grade ROS enhances diverse intracellular 
signalling pathways including osteogenic signals (Atashi et al., 2015) 
while uncontrollable or chronic ROS exposure induces detrimental 
effects such as cell senescence and DNA damage (Droge, 2002) as well 
as suppressing osteogenesis but inducing adipogenesis (M. Arai et al., 
2007; C. H. Lin et al., 2018); low levels of inflammation enhance 
osteogenesis (R. L. Huang et al., 2018; Y. Li, Backesjo, Haldosen, & 
Lindgren, 2008; M. Sun et al., 2017) but chronic or high levels can 
suppress osteogenesis (Lacey et al., 2009). As NS amplitude is 
adjustable and stimulating duration is controllable, the effect of long- 
term exposure and high intensity of NS should be conducted to define 
an upper limit of stimulation.  
To overcome the current strategy of bone defect treatments, such as 
distraction osteogenesis provides a good treatment outcome but takes 
a long time and is costly, NS needs to rapidly enhance osteogenesis. 
Increasing NS amplitude beyond 90 nm aiming to gain quicker and 
higher osteogenic phenotype expression could be trialed. As shown by 
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our results, the increase of NS amplitude concomitantly induced 
greater oxidative stress and inflammation. Thus, pre-treating MSCs 
with anti-inflammatory (e.g. NSAIDs) or anti-ROS (e.g. N-acetyl 
cysteine; NAC) drugs may help controlling inflammation and oxidative 
stress in very high amplitude stimulation (>90 nm). Some evidence 
showed that NAC may improve osteogenesis (Ji, Liu, Zhao, & Zhang, 
2011; Yamada et al., 2013). However, NSAIDs treatment may reduce 
bone formation (I. Pountos, Georgouli, Calori, & Giannoudis, 2012; 
Ippokratis Pountos et al., 2011; Yoon et al., 2010), thus pre-treatment 
inflammation protocols need to be considered with care. Patterning 
of NS stimulation with resting intervals is another option to balance 
the oxidative stress products if the study of 3D osteogenesis in the 
hydrogel with very high amplitude stimulation (>90 nm) is carried out 
to accelerate osteogenic gene expression. The phenotypic studies of 
NS stimulation-resting intervals are needed to avoid either overdose 
stimulation (from long duration of very high intensity NS exposure) 
resulting cell apoptosis or phenotypic reversibility (from a long time 
of NS free-interval) ending up with osteogenic induction failure. 
7.1.4 Reversibility and gel-sponge composite  
It was shown that the cell-hydrogel-sponge composite (CHSC) concept 
is possible for osteogenesis and the 2 week-N90 stimulation is 
adequate for preosteoblast commitment. However, OPN which is 
important for mineralization and bone remodelling (Lund et al., 2009; 
P. J. Thurner et al., 2010) was downregulated at week 3 (Figure 
6.15). Optimistically, the decrease of OPN is possibly compensated by 
the host-inflammatory response at the surgical site after post scaffold 
implantation surgery. Considering an induced membrane surgical 
technique or Masquelet technique (two-step surgery which allows the 
host to create a self membrane pouch for autograft implantation 
(Giannoudis et al., 2011)), this membrane secretes transcription 
factors such as BMP2, TGFβ and inflammatory cytokines including IL-
6 (Toth et al., 2019). OPN plays a role not only in regulating osteoclast 
function but also affecting inflammatory cells (Florian Kahles, Hannes 
M. Findeisen, & Dennis Bruemmer, 2014). Further, it is known that IL-
6 can upregulate OPN expression, as it is found in macrophages 
(Uchibori et al., 2017). Thus, in post scaffold-implantation surgery, if 
the host generates an optimal inflammation (in turn producing 
optimal level of IL-1β and IL-6), we could extrapolate that OPN 
(enhanced by the inflammatory niche) may continuously promote the 
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remodelling process of mineralized scaffold in in vivo study (Florian 
Kahles et al., 2014; Lund et al., 2009; P. J. Thurner et al., 2010). 
7.1.5 Cell sources and quality 
Regarding this thesis, the success of NS induced osteogenesis is 
strongly related to ‘cell quality’, and pre-stimulated MSC status 
affects the stimulation outcome. A high degree of subculturing (more 
than passage 3) risked poor osteogenic responses. Moreover, cell 
senescence, over density/overgrowth of cell culture, high passages 
can change NFB level (Hellweg, Arenz, Bogner, Schmitz, & 
Baumstark-Khan, 2006). To minimise this problem, developing cell 
status screening techniques or protocols (before NS) may improve NS 
induction outcomes and save costs from failed experiments.  
Stem cell seeded scaffolds for large bone defect treatment is 
challenging as it requires an extremely large number of cells. 
However, autologous bone graft sources, commonly derived from iliac 
crest, are inadequate. Other cell types such as iPSCs and ESCs may be 
alternative options for NS in the future. 
7.1.6 Future design scaffolds for NS 
The concept of the biphasic scaffold is an upcoming trend in bone 
tissue engineering providing both structural support (via the rigid 
phase) and biological enhancement (via the hydrogel phase). Our cell-
gel-sponge composite is a simple model which can be implemented 
with various type of scaffolds such as 3D bioprinted scaffolds. 
However, changing the scaffold form and structure can change the 
cell response pathways; thus, biological responses analysis needs to 
be repeated. 
Developing bone scaffolds for clinical applications is challenging. They 
need to provide not only the mechanical support but also the 
biological advantages. Moreover, they have to contribute to 
osteogenic and angiogenic inductions. Together with NS, the scaffolds 
may be supplemented with growth factors such as BMP2 and VEGF for 
fast driving of osteogenesis and vascular formation. As bone loss often 
results in open fractures, the wound is regularly exposed to 
microorganisms (Otchwemah et al., 2015) and is prone to be infected 
(Guerra, Gregio, Bernardi, & Castro, 2017). Developing scaffolds, 
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which allow NS to enhance osteogenesis  and provide an antibacterial 
effect, is an ideal target in the future (Nair, Kretlow, Mikos, & Kasper, 
2011).  
7.2 Conclusion 
7.2.1 Increased concentration improves hydrogel handleability  
Hydrogel contraction is an obstacle in allowing adequate doses of NS 
for inducing 3D osteogenesis of MSCs within the NS bioreactor. In 
chapter 3, three strategies including in-gel scaffolds, collagen 
concentration optimization and genipin crosslinking were trialed to 
improving hydrogel properties. In conclusion, the in-gel scaffold was 
discontinued as it did not prevent contraction and was less feasible 
for potential clinical application. Genipin was also discounted as its 
cytotoxicity was an unwanted side effect though it could improve 
hydrogel stiffness. Increasing collagen concentration from 0.8 mg/ml 
to 1.8 mg/ml was seen to delay hydrogel contraction. This simple 
approach allows a straight forward strategy. 
7.2.2 High amplitude nanovibrational stimulation enhances 
osteogenesis through multiple pathways  
High amplitude stimulation (N90) showed better osteogenic induction 
than the standard amplitude used in the group (N30). High amplitude 
stimulation increased osteogenic gene and protein expression at day 
9 and did not effect MSC viability. From a temporal gene study, N90 
induced osteogenic gene expression corresponding to a normal 
osteogenic pattern. N90 significantly induced TRPV1, piezo2, ion 
channels and ERK1 which corresponded well to Tsimbouri et al 
(Tsimbouri P.M., 2017) showing that N30 stimulates TRPV1-PKC-β-
catenin to induce bone differentiation in MSCs (Tsimbouri P.M., 2017). 
N90 stimulation tended to involve the BMP2-SMAD1/5 and ROCK 
pathways in 3D culture suggesting that high stimulating amplitude 
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possibly activated more osteogenic pathways through BMP2 and 
cytoskeletal tension regulations.  
7.2.3 NS enhanced osteogenesis and produced controllable 
oxidative stress and inflammation  
The metabolomic study showed that N90 stimulation involved lipid 
metabolism and produced low levels of oxidative stress which is well 
regulated through redox balancing and counterregulatory responses 
such as superoxide dismutase enzyme (a ROS reducing enzyme), NFκB 
and Akt (anti-apoptosis mechanisms). The evidence of inflammatory 
responses (such as IL-6, TNFα) was found during N90 NS. Through 
protein inhibition tests, it was shown that MAPK (JNK, p38) and NFkB 
positively correlated to RUNX2 and OSX gene expressions. It was 
hypothesised that N90 enhanced osteogenesis through JNK and p38 
MAPK activation. NFκB was produced to control oxidative stress and 
inflammation. In conclusion, N90 enhances osteogenesis though 
multiple pathways with low levels of ROS and inflammation. 
7.2.4 Cell-hydrogel-sponge composite potential for clinical use  
From our study, we proposed the CHSC to use with the NS bioreactor. 
CHSCs are reproducible and handlable in the clinic. CHSCs allowed NS 
force transmission and produced reliable stimulating amplitudes. 
Contracted CHSCs did not adversely effect MSC viability. Temporal 
gene studies showed that NS promoted osteogenesis corresponding to 
the normal osteogenic pattern. It was found that 2 week-NS in CHSCs 
possibly maintained osteogenic phenotype. The results can be used to 
develop the NS protocol for osteogenic induction without phenotypic 
reversibility and could be useful in in vivo studies and clinics in the 
future.  
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Appendix I  
Protein antibody microarray 
Processed by Dr Marc Antoni Fernandez-Yague, Centre for Research in 
Medical devices, National University of Ireland, Galway. 
Protein samples were labeled with Alexa Fluor 555 carboxylic acid 
succinimidyl ester (Life Technologies, CA, USA). Excess label was 
removed and buffer was exchanged with PBS, pH 7.4, by 
centrifugation through 3 kDa molecular weight cutoff filters. 
Absorbance at 555 and 280 nm was measured for labeled samples and 
calculations were performed according to the manufacturer’s 
instructions using an arbitrary extinction coefficient of 100 000 and 
molecular mass of 100 000 to enable quantification of relative protein 
concentration and label substitution efficiency. All commercial 
antibodies (Table AI.1) were buffer exchanged into PBS and 
quantified by bicinchoninic acid (BCA) assay. Antibodies were diluted 
to print concentration in PBS and printed in six replicates on Nexterion 
H amine reactive, hydrogel coated glass slides (Schott AG, Mainz, 
Germany) using a SciFLEXARRAYER S3 piezoelectric printer (Scienion, 
Berlin, Germany) under constant humidity (62% +/− 2%) at 20°C. Each 
feature was printed using ≈1 nL of diluted antibody using an uncoated 
90 µm glass nozzle with eight replicated subarrays per microarray 
slide. After printing, slides were incubated in a humidity chamber 
overnight at room temperature to facilitate complete conjugation. 
The slides were then blocked in 100 × 10−3 m ethanolamine in 50 × 10−3 
m sodium borate, pH 8.0, for 1 h at room temperature. Slides were 
washed in PBS with 0.05% Tween 20 (PBS-T) three times for 2 minutes 
each wash followed by one wash in PBS, dried by centrifugation (470 
× g, 5 min), and then stored with desiccant at 4 °C until use. 
Incubations were carried out in the dark. Microarray slides were 
incubated essentially as previously described. Initially, one labeled 
sample was titrated (2.5–15 µg mL−1) for optimal signal to noise ratio 
and all samples were subsequently incubated for 1 h at 23 °C at 9 µg 
mL−1 in Tris-buffered saline (TBS; 20 × 10−3 m Tris-HCl, 100 × 10−3 m 
NaCl, 1 × 10−3 m CaCl2, 1 × 10−3 m MgCl2, pH 7.2) with 0.05% Tween 20 
(TBS-T). All microarray experiments were carried out using three 
replicate slides. Alexa Fluor 555 labeled mesenchymal stem cells 
lysate (10 µg mL−1) were incubated in two separate subarrays on every 
slide to confirm retained antibody performance and printing, 
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respectively. After incubation, slides were washed three times in TBS-
T for 2 minutes per wash, once in TBS and then centrifuged dry as 
above. Dried slides were scanned immediately on an Agilent G2505 
microarray scanner using the Cy3 channel (532 nm excitation, 90% 
photomultiplier tubes (PMT), 5 µm resolution) and the intensity data 
were saved as a .tif file. Antibody microarrays were verified to remain 
active for at least 2 weeks after printing, and all incubations were 
carried out within that timeframe. Data extraction from .tif files was 
performed essentially as previously described. Data were normalized 
to the mean of three replicate microarray slides (subarray-by-
subarray using subarray total intensity, n = 3, 18 data points).  
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 Table AI. 1 List of commercial antibodies used in the protein antibody microarray 
Probe 
Concentration 
(mg/mL) 
Information Company 
Stock conc 
(mg/mL) 
Cat. no. Lot Species 
Integrin β1 1 
Integrin β1 [EPR1040Y] 100μl (0.157 
mg/ml) 
Abcam® 3.54 ab134179 GR97005-9 Rabbit 
Integrin β3 0.1 Integrin β3 [crc54] Abcam® 0.17 ab34409 GR31565-1 Rabbit 
Integrin β5 <0.002 Integrin β5 Cell signalling® <0.002 D24A5 3629S Rabbit 
BMPR1A 1 BMPR1A 800 μg ThermoFisher® 12.71 PA5-11856 SH30123J  
Collagen I 1 
Collagen I [EPR7785] 100 μl (0.875 
mg/ml) 
Abcam® 1.72 ab138492 GR247379-29 Rabbit 
Collagen II 0.25 
Collagen II [2B1.5] 250 μl (0.2 
mg/ml) 
Abcam® 2.29 ab185430 GR322394-1 Mouse 
Collagen III 0.5 Collagen III  100 μg (1mg/ml) Abcam® 1.03 ab7778 GR312095-3 Rabbit 
Collagen V 1 Collagen V 100 μg (1mg/ml) Abcam® 1.86 ab7046 GR255156-3 Rabbit 
KCNK2 1 TREK-1 Antibody (C-20) SantaCruz® 4.84 sc-11557   
KCNK4 0.02 KCNK4 100 μl (0.5mg/ml) Abcam® 0.02 ab81367 GR193770-5 Rabbit 
TRPA1 0.5 ANKTM1 (C-19) SantaCruz® 5.45 sc-32353 - Goat 
TRPV1 1 VR1 (H-150) SantaCruz® 6.06 sc-20813 - Rabbit 
PIEZO1 1 PIEZO1 Antibody (N-15) SantaCruz® 3.13 sc-164319 - Goat 
PIEZO2 1 PIEZO2 Antibody (G-20) SantaCruz® 2.99 sc-84763 - Goat 
L-type Ca2+ 0.5 Anticorps L-type Ca2+ CP α1C (H-280) SantaCruz® 4.98 sc-25686 - Rabbit 
β-actin 
1, 0.25, 0.5, 0.75, 
2 
IBA1 WAKO® 2.56 019-19741 - Rabbit 
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Appendix II  
Metabolomic profile assessment  
Metabolite selection of glycolysis, PPP, TCA cycle, OXPHOS, L-, L-
aromatic amino acid, LC-PUFAs and -oxidation was performed. These 
metabolites were carried out using IDEOM. Metabolite intensities were 
then relatively compared as fold change. Statistical change and P-
value were calculated using Graphpad software. The summarized data 
is shown in Table AII.1. 
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Table AII. 1 Metabolite profile analysis at 1 and 2 weeks of NS 
Pathways week Metabolites Metabolite change Interpretation Figure 
Glycolysis 
1 Pyruvate (NS) - A1 
2 Pyruvate (T) N90 
NS may 
increase 
energy 
consumption 
A1 
1 Lactate (T) N30, N90 
NS may 
increase 
energy 
consumption 
A1 
2 Lactate (NS) - A1 
Pentose 
Phosphate 
Pathway 
(PPP) 
1 D-gluconic acid (T) N90 
NS may 
involve PPP 
A2 
2 D-gluconic acid (NS) - A2 
1 D-ribose (NS) - A2 
2 D-ribose (T) N30, N90 
NS may 
involve PPP 
A2 
TCA cycle 
1 Citrate (T) N90 NS effect A4 
1 Isocitrate (T) N90 NS effect A4 
1 Succinate (NS) - A4 
1 S-malate (T) N90 NS effect A4 
2 Succinate (NS) - A4 
OXPHOS 
1 Sn-Glycerol-3-phosphate (T) N30, N90 NS effect A5 
2 Sn-Glycerol-3-phosphate (T) N90 NS effect A5 
1 Orthophosphate (T) N90 NS effect A5 
L-, L-
aromatic 
amino acid 
1 L-alanine (T) N90 NS effect A6 
1,2 L-phynylalanine (NS) - A6 
1,2 L-tryptophan (NS) - A6 
LCPU-FAs 
1 Eicosapentaenoic acid (T) N30, N90 NS effect A8 
1 Docosapentaenoic acid (T) N90 NS effect A8 
1 Docosahexaenoic acid (T) N90 NS effect A8 
2 Eicosapentaenoic acid (T) N90 NS effect A8 
-oxidation 
1 Hexanoic acid (T) N90 NS effect A9 
1 
4-8 
dimethylnonanoylcarnitine 
(T) N90 NS effect A9 
1 O-propanoylcarnitine (NS) - A9 
2 Hexanoic acid (NS) - A9 
2 
4-8 
dimethylnonanoylcarnitine 
(T) N90 NS effect A9 
2 O-propanoylcarnitine (NS) - A9 
 decrease;  increase; (S) Statistic significance, (T) Trend, LC-PUFAs= long-
chain polyunsaturated fatty acid, NS= nanovibrational stimulation, 
OXPHOS=oxidative phosphorylation, PPP; Pentose phosphate pathway 
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Carbohydrate metabolism at 1 and 2 week.  
To study effect of NS on carbohydrate metabolism, metabolites 
involving the glycolysis pathway and TCA cycle were focused. It was 
found that there were no significant differences in the TCA cycle and 
glycolysis metabolites of NS group compared to control. Interestingly, 
lactate tended to increase in N90 at week 1 but reduced at week 2. 
Pyruvate tended to increase at week 2. This result indicated that MSCs 
still used glycolysis in N90 (Figure AII.1). Increase trend of ribose and 
gluconic acid indicated that PPP was involved (Figure AII.2-3). N90 
also involved TCA cycle (by increasing trend of citrate, isocitrate and 
malate in N90) (Figure AII.4). 
 
Figure AII. 1  Glycolysis and glucose metabolism 
In N90 group, pyruvate tended to increase at week 2 while 
lactate increased at week 1. The results indicated that MSCs 
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still produced energy via glycolysis (meanSD, n=4, * P≤ 0.5, ** 
P≤ 0.01, *** P≤ 0.001, one-way ANOVA, Tukey’s post hoc test). 
 
Figure AII. 2  Pentose phosphate pathway 
D-gluconic acid and D-ribose were increased in N90 at week 1 
and 2. The result may implied that PPP was involved in redox 
balancing during oxidative stress (meanSD, n=4, * P≤ 0.5, ** P≤ 
0.01, *** P≤ 0.001, one-way ANOVA, Tukey’s post hoc test). 
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Figure AII. 3  Pentose phosphate pathway KEGG pathway 
KEGG pathway shown shifting of glycolysis to pentose phosphate pathway (PPP). D-ribose and D-gluconate, which are PPP 
metabolites were identified in the map (n=4). 
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Figure AII. 4  TCA cycle metabolites. 
N90 tend to increase citrate, isocitrate and malate indicating that 
N90 involved in TCA cycle generating ATP. The increase of 
isocitrate may protect cells from oxidative stress (J. Yang et al., 
2017) (meanSD, n=4, * P≤ 0.5, ** P≤ 0.01, *** P≤ 0.001, one-way 
ANOVA, Tukey’s post hoc test). 
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Oxidative phosphorylation and nanovibrational 
stimulation 
It has been known that oxidative phosphorylation (OXPHOS) is important 
for stem cell differentiation (Atashi et al., 2015; Q. Q. Li et al., 2017). 
OXPHOS produces reactive oxygen species (ROS) which can damage cells 
and affect cell aging. However, the optimal level of ROS promotes 
osteogenesis (Shyh-Chang et al., 2013). From our results, nanovibrational 
stimulation showed slightly increase of glycerol-3-phosphate shuttle at 1 
week (Figure All.5) representing that nanovibration required rapid 
energy bypassing the complete OXPHOS process. Glycerol-3-phosphate 
shuttle is the junction linking the oxidative phosphorylation, glycolysis 
and fatty acid metabolism together (Mracek et al., 2013). Furthermore, 
the increase of orthophosphate level in N90 group was found. This 
represented that MSCs required higher energy during the stimulation. 
Orthophosphate is the metabolite involving in OXPHOS for ATP synthesis 
at complex V in mitochondria (Huttemann et al., 2007) (Figure AII.5). 
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Figure AII. 5  Oxidative phosphorylation metabolites. 
At 1 week stimulation, (A) sn-Glycerol-3-phosphate, which is a 
metabolite involving in glycerol-3-phosphate shuttle, slightly 
increased in N30 and N90 group. Glycerol-3-phosphate shuttle was 
activated requiring rapid energy production (bypass complex I of 
electron transport chain). (B) Orthophosphate level, involving 
complex V of OXPHOS, showed an increase trend in N90 group. It 
was hypothesized that nanovibrational stimulation increased lipid 
catabolism siphoning pathway through Glycerol-3-phosphate 
shuttle and in turn activated OXPHOS (Mracek et al., 2013; Nsiah-
Sefaa & McKenzie, 2016) (meanSD, n=4, * P≤ 0.5, ** P≤ 0.01, *** P≤ 
0.001, one-way ANOVA, Tukey’s post hoc test). 
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Amino acid metabolism: Roles of L-type, L-aromatic 
amino acid and calcium sensing receptor at 1 and 2 
weeks.   
To further explore the effect of nanovibrational stimulation, L-type and 
L-aromatic amino acids which might linked to osteogenic differentiation 
through Calcium sensing receptor (CaSR) (Conigrave et al., 2007) were 
studied. CaSR is a G-protein coupled receptor class III which responds to 
extracellular amino acid change (Conigrave & Hampson, 2006). 
Therefore, if L- or L-aromatic amino acid increases, CaSR in turn is 
possibly upregulated. However, it was found that only L-alanine (Figure 
AII.6) showed the increase trend after N90 which corresponded to CaSR 
gene upregulation showing in chapter 4 (Figure 4.17).  
 
Figure AII. 6  L- and L-aromatic amino acid. 
L- and L-aromatic amino acid associating to CaSR. Only, L-alanine  
showed the significant upregulation after N90 for 1 week (A) 
(meanSD, n=4, * P≤ 0.5, ** P≤ 0.01, *** P≤ 0.001, one-way ANOVA, 
Tukey’s post hoc test).  
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Glutamine and aspartate  
Glutamine and aspatate also play a role in reducing oxidative stress (J. 
Duan et al., 2016; Mates et al., 2002). The increase trend of glutamine 
and aspartate were noted in N90 group at 1 week (Figure AII.7).  
 
Figure AII. 7  Glutamine and aspartate 
The increase of glutamine and aspartate indicates that MSCs 
possibly produce these metabolites protecting cells from oxidative 
stress (meanSD, n=4, * P≤ 0.5, ** P≤ 0.01, *** P≤ 0.001, one-way 
ANOVA, Tukey’s post hoc test). 
Lipid metabolism: Long-chain polyunsaturated fatty 
acids and nanovibrational stimulation at 1 and 2 weeks.  
Many literatures support the effect of long-chain polyunsaturated fatty 
acid (LCPU-FAs) metabolism on osteoblast proliferation and 
differentiation (Burke & Weiler, 2002; Damsgaard, Molgaard, 
Matthiessen, Gyldenlove, & Lauritzen, 2012; Jeromson et al., 2015; 
Kruger et al., 2010; Watkins, Li, Lippman, & Feng, 2003). Therefore, 
LCPU-FAs metabolites including eicosapentaenoic acid (EPA), 
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docosapentaenoic acid (DPA) and docohexanoic acid (DHA) were studied 
at 1 and 2 weeks. The slightly increase of LCPU-FAs was found in N30 and 
N90 groups at 1 and 2 weeks (Figure AII.8). 
To link the effect of NS with cellular energy consumption through lipid 
metabolism, lipid metabolites relating to -oxidation were therefore 
considered. It was found that NS increased hexanoic acid and 4-8 
dimethylnonanoyl carnitine while there was no change of O-
propanoylcarnitine (or Propionyl L-carnitine) levels (Figure AII.9).  
 
Figure AII. 8  Long chain poly unsaturated fatty acids 
Metabolites of LCPU-FAs were studied. Increasing trend of PUFAs 
synthesis was found in both N30 and N90 stimulations (meanSD, 
n=4, * P≤ 0.5, ** P≤ 0.01, *** P≤ 0.001, one-way ANOVA, Tukey’s 
post hoc test). 
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Figure AII. 9  -oxidation of lipids 
NS increased hexanoic acid and dimethylnonanoylcartinine levels. 
This evidence possibly implied that cells required more ATPs via 
fatty acid oxidation responded to NS. No change of O-
propanoylcarnitine was found (meanSD, n=4, * P≤ 0.5, ** P≤ 0.01, 
*** P≤ 0.001, one-way ANOVA, Tukey’s post hoc test). 
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Appendix III  
Compression test 
After 5% collagen sponges were prepared (n=9), compression tests were 
then performed. Stress-strain graph were plotted to identify the elastic 
range of sponges. The slopes of the selected linear range (0.05-0.1 of 
strain) were calculated representing Young’s modulus (material 
stiffness, mPA) (Figure Alll.1, Table AIII.1).   
 
Figure AIII. 1  Stress-strain plot of compression test 
Graph plotted between force (N) and changing (delta) length (mm) 
of compression test study. Linear relationship of the stress-strain 
graphs was identified which indicated the elastic range of collagen 
sponge. The range of altered length from 0.05- 0.1 of strain (ΔL/L0) 
were chosen for Young’s modulus calculation (asterix; selected 
range for Young’s modulus calculation).  
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Table AIII. 1 Young modulus (MPa) of each sample 
Samples 
Young modulus  
(Elastic modulus, MPa) 
S1 1.705 
S2 1.105 
S3 0.893293 
S4 1.251 
S5 1.22 
S6 1.001 
S7 1.051 
S8 0.769168 
S9 0.704246 
Ave 1.077745222 
SD 0.299957153 
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